- Friday, October 14, 2022
12:00 PM – 5:00 PM ET
Registration Hours
12:00 PM – 5:00 PM ET
Registration Hours
Location:North Lobby
1:00 PM – 5:00 PM ET
Exhibitor Move-In (Booths 300 SF or larger)
1:00 PM – 5:00 PM ET
Exhibitor Move-In (Booths 300 SF or larger)
Location:Exhibit Hall A&B
- Saturday, October 15, 2022
7:30 AM – 5:00 PM ET
Registration Hours
7:30 AM – 5:00 PM ET
Registration Hours
Location:North Lobby
8:00 AM – 5:00 PM ET
Exhibitor Move-In
8:00 AM – 5:00 PM ET
Exhibitor Move-In
Location:Exhibit Hall A&B
- Sunday, October 16, 2022
7:00 AM – 7:00 PM ET
Registration Hours
7:00 AM – 7:00 PM ET
Registration Hours
Location:North Lobby
8:00 AM – 5:00 PM ET
Exhibitor Move-In
8:00 AM – 5:00 PM ET
Exhibitor Move-In
Location:Exhibit Hall A&B
9:00 AM – 1:00 PM ET
Business Development Advisory Board (by invitation only)
9:00 AM – 1:00 PM ET
Business Development Advisory Board (by invitation only)
Location:Harbor 1, Westin Boston Seaport District Hotel
12:00 PM – 4:00 PM ET
Speaker Ready Room
12:00 PM – 4:00 PM ET
Speaker Ready Room
Location:252 AB
5:00 PM – 6:30 PM ET
Opening Plenary with Tim Urban & Awards CelebrationPlenary Speaker: – Wait But Why
5:00 PM – 6:30 PM ET
Opening Plenary with Tim Urban & Awards CelebrationLocation:Grand Ballroom, Boston Convention and Exhibition CenterPlenary Speaker: – Wait But Why
Tim Urban – Wait But Why ### 1718681###Plenary Speaker###Celebrated Blogger###Wait But Why###Plenary Speaker: – Wait But Why
### 6:30 PM – 8:00 PM ET
Welcome Reception
6:30 PM – 8:00 PM ET
Welcome ReceptionLocation:Grand Ballroom & Pavilion, Westin Boston Seaport District Hotel
8:00 PM – 9:30 PM ET
ASIPS (American Society of Iranian Pharmaceutical Scientists) Annual Meeting
8:00 PM – 9:30 PM ET
ASIPS (American Society of Iranian Pharmaceutical Scientists) Annual MeetingLocation:Harbor Ballroom 3, Westin Boston Seaport District Hotel
- Monday, October 17, 2022
7:00 AM – 8:30 AM ET
Exploring funding opportunities and considerations within current capital markets
7:00 AM – 8:30 AM ET
Exploring Funding Opportunities and Considerations Within Current Capital MarketsLocation:153 BCModerator: – Rutgers University
Executive Education Speaker: – Ampersand Capital Partners
Executive Education Speaker: – EverGlade Consulting
Executive Education Speaker: – Nevakar, Inc
Patrick J. Sinko, PhD – Rutgers University ### 602328###Moderator###Distinguished Professor###Rutgers University###Moderator: – Rutgers University
### @@@ Dave Patteson – Ampersand Capital Partners ### 1794643###Executive Education Speaker###Partner###Ampersand Capital Partners###Executive Education Speaker: – Ampersand Capital Partners
### @@@ Andrew Stiles – EverGlade Consulting ### 1779402###Executive Education Speaker###Principal###EverGlade Consulting###Executive Education Speaker: – EverGlade Consulting
### @@@ Navneet Puri, PhD (he/him/his) – Nevakar, Inc ### 1794644###Executive Education Speaker###Chairman, Founder & President###Nevakar, Inc###Executive Education Speaker: – Nevakar, Inc
### he/him/his7:30 AM – 8:30 AM ET
The Journals of AAPS Editorial Board Breakfast (by invitation only)
7:30 AM – 8:30 AM ET
The Journals of AAPS Editorial Board Breakfast (by invitation only)Location:Douglas Room, Westin Boston Seaport District Hotel
7:30 AM – 5:00 PM ET
Registration Hours
7:30 AM – 5:00 PM ET
Registration Hours
Location:North Lobby
7:30 AM – 5:00 PM ET
Speaker Ready Room
7:30 AM – 5:00 PM ET
Speaker Ready Room
Location:252 AB
8:30 AM – 9:00 AM ET
Prologue: An Evolving Biologics Landscape Driving Innovation and OptimizationPrologue Speaker: – Merck
Preclinical Development – Biomolecular
8:30 AM – 9:00 AM ET
Prologue: An Evolving Biologics Landscape Driving Innovation and OptimizationLocation:254 APrologue Speaker: – Merck
Preclinical Development – Biomolecular
Robert S. Foti, PhD – Merck ### 1759594###Prologue Speaker###Senior Director - Bioanalysis, ADME & Discovery Toxicology###Merck###Prologue Speaker: – Merck
### 8:30 AM – 9:00 AM ET
Prologue: Analytical Challenges for Biomolecules Prologue Speaker: – AbbVie
Manufacturing & Analytical Characterization – Biomolecular
8:30 AM – 9:00 AM ET
Prologue: Analytical Challenges for Biomolecules Location:205 CPrologue Speaker: – AbbVie
Manufacturing & Analytical Characterization – Biomolecular
Paul Logan Walsh, PhD – AbbVie ### 846991###Prologue Speaker###Director###AbbVie###Prologue Speaker: – AbbVie
### 8:30 AM – 9:00 AM ET
Prologue: Can Computers Accelerate the Discovery of New Drugs? Comments From a Sarcastic but Optimistic Computational ChemistPrologue Speaker: – University of North Carolina
Discovery and Basic Research
8:30 AM – 9:00 AM ET
Prologue: Can Computers Accelerate the Discovery of New Drugs? Comments From a Sarcastic but Optimistic Computational ChemistLocation:254 BPrologue Speaker: – University of North Carolina
Discovery and Basic Research
Alexander Tropsha, PhD – University of North Carolina ### 1695022###Prologue Speaker###KH Lee Distinguished Professor###University of North Carolina ###Prologue Speaker: – University of North Carolina
### 8:30 AM – 9:00 AM ET
Prologue: Challenges and Opportunities During COVID-19 Pandemic and its Impact on Clinical Trials: A Clinical Pharmacology PerspectivePrologue Speaker: – Gilead Sciences
Clinical Pharmacology – Chemical
8:30 AM – 9:00 AM ET
Prologue: Challenges and Opportunities During COVID-19 Pandemic and its Impact on Clinical Trials: A Clinical Pharmacology PerspectiveLocation:151 ABPrologue Speaker: – Gilead Sciences
Clinical Pharmacology – Chemical
Sandhya Girish, M.Pharm, PhD – Gilead Sciences ### 1718494###Prologue Speaker###Vice President, Head Clinical Pharmacology, Bioanalytical & Pharmacometrics###Gilead Sciences###Prologue Speaker: – Gilead Sciences
### 8:30 AM – 9:00 AM ET
Prologue: Immunogenicity of AAV Vectors in Gene TherapyGovernment Speaker: – U.S. Food and Drug Administration
Bioanalytics – Biomolecular
8:30 AM – 9:00 AM ET
Prologue: Immunogenicity of AAV Vectors in Gene TherapyLocation:253 BGovernment Speaker: – U.S. Food and Drug Administration
Bioanalytics – Biomolecular
Ronit Mazor, Ph.D. – U.S. Food and Drug Administration ### 1216533###Government Speaker###Principal investigator, Gene Transfer and Immunogenicity Branch###U.S. Food and Drug Administration###Government Speaker: – U.S. Food and Drug Administration
### 8:30 AM – 9:00 AM ET
Prologue: Modeling and Predictive Design in Pharmaceutical DevelopmentManufacturing & Analytical Characterization – Chemical
8:30 AM – 9:00 AM ET
Prologue: Modeling and Predictive Design in Pharmaceutical DevelopmentLocation:206 ABManufacturing & Analytical Characterization – Chemical
Sayantan Chattoraj, Ph.D. – GSK ### 828674###Prologue Speaker###Director & GSK Fellow, Drug Product Development###GSK###Prologue Speaker: – GSK
### 8:30 AM – 9:00 AM ET
Prologue: Pharmacokinetics and Interaction Implications for LNP TherapyPrologue Speaker: – Moderna Therapeutics
Formulation and Delivery – Biomolecular
8:30 AM – 9:00 AM ET
Prologue: Pharmacokinetics and Interaction Implications for LNP TherapyLocation:204 ABPrologue Speaker: – Moderna Therapeutics
Formulation and Delivery – Biomolecular
Douglas Burdette, Ph.D. – Moderna Therapeutics ### 1718882###Prologue Speaker###Director, DMPK###Moderna Therapeutics###Prologue Speaker: – Moderna Therapeutics
### 8:30 AM – 9:00 AM ET
Prologue: PRiME: A Vision for Accelerating Academic Drug DiscoveryPrologue Speaker: – University of Toronto
Preclinical Development – Chemical
8:30 AM – 9:00 AM ET
Prologue: PRiME: A Vision for Accelerating Academic Drug DiscoveryLocation:253 CPrologue Speaker: – University of Toronto
Preclinical Development – Chemical
Carolyn Cummins, Ph.D. – University of Toronto ### 1446757###Prologue Speaker###Associate Professor###University of Toronto###Prologue Speaker: – University of Toronto
### 8:30 AM – 9:00 AM ET
Prologue: Smaliobiotideocules: Where Do Small Molecules End and Large Molecules Start?Prologue Speaker: – Veloxity Labs, LLC
Bioanalytics – Chemical
8:30 AM – 9:00 AM ET
Prologue: Smaliobiotideocules: Where Do Small Molecules End and Large Molecules Start?Location:253 APrologue Speaker: – Veloxity Labs, LLC
Bioanalytics – Chemical
Shane Needham, Ph.D. – Veloxity Labs, LLC ### 1611936###Prologue Speaker###Founder, President and CEO###Veloxity Labs, LLC###Prologue Speaker: – Veloxity Labs, LLC
### 8:30 AM – 9:00 AM ET
Prologue: Systems and Clinical Pharmacology of Covid-19 Therapeutic Candidates: A Clinical and Translational Medicine Perspective Prologue Speaker: – University of Washington
Clinical Pharmacology – Biomolecular
8:30 AM – 9:00 AM ET
Prologue: Systems and Clinical Pharmacology of Covid-19 Therapeutic Candidates: A Clinical and Translational Medicine Perspective Location:152Prologue Speaker: – University of Washington
Clinical Pharmacology – Biomolecular
Simone Perazzolo, PhD – University of Washington ### 1695214###Prologue Speaker###Scientist###University of Washington###Prologue Speaker: – University of Washington
### 8:30 AM – 9:00 AM ET
Prologue: The Elimination of Biochemical and Immunological Barriers in the Tumor Microenvironment to Improve Cancer ImmunotherapyPrologue Speaker: – Northeastern University
Discovery and Basic Research
8:30 AM – 9:00 AM ET
Prologue: The Elimination of Biochemical and Immunological Barriers in the Tumor Microenvironment to Improve Cancer ImmunotherapyLocation:255Prologue Speaker: – Northeastern University
Discovery and Basic Research
Stephen Hatfield, PhD – Northeastern University ### 1691763###Prologue Speaker###Assistant Professor###Northeastern University ###Prologue Speaker: – Northeastern University
### 8:30 AM – 4:00 PM ET
Guest Tour: The North Shore of Boston (additional fee required)
8:30 AM – 4:00 PM ET
Guest Tour: The North Shore of Boston (additional fee required)Location:Meet in Lobby of Westin at 8:45 am
8:30 AM – 4:30 PM ET
Coffee Station
8:30 AM – 4:30 PM ET
Coffee StationLocation:Booth #1344, Exhibit Hall A&B
8:30 AM – 4:30 PM ET
Free Professional Headshots
8:30 AM – 4:30 PM ET
Free Professional HeadshotsLocation:Career Development Center, Exhibit Hall A&B
8:30 AM – 4:30 PM ET
LinkedIn Profile Critiques & Resume Reviews
8:30 AM – 4:30 PM ET
LinkedIn Profile Critiques & Resume ReviewsLocation:Career Development Center, Exhibit Hall A&B
8:30 AM – 5:00 PM ET
Solution Center Hours & Poster Presentations
8:30 AM – 5:00 PM ET
Solution Center Hours & Poster PresentationsLocation:Exhibit Hall A&B
9:00 AM – 10:00 AM ET
Hot Topic: Current Learnings From Diverse Global Immune Responses to COVID-19 VaccinesHot Topic Speaker: – Mercer University
Hot Topic Speaker: – Mercer University College of Pharmacy
Hot Topic Moderator: – Moderna Therapeutics
Discovery and Basic Research
9:00 AM – 10:00 AM ET
Hot Topic: Current Learnings From Diverse Global Immune Responses to COVID-19 VaccinesLocation:153 AHot Topic Speaker: – Mercer University
Hot Topic Speaker: – Mercer University College of Pharmacy
Hot Topic Moderator: – Moderna Therapeutics
Discovery and Basic Research
Sharon Vijayanand, B. Pharm – Mercer University ### 1045775###Hot Topic Speaker###Ph.D. Candidate###Mercer University###Hot Topic Speaker: – Mercer University
### @@@ Smital R. Patil, Bachelor of Pharmacy – Mercer University College of Pharmacy ### 1045776###Hot Topic Speaker###Ph.D Candidate###Mercer University College of Pharmacy###Hot Topic Speaker: – Mercer University College of Pharmacy
### @@@ Satish Singh – Moderna Therapeutics ### 1650363###Hot Topic Moderator###Vice President###Moderna Therapeutics###Hot Topic Moderator: – Moderna Therapeutics
### 9:00 AM – 10:00 AM ET
The Skills You Need to be a Pharmaceutical ConsultantCareer Center Moderator: – Certara
Career Center Moderator: – Certara
Career Center Speaker: – Certara
Career Center Speaker: – Simulations Plus, Inc., Cognigen division
Career Center Speaker: – Simulations Plus
Career Center Speaker: – qPharmetra
Career Development
9:00 AM – 10:00 AM ET
The Skills You Need to be a Pharmaceutical ConsultantLocation:360 Stage #3, Exhibit Hall A&BCareer Center Moderator: – Certara
Career Center Moderator: – Certara
Career Center Speaker: – Certara
Career Center Speaker: – Simulations Plus, Inc., Cognigen division
Career Center Speaker: – Simulations Plus
Career Center Speaker: – qPharmetra
Career Development
Suzanne Minton, PhD – Certara ### 1650327###Career Center Moderator###Director, Content Strategy###Certara###Career Center Moderator: – Certara
### @@@ Mark Lovern, PhD – Certara ### 1650338###Career Center Moderator###Senior Vice President###Certara###Career Center Moderator: – Certara
### @@@ Dave Mitchell, PhD – Certara ### 1650339###Career Center Speaker###Senior Vice President###Certara###Career Center Speaker: – Certara
### @@@ Jill Fiedler-Kelly, MS, FISoP – Simulations Plus, Inc., Cognigen division ### 1777569###Career Center Speaker###President###Simulations Plus, Inc., Cognigen division###Career Center Speaker: – Simulations Plus, Inc., Cognigen division
### @@@ Alexander Berg, PharmD, PhD, FCP – Simulations Plus ### 1777570###Career Center Speaker###Vice President, Operations###Simulations Plus###Career Center Speaker: – Simulations Plus
### @@@ Ben Suttle, PhD – qPharmetra ### 1777571###Career Center Speaker###Principal Clinical Pharmacologist###qPharmetra###Career Center Speaker: – qPharmetra
### 9:00 AM – 10:00 AM ET
Understanding Formulation Challenges Early to Accelerate Timelines for FIH TrialsPartner Presentation Speaker: – Charles River Laboratories
Partner Presentation Speaker: – Charles River Laboratories
Preclinical Development
9:00 AM – 10:00 AM ET
Understanding Formulation Challenges Early to Accelerate Timelines for FIH TrialsLocation:360 Stage #1, Exhibit Hall A&BPartner Presentation Speaker: – Charles River Laboratories
Partner Presentation Speaker: – Charles River Laboratories
Preclinical Development
Presented By Charles River
Russell Scammell – Charles River Laboratories ### 1743113###Partner Presentation Speaker###Director Small Molecule Drug Discovery###Charles River Laboratories###Partner Presentation Speaker: – Charles River Laboratories
### @@@ Darren Matthews – Charles River Laboratories ### 1743114###Partner Presentation Speaker###Research Leader###Charles River Laboratories###Partner Presentation Speaker: – Charles River Laboratories
### 9:00 AM – 10:30 AM ET
Symposium: Analytical and Predictive Approaches in Drug Development and Manufacturing (CE)Manufacturing & Analytical Characterization – Chemical
9:00 AM – 10:30 AM ET
Symposium: Analytical and Predictive Approaches in Drug Development and Manufacturing (CE)Location:206 ABManufacturing & Analytical Characterization – Chemical
Sayantan Chattoraj, Ph.D. – GSK ### 828674###Moderator###Director & GSK Fellow, Drug Product Development###GSK###Moderator: – GSK
### 9:00 AM – 9:30 AM ET
Interplay between ML and Physics-Based Modeling Frameworks for Higher Fidelity and Deeper Structural InsightsLocation:206 ABManufacturing & Analytical Characterization – Chemical
Ahmad Sheikh, Ph.D – AbbVie ### 602532###Speaker###Senior Research Fellow###AbbVie###Speaker: – AbbVie
### 9:30 AM – 10:00 AM ET
Experimentally Validated Multiscale Modeling of Continuous Manufacturing of Complex InjectablesLocation:206 ABSpeaker: – University of Connecticut
Manufacturing & Analytical Characterization – Chemical
Bodhi Chaudhuri, Ph.D – University of Connecticut ### 603204###Speaker###Professor###University of Connecticut###Speaker: – University of Connecticut
### 10:00 AM – 10:30 AM ET
Accelerate Manufacturing Processes Development with Computational ChemistryLocation:206 ABSpeaker: – Hovione FarmaCiencia SA
Manufacturing & Analytical Characterization – Chemical
Luís M. Sobral, BS, MS – Hovione FarmaCiencia SA ### 1045417###Speaker###Fellow Scientist###Hovione FarmaCiencia SA###Speaker: – Hovione FarmaCiencia SA
### 9:00 AM – 10:30 AM ET
Symposium: COVID Pandemic and Beyond: Role of Clinical Pharmacology in Development of Non-COVID and COVID Drugs (BM)Clinical Pharmacology – Biomolecular
9:00 AM – 10:30 AM ET
Symposium: COVID Pandemic and Beyond: Role of Clinical Pharmacology in Development of Non-COVID and COVID DrugsLocation:152Clinical Pharmacology – Biomolecular
Nimita Dave, PhD – Nimbus Therapeutics ### 1650370###Moderator###Director, Clinical Pharmacology###Nimbus Therapeutics###Moderator: – Nimbus Therapeutics
### 9:00 AM – 9:30 AM ET
Role of Clinical Pharmacology in the Development of COVID-19 TherapeuticsLocation:152Speaker: – Regeneron Pharmaceuticals
Clinical Pharmacology – Biomolecular
Kenneth Turner, PhD – Regeneron Pharmaceuticals ### 1650345###Speaker###Sr Group Director, Clinical Pharmacology###Regeneron Pharmaceuticals###Speaker: – Regeneron Pharmaceuticals
### 9:30 AM – 10:00 AM ET
Role of Clinical Pharmacology in the Development of COVID-19 TherapeuticsLocation:152Clinical Pharmacology – Biomolecular
Bharat Damle, PhD – Pfizer ### 845568###Speaker###Executive Director###Pfizer###Speaker: – Pfizer
### 10:00 AM – 10:30 AM ET
Model Informed Drug Development of mRNA Vaccines: To COVID and BeyondLocation:152Speaker: – Moderna Therapeutics
Clinical Pharmacology – Biomolecular
Stephen A. Greene, PharmD – Moderna Therapeutics ### 1686435###Speaker###Associated Scientific Director, Clinical Pharmacology and Pharmacometrics###Moderna Therapeutics###Speaker: – Moderna Therapeutics
### 9:00 AM – 10:30 AM ET
Symposium: COVID Pandemic and Beyond: Role of Clinical Pharmacology in Development of Non-COVID and COVID Drugs (CE)Moderator: – Gilead Sciences
Clinical Pharmacology – Chemical
9:00 AM – 10:30 AM ET
Symposium: COVID Pandemic and Beyond: Role of Clinical Pharmacology in Development of Non-COVID and COVID Drugs (CE)Location:151 ABModerator: – Gilead Sciences
Clinical Pharmacology – Chemical
Sandhya Girish, M.Pharm, PhD – Gilead Sciences ### 1718494###Moderator###Vice President, Head Clinical Pharmacology, Bioanalytical & Pharmacometrics###Gilead Sciences###Moderator: – Gilead Sciences
### 9:00 AM – 9:30 AM ET
Adapting a Controlled Infection Model Trial Interrupted by COVID19 PandemicLocation:151 ABGovernment Speaker: – NIH/NIAID
Clinical Pharmacology – Chemical
Richard Wu, MD – NIH/NIAID ### 1650355###Government Speaker###Staff Clinician###NIH/NIAID###Government Speaker: – NIH/NIAID
### 9:30 AM – 10:00 AM ET
Successful Development of siRNA, Vutrisiran, During COVID PandemicLocation:151 ABSpeaker: – Alnylam Pharmaceuticals
Clinical Pharmacology – Chemical
Gabriel Robbie, PhD – Alnylam Pharmaceuticals ### 1686438###Speaker###Senior Vice President###Alnylam Pharmaceuticals###Speaker: – Alnylam Pharmaceuticals
### 10:00 AM – 10:30 AM ET
Perspectives on the MIDD Aspects in Development of New Drugs During the COVID-19 PandemicLocation:151 ABGovernment Speaker: – FDA
Clinical Pharmacology – Chemical
Eliford Ngaimisi Kitabi, PhD – FDA ### 1686439###Government Speaker###Pharmacometrics reviewer###FDA###Government Speaker: – FDA
### 9:00 AM – 10:30 AM ET
Symposium: Recent Development in Prophylactic Therapies and Vaccines (BM)Moderator: – Moderna Therapeutics
Formulation and Delivery – Biomolecular
9:00 AM – 10:30 AM ET
Symposium: Recent Development in Prophylactic Therapies and Vaccines (BM)Location:204 ABModerator: – Moderna Therapeutics
Formulation and Delivery – Biomolecular
Douglas Burdette, Ph.D. – Moderna Therapeutics ### 1718882###Moderator###Director, DMPK###Moderna Therapeutics###Moderator: – Moderna Therapeutics
### 9:00 AM – 9:30 AM ET
Addressing Global Health and Pandemic Threats by Microneedle Patch VaccinationLocation:204 ABSpeaker: – Georgia Institute of Technology
Formulation and Delivery – Biomolecular
Mark R. Prausnitz, PhD – Georgia Institute of Technology ### 605551###Speaker###Regents’ Professor###Georgia Institute of Technology###Speaker: – Georgia Institute of Technology
### 9:30 AM – 10:00 AM ET
Eliminating the Freeze: Vaccine Production is a Breeze with Thermostable FilmLocation:204 ABSpeaker: – University of Texas at Austin
Formulation and Delivery – Biomolecular
Maria A. Croyle, Ph.D. – University of Texas at Austin ### 1377356###Speaker###Glaxo Wellcome Professor of Pharmaceutics###University of Texas at Austin###Speaker: – University of Texas at Austin
### 10:00 AM – 10:30 AM ET
Thermal Stabilization of Biopharmaceuticals Using EnsilicationLocation:204 ABSpeaker: – University of Bath
Formulation and Delivery – Biomolecular
Asel Sartbaeva, PhD(Cantab) – University of Bath ### 1691767###Speaker###Associate Professor in Chemistry###University of Bath###Speaker: – University of Bath
### 9:00 AM – 11:00 AM ET
Symposium: Analytical and Predictive Approaches in Drug Development and Manufacturing (BM)Manufacturing & Analytical Characterization – Biomolecular
9:00 AM – 11:00 AM ET
Symposium: Analytical and Predictive Approaches in Drug Development and Manufacturing (BM)Location:205 CManufacturing & Analytical Characterization – Biomolecular
Paul Logan Walsh, PhD – AbbVie ### 846991###Moderator###Director###AbbVie###Moderator: – AbbVie
### 9:00 AM – 9:30 AM ET
Microrheology of Biomolecular SolutionsLocation:205 CSpeaker: – University of Delaware
Manufacturing & Analytical Characterization – Biomolecular
Eric M. Furst, PhD – University of Delaware ### 1666001###Speaker###Professor###University of Delaware###Speaker: – University of Delaware
### 9:30 AM – 10:00 AM ET
Design of Biopharmaceutical Formulations Accelerated by Machine LearningLocation:205 CManufacturing & Analytical Characterization – Biomolecular
Harini Narayanan, MSc, PhD – MIT ### 1773702###Speaker###Postdoctoral associate###MIT###Speaker: – MIT
### 10:00 AM – 10:30 AM ET
Frozen State Protein Aggregation and its Impact on Process DevelopmentLocation:205 CManufacturing & Analytical Characterization – Biomolecular
Bharat Jagannathan, PhD – Amgen ### 1011706###Speaker###Principal Scientist###Amgen###Speaker: – Amgen
### 10:30 AM – 11:00 AM ET
2D-NMR for Higher Order Structure Assessment of Forced Degraded AntibodiesLocation:205 CManufacturing & Analytical Characterization – Biomolecular
Nithya Srinivasan, PhD – Amgen ### 1601015###Speaker###Sr Scientist###Amgen###Speaker: – Amgen
### 9:00 AM – 11:00 AM ET
Symposium: Beyond Legacy Therapeutics - Navigating the Path Less Traveled (BM)Moderator: – BioAgilytix Labs
Bioanalytics – Biomolecular
9:00 AM – 11:00 AM ET
Symposium: Beyond Legacy Therapeutics - Navigating the Path Less Traveled (BM)Location:253 BModerator: – BioAgilytix Labs
Bioanalytics – Biomolecular
Lynn Kamen, PhD – BioAgilytix Labs ### 1680382###Moderator###Scientific Officer###BioAgilytix Labs###Moderator: – BioAgilytix Labs
### 9:00 AM – 9:30 AM ET
Anti-AAV Pre-Existing Antibody Assays for Patient Enrollment: Format, Concordance and Clinical SensitivityLocation:253 BSpeaker: – Sangamo Therapeutics
Bioanalytics – Biomolecular
Yanmei Lu, PhD – Sangamo Therapeutics ### 1650349###Speaker###VP of Biomarker and BioAnalytical Sciences###Sangamo Therapeutics###Speaker: – Sangamo Therapeutics
### 9:30 AM – 10:00 AM ET
Characterization of Early Immune Response to AAV Capsid; Case StudiesLocation:253 BBioanalytics – Biomolecular
John Kamerud, PhD – Pfizer ### 627136###Speaker###Director###Pfizer###Speaker: – Pfizer
### 10:00 AM – 10:30 AM ET
Characterizing Pre/Post Anti Capsid Immune-Response to Establish a Treatment-Emergent CriterionLocation:253 BBioanalytics – Biomolecular
Yanshan Dai, PhD – BMS ### 604744###Speaker###Senior Principal Scientist###BMS###Speaker: – BMS
### 10:30 AM – 11:00 AM ET
Designing a Cellular Immunogenicity Strategy for AAV Mediated ImmunityLocation:253 BBioanalytics – Biomolecular
Mitra Azadeh, PhD – Alkermes ### 1650351###Speaker###Director, Biomarker Operations, Translational Medicine & ESCD###Alkermes###Speaker: – Alkermes
### 9:00 AM – 11:00 AM ET
Symposium: Beyond Legacy Therapeutics - Navigating the Path Less Traveled (CE)Moderator: – Bristol-Myers Squibb
Bioanalytics – Chemical
9:00 AM – 11:00 AM ET
Symposium: Beyond Legacy Therapeutics - Navigating the Path Less Traveled (CE)Location:253 AModerator: – Bristol-Myers Squibb
Bioanalytics – Chemical
Jian Chen, PhD – Bristol-Myers Squibb ### 1680383###Moderator###Senior Principal Scientist###Bristol-Myers Squibb###Moderator: – Bristol-Myers Squibb
### 9:00 AM – 9:30 AM ET
LC-MS Based Bioanalysis of Complex BiotherapeuticsLocation:253 ASpeaker: – Bristol Myers Squibb
Bioanalytics – Chemical
Srikanth Kotapati, PhD – Bristol Myers Squibb ### 1675272###Speaker###Senior Principal Scientist###Bristol Myers Squibb###Speaker: – Bristol Myers Squibb
### 9:30 AM – 10:00 AM ET
Keys to the Successful Development of Bioanalytical Method for OligonucleotidesLocation:253 ABioanalytics – Chemical
Jim Yamashita, PhD – WuXi AppTec ### 1650378###Speaker###Senior Director, Small Molecule Bioanalysis###WuXi AppTec###Speaker: – WuXi AppTec
### 10:00 AM – 10:30 AM ET
The Critical Role of Mobile Phase pH In the Performance of Oligonucleotide Ion-Pair Liquid Chromatography–Mass Spectrometry MethodsLocation:253 ASpeaker: – University of Georgia
Bioanalytics – Chemical
Gui Guimaraes – University of Georgia ### 1663781###Speaker###Graduate Student###University of Georgia###Speaker: – University of Georgia
### 10:30 AM – 11:00 AM ET
Reaching the Next Level of Sensitivity in Oligonucleotide Bioanalysis: A Hybridization-Based Method on Quanterix Simoa®Location:253 ASpeaker: – Labcorp Drug Development
Bioanalytics – Chemical
Bingbing Wang, PhD – Labcorp Drug Development ### 1663783###Speaker###Staff Scientist II###Labcorp Drug Development###Speaker: – Labcorp Drug Development
### 9:00 AM – 11:00 AM ET
Symposium: Bridging The Cross-Functional Silos To Expedite Compound Progression Into The Clinic (BM)Moderator: – Merck & Co. Inc
Preclinical Development – Biomolecular
9:00 AM – 11:00 AM ET
Symposium: Bridging The Cross-Functional Silos To Expedite Compound Progression Into The Clinic (BM)Location:254 AModerator: – Merck & Co. Inc
Preclinical Development – Biomolecular
Morgan B. Giles, PhD – Merck & Co. Inc ### 1759598###Moderator###Associate Principal Scientist###Merck & Co. Inc###Moderator: – Merck & Co. Inc
### 9:00 AM – 9:30 AM ET
An Unaddressed Scientific Need: Predicting Human Bioavailability of Subcutaneously Administered Fc-Fusion Proteins and Monoclonal AntibodiesLocation:254 ASpeaker: – Daiichi Sankyo Inc.
Preclinical Development – Biomolecular
Peng Zou, PhD – Daiichi Sankyo Inc. ### 844096###Speaker###Clinical Pharmacologist###Daiichi Sankyo Inc.###Speaker: – Daiichi Sankyo Inc.
### 9:30 AM – 10:00 AM ET
A Multifunctional Pre-Clinical Workstream to Advance ADC’s From Discovery to FIH DosingLocation:254 ASpeaker: – SUTRO Biopharma
Preclinical Development – Biomolecular
Werner Rubas, PhD – SUTRO Biopharma ### 856966###Speaker###VIP Preclinical Development###SUTRO Biopharma###Speaker: – SUTRO Biopharma
### 10:00 AM – 10:30 AM ET
Understanding Protein Excipient Compatibility- Smart Decision for Speed to ClinicLocation:254 ASpeaker: – Boehringer Ingelheim Pharmaceutical Inc
Preclinical Development – Biomolecular
Seema Thakral, PhD – Boehringer Ingelheim Pharmaceutical Inc ### 1045161###Speaker###Head, Preclinical Formulations###Boehringer Ingelheim Pharmaceutical Inc###Speaker: – Boehringer Ingelheim Pharmaceutical Inc
### 10:30 AM – 11:00 AM ET
Challenges in Development of Cell and Gene Therapies GloballyLocation:254 ASpeaker: – SymphonyTech Biologucs
Preclinical Development – Biomolecular
Narendra Chirmule, Dr. – SymphonyTech Biologucs ### 516216###Speaker###CEO###SymphonyTech Biologucs###Speaker: – SymphonyTech Biologucs
### 9:00 AM – 11:00 AM ET
Symposium: Bridging The Cross-Functional Silos To Expedite Compound Progression Into The Clinic (CE)Moderator: – University of Toronto
Preclinical Development – Chemical
9:00 AM – 11:00 AM ET
Symposium: Bridging The Cross-Functional Silos To Expedite Compound Progression Into The Clinic (CE)Location:253 CModerator: – University of Toronto
Preclinical Development – Chemical
Sarah Cash – University of Toronto ### 1447132###Moderator###PhD Candidate###University of Toronto###Moderator: – University of Toronto
### 9:00 AM – 9:30 AM ET
Single Formulation for Preclinical, F-I-H and Commercial Dosage FormLocation:253 CSpeaker: – Nano PharmaSolutions
Preclinical Development – Chemical
Kay Olmstead, PhD – Nano PharmaSolutions ### 1650361###Speaker###CEO###Nano PharmaSolutions###Speaker: – Nano PharmaSolutions
### 9:30 AM – 10:00 AM ET
In vitro Models of Subcutaneous DeliveryLocation:253 CSpeaker: – Massachusetts Institute of Technology
Preclinical Development – Chemical
Maria Proestaki, PhD – Massachusetts Institute of Technology ### 1778458###Speaker###Postdoctoral Associate###Massachusetts Institute of Technology ###Speaker: – Massachusetts Institute of Technology
### 10:00 AM – 10:30 AM ET
Model Informed Drug Development: A Key Metric to Expedite Compound Progression in Drug DiscoveryLocation:253 CSpeaker: – Quotient Sciences, UK
Preclinical Development – Chemical
Shriram M. Pathak, PhD – Quotient Sciences, UK ### 847359###Speaker###Senior Research Fellow, Drug Development Consulting###Quotient Sciences, UK###Speaker: – Quotient Sciences, UK
### 10:30 AM – 11:00 AM ET
New Tools to Bridge Chemistry and Biology SilosLocation:253 CPreclinical Development – Chemical
Keith Hornberger, PhD – Arvinas, Inc. ### 1686551###Speaker###Senior Director, Medicinal Chemistry###Arvinas, Inc.###Speaker: – Arvinas, Inc.
### 9:00 AM – 11:00 AM ET
Symposium: Oncotargets: Challenges & OpportunitiesModerator: – Northeastern University
Discovery and Basic Research
9:00 AM – 11:00 AM ET
Symposium: Oncotargets: Challenges & OpportunitiesLocation:255Moderator: – Northeastern University
Discovery and Basic Research
Stephen Hatfield, PhD – Northeastern University ### 1691763###Moderator###Assistant Professor###Northeastern University ###Moderator: – Northeastern University
### 9:00 AM – 9:30 AM ET
New Therapeutic Approaches in Acute Myeloid LeukemiaLocation:255Speaker: – University of Southern California
Discovery and Basic Research
Houda Alachkar, PharmD, PhD – University of Southern California ### 1699108###Speaker###Associate Professor ###University of Southern California###Speaker: – University of Southern California
### 9:30 AM – 10:00 AM ET
Novel Thyrointegrin αvβ3 Antagonist in the Effective Treatment of Glioblastoma Multiforme and Other CancersLocation:255Speaker: – PRI at ACPHS & NanoPharmaceuticals LLC
Discovery and Basic Research
Shaker A. Mousa, PhD, MBA, – PRI at ACPHS & NanoPharmaceuticals LLC ### 1676845###Speaker###Prof., Executive VP of R&D and Founder of NanoPharmaceuticals LLC###PRI at ACPHS & NanoPharmaceuticals LLC###Speaker: – PRI at ACPHS & NanoPharmaceuticals LLC
### 10:00 AM – 10:30 AM ET
Systems Pharmacology in Developing Targeted and Long-Acting (Long-Lasting) Drug Combinations for Metastatic CancersLocation:255Speaker: – Center for WE-REACH
Discovery and Basic Research
Rodney J. Ho, Ph.D NAI FAAPS FAAAS – Center for WE-REACH ### 1046065###Speaker###Executive Director and Professor###Center for WE-REACH###Speaker: – Center for WE-REACH
### 10:30 AM – 11:00 AM ET
High-Throughput 3D Bio-Printed Tumor Microenvironment Platform for Mimicking Lung CancerLocation:255Speaker: – University of Florida
Discovery and Basic Research
Nina Erwin – University of Florida ### 1755669###Speaker###Graduate Student###University of Florida###Speaker: – University of Florida
### 9:00 AM – 11:00 AM ET
Symposium: Rapid Discovery of Therapeutics: Past Experience and Computational ApproachesModerator: – University of North Carolina
Discovery and Basic Research
9:00 AM – 11:00 AM ET
Symposium: Rapid Discovery of Therapeutics: Past Experience and Computational ApproachesLocation:254 BModerator: – University of North Carolina
Discovery and Basic Research
Alexander Tropsha, PhD – University of North Carolina ### 1695022###Moderator###KH Lee Distinguished Professor###University of North Carolina ###Moderator: – University of North Carolina
### 9:00 AM – 9:30 AM ET
Mass Spectrometry Imaging in Drug Discovery and Better Therapeutic DesignLocation:254 BSpeaker: – Columbia University
Discovery and Basic Research
Presha Rajbhandari, PhD – Columbia University ### 1650384###Speaker###Associate Research Scientist, Department of Biological Sciences###Columbia University###Speaker: – Columbia University
### 9:30 AM – 10:00 AM ET
Bioinformatic Driven Translation of Precision Genomic TherapyLocation:254 BSpeaker: – University of Florida
Discovery and Basic Research
Kiley Graim, PhD – University of Florida ### 1378144###Speaker###Assistant Professor###University of Florida###Speaker: – University of Florida
### 10:00 AM – 10:30 AM ET
Accelerating Computational Drug Discovery with Machine Learning and AILocation:254 BSpeaker: – Carnegie Mellon University
Discovery and Basic Research
Olexandr Isayev, PhD (he/him/his) – Carnegie Mellon University ### 1688940###Speaker###Professor###Carnegie Mellon University###Speaker: – Carnegie Mellon University
### he/him/his10:30 AM – 11:00 AM ET
What's Needed to Fully Enable Artificial Intelligence (AI) for Drug Discovery?Location:254 BDiscovery and Basic Research
Han Lim, PhD – DeepCure ### 1688941###Speaker###Chief Business Officer###DeepCure###Speaker: – DeepCure
### 9:00 AM – 11:00 AM ET
Symposium: Recent Development in Prophylactic Therapies and Vaccines (CE)Moderator: – University of Florida
Formulation and Delivery – Chemical
9:00 AM – 11:00 AM ET
Symposium: Recent Development in Prophylactic Therapies and Vaccines (CE)Location:205 ABModerator: – University of Florida
Formulation and Delivery – Chemical
Rodrigo Cristofoletti, PhD – University of Florida ### 1650917###Moderator###Assistant Professor ###University of Florida###Moderator: – University of Florida
### 9:00 AM – 9:30 AM ET
Maturing Role of Systems Pharmacology, Long-Acting and Targeted Drug-Combination Technologies in Making Health Impact in Long-Acting TherapeuticsLocation:205 ABSpeaker: – Center for WE-REACH
Formulation and Delivery – Chemical
Rodney J. Ho, Ph.D NAI FAAPS FAAAS – Center for WE-REACH ### 1046065###Speaker###Executive Director and Professor###Center for WE-REACH###Speaker: – Center for WE-REACH
### 9:30 AM – 10:00 AM ET
Long-Acting Drug Delivery Systems for ContraceptionLocation:205 ABFormulation and Delivery – Chemical
Jennifer Ayres, PhD – FHI 360 ### 1730308###Speaker###Pharmaceutical Development Manager###FHI 360###Speaker: – FHI 360
### 10:00 AM – 10:30 AM ET
Developments in Prophylactic Treatments for MalariaLocation:205 ABSpeaker: – Medicines for Malaria Venture (MMV)
Formulation and Delivery – Chemical
Hanu Ramachandruni, PhD – Medicines for Malaria Venture (MMV) ### 1698804###Speaker###Senior Director, Pharmaceutical Development###Medicines for Malaria Venture (MMV)###Speaker: – Medicines for Malaria Venture (MMV)
### 10:30 AM – 11:00 AM ET
Optimizing HIV Postnatal Prophylaxis: Ongoing Collaborative EffortsLocation:205 ABSpeaker: – World Health Organization
Formulation and Delivery – Chemical
Martina Penazzato, MD, MSc, PhD (she/her/hers) – World Health Organization ### 1795256###Speaker###GAP-f lead###World Health Organization###Speaker: – World Health Organization
### she/her/hers9:30 AM – 10:00 AM ET
Coffee Break in the Solution Center
9:30 AM – 10:00 AM ET
Coffee Break in the Solution CenterLocation:Exhibit Hall A&B
9:30 AM – 10:30 AM ET
Evaluation of Advanced Container Surface Technologies for Sensitive Drugs ProductsFormulation and Delivery
9:30 AM – 10:30 AM ET
Evaluation of Advanced Container Surface Technologies for Sensitive Drug ProductsLocation:360 Stage #4, Exhibit Hall A&BFormulation and Delivery
Rob Swanda, PhD – Becton Dickinson ### 1764085###Partner Presentation Speaker###R&D Innovation Leader###Becton Dickinson###Partner Presentation Speaker: – Becton Dickinson
### 9:30 AM – 10:30 AM ET
Speaker Spotlight: Advances in Co-Processed APIs, Transformative Technologies to Optimize Physicochemical PropertiesSpotlight Speaker: – Merck & Co., Inc.
Moderator: – Organon
Manufacturing & Analytical Characterization
9:30 AM – 10:30 AM ET
Speaker Spotlight: Advances in Co-Processed APIs, Transformative Technologies to Optimize Physicochemical PropertiesLocation:Spotlight Stage 3, Exhibit Hall A&BSpotlight Speaker: – Merck & Co., Inc.
Moderator: – Organon
Manufacturing & Analytical Characterization
Luke Schenck – Merck & Co., Inc. ### 604981###Spotlight Speaker###Principal Scientist###Merck & Co., Inc.###Spotlight Speaker: – Merck & Co., Inc.
### @@@ Maria Cruanes, PhD Chemistry (she/her/hers) – Organon ### 1680406###Moderator###Director Analytical Chemistry ###Organon###Moderator: – Organon
### she/her/hers9:30 AM – 10:30 AM ET
Speaker Spotlight: The Intersection of Hepatic Transporters and Drug-Induced Liver Injury: Preclinical Tools to Advance Mechanistic Understanding and Precision MedicineSpotlight Speaker: – UNC Eshelman School of Pharmacy
The University of North Carolina at Chapel Hill
Moderator: – University of North Carolina - Chapel Hill
Preclinical Development
9:30 AM – 10:30 AM ET
Speaker Spotlight: The Intersection of Hepatic Transporters and Drug-Induced Liver Injury: Preclinical Tools to Advance Mechanistic Understanding and Precision MedicineLocation:Spotlight Stage 1, Exhibit Hall A&BSpotlight Speaker: – UNC Eshelman School of Pharmacy
The University of North Carolina at Chapel Hill
Moderator: – University of North Carolina - Chapel Hill
Preclinical Development
Kim L.R Brouwer, PharmD, PhD – UNC Eshelman School of Pharmacy
The University of North Carolina at Chapel Hill
### 567627###Spotlight Speaker###Associate Dean for Research and Graduate Education
William R. Kenan, Jr., Distinguished Professor###UNC Eshelman School of Pharmacy
The University of North Carolina at Chapel Hill
###Spotlight Speaker: – UNC Eshelman School of Pharmacy
The University of North Carolina at Chapel Hill
### @@@ Mattie Hartauer – University of North Carolina - Chapel Hill ### 1678282###Moderator###Graduate Student###University of North Carolina - Chapel Hill###Moderator: – University of North Carolina - Chapel Hill
### 9:30 AM – 10:30 AM ET
Speaker Spotlight: Translational Biomarkers for Rare Disease Gene Therapies, Limitations and OpportunitiesSpotlight Speaker: – Pfizer
Moderator: – BioAgilytix
Clinical Pharmacology – Biomolecular
9:30 AM – 10:30 AM ET
Speaker Spotlight: Translational Biomarkers for Rare Disease Gene Therapies, Limitations and OpportunitiesLocation:Spotlight Stage 2, Exhibit Hall A&BSpotlight Speaker: – Pfizer
Moderator: – BioAgilytix
Clinical Pharmacology – Biomolecular
Mohamed Hassanein, PhD – Pfizer ### 1328461###Spotlight Speaker###Associate Director###Pfizer###Spotlight Speaker: – Pfizer
### @@@ Shazia Baig, PhD (she/her/hers) – BioAgilytix ### 1601056###Moderator###Scientist II###BioAgilytix###Moderator: – BioAgilytix
### she/her/hers9:30 AM – 10:30 AM ET
Successful Collaboration Delivering Impactful Solutions to Novel Challenges in PharmaPartner Presentation Speaker: – SGS Health Science
Partner Presentation Speaker: – Thermo Fisher Scientific
Manufacturing & Analytical Characterization
9:30 AM – 10:30 AM ET
Successful Collaboration Delivering Impactful Solutions to Novel Challenges in PharmaLocation:360 Stage #2, Exhibit Hall A&BPartner Presentation Speaker: – SGS Health Science
Partner Presentation Speaker: – Thermo Fisher Scientific
Manufacturing & Analytical Characterization
Paulina Pinedo-Gonzalez, PhD – SGS Health Science ### 1743111###Partner Presentation Speaker###Chemist###SGS Health Science###Partner Presentation Speaker: – SGS Health Science
### @@@ Simon Szwandt, PhD (he/him/his) – Thermo Fisher Scientific ### 1804041###Partner Presentation Speaker###Senior Field Scientist###Thermo Fisher Scientific###Partner Presentation Speaker: – Thermo Fisher Scientific
### he/him/his10:00 AM – 11:00 AM ET
Hot Topic: Careers in Biopharmaceutics Related Fields: A Career Development Panel DiscussionHot Topic Moderator: – Eli Lilly and Company
Hot Topic Speaker: – Eli Lilly and Company
Hot Topic Speaker: – Merck & Co., Inc.
Hot Topic Speaker: – University of Bath
Government Speaker: – US Food and Drug Administration, Invited
Formulation and Delivery – Chemical
10:00 AM – 11:00 AM ET
Hot Topic: Careers in Biopharmaceutics Related Fields: A Career Development Panel DiscussionLocation:153 BCHot Topic Moderator: – Eli Lilly and Company
Hot Topic Speaker: – Eli Lilly and Company
Hot Topic Speaker: – Merck & Co., Inc.
Hot Topic Speaker: – University of Bath
Government Speaker: – US Food and Drug Administration, Invited
Formulation and Delivery – Chemical
Siddhi S. Hate, PhD – Eli Lilly and Company ### 1650342###Hot Topic Moderator###Advisor###Eli Lilly and Company###Hot Topic Moderator: – Eli Lilly and Company
### @@@ David C. Sperry, PhD – Eli Lilly and Company ### 1011708###Hot Topic Speaker###Executive Director###Eli Lilly and Company###Hot Topic Speaker: – Eli Lilly and Company
### @@@ Andre Hermans, PhD – Merck & Co., Inc. ### 624038###Hot Topic Speaker###Director###Merck & Co., Inc.###Hot Topic Speaker: – Merck & Co., Inc.
### @@@ Nikoletta Fotaki, PhD – University of Bath ### 847632###Hot Topic Speaker###Reader in (Bio)Pharmaceutics###University of Bath###Hot Topic Speaker: – University of Bath
### @@@ Paul Seo, PhD – US Food and Drug Administration, Invited ### 603903###Government Speaker###Policy Lead###US Food and Drug Administration, Invited###Government Speaker: – US Food and Drug Administration, Invited
### 10:00 AM – 11:00 AM ET
Meet The Employers: Hosted by Certara
10:00 AM – 11:00 AM ET
Meet The Employer: Hosted by CertaraLocation:Career Development Center, Exhibit Hall A&BCareer Development
10:30 AM – 11:30 AM ET
Nose to Brain Delivery: possibility or a pipedream?Partner Presentation Speaker: – Lovelace Biomedical Research Institute
Partner Presentation Speaker: – Aptar Pharma
Preclinical Development
10:30 AM – 11:30 AM ET
Nose to Brain Delivery: possibility or a pipedream?Location:360 Stage #1, Exhibit Hall A&BPartner Presentation Speaker: – Lovelace Biomedical Research Institute
Partner Presentation Speaker: – Aptar Pharma
Preclinical Development
Philip J. Kuehl, PhD – Lovelace Biomedical Research Institute ### 603512###Partner Presentation Speaker###Senior Scientist###Lovelace Biomedical Research Institute###Partner Presentation Speaker: – Lovelace Biomedical Research Institute
### @@@ Julie D. Suman, PhD – Aptar Pharma ### 848555###Partner Presentation Speaker###Vice President, Scientific Affairs###Aptar Pharma###Partner Presentation Speaker: – Aptar Pharma
### 10:30 AM – 11:30 AM ET
Special Poster Collection - 2022 PharmSci 360 Best Posters
10:30 AM – 11:30 AM ET
Special Poster Collection - 2022 PharmSci 360 Best PostersLocation:Poster Forum #10, Exhibit Hall A&BPoster Collection Host: – Trinity College Dublin
Carsten Ehrhardt, Ph.D. – Trinity College Dublin ### 1536972###Poster Collection Host###Professor in Pharmaceutics and Biopharmaceutics###Trinity College Dublin###Poster Collection Host: – Trinity College Dublin
### 10:30 AM – 11:30 AM ET
Strategically Design Your Path to Career SuccessCareer Center Speaker: – Merck & Co.
Career Center Speaker: – Pharmawyze
Career Center Speaker: – BMS
Career Center Speaker: – Bristol Myers Squibb
Career Center Moderator: – Merck & Co., Inc.
Career Development
10:30 AM – 11:30 AM ET
Strategically Design Your Path to Career SuccessLocation:360 Stage #3, Exhibit Hall A&BCareer Center Speaker: – Merck & Co.
Career Center Speaker: – Pharmawyze
Career Center Speaker: – BMS
Career Center Speaker: – Bristol Myers Squibb
Career Center Moderator: – Merck & Co., Inc.
Career Development
Nicole Buist, PhD – Merck & Co. ### 1529534###Career Center Speaker###Senior Director###Merck & Co.###Career Center Speaker: – Merck & Co.
### @@@ Ronald L. Smith, PhD, FAAPS – Pharmawyze ### 1529533###Career Center Speaker###Principal###Pharmawyze###Career Center Speaker: – Pharmawyze
### @@@ Anthony Leone, PhD – BMS ### 1650350###Career Center Speaker###Executive Director-Head Analytical Development and Attribute Sciences###BMS###Career Center Speaker: – BMS
### @@@ Tapan Das, PhD, FAAPS – Bristol Myers Squibb ### 567541###Career Center Speaker###Senior Director###Bristol Myers Squibb###Career Center Speaker: – Bristol Myers Squibb
### @@@ Jing Ling, PhD – Merck & Co., Inc. ### 1650352###Career Center Moderator###Associate Principal Scientist###Merck & Co., Inc.###Career Center Moderator: – Merck & Co., Inc.
### 11:00 AM – 12:00 PM ET
A toxicologist’s viewpoint on the safe manufacturing of oncology drugsPartner Presentation Speaker: – Thermo Fisher Scientific
Manufacturing & Analytical Characterization
11:00 AM – 12:00 PM ET
A toxicologist’s viewpoint on the safe manufacturing of oncology drugsLocation:360 Stage #2, Exhibit Hall A&BPartner Presentation Speaker: – Thermo Fisher Scientific
Manufacturing & Analytical Characterization
Joe Galati, PhD – Thermo Fisher Scientific ### 1743097###Partner Presentation Speaker###Sr. Director, Global Toxicology Services###Thermo Fisher Scientific###Partner Presentation Speaker: – Thermo Fisher Scientific
### 11:00 AM – 12:00 PM ET
Patient Centric Sampling to Enable Decentralization of Clinical TrialsPartner Presentation Speaker: – Labcorp
Bioanalytics
11:00 AM – 12:00 PM ET
Patient Centric Sampling to Enable Decentralization of Clinical TrialsLocation:360 Stage #4, Exhibit Hall A&BPartner Presentation Speaker: – Labcorp
Bioanalytics
Stephanie Cape, PhD (she/her/hers) – Labcorp ### 627114###Partner Presentation Speaker###Head of R&D - Scientific Affairs, Clinical Trials Testing Solutions###Labcorp###Partner Presentation Speaker: – Labcorp
### she/her/hers11:00 AM – 1:30 PM ET
Dedicated Solution Center Hours
11:00 AM – 1:30 PM ET
Dedicated Solution Center HoursLocation:Exhibit Hall A&B
11:15 AM – 12:00 PM ET
Characterization of Dextran/Heparin via GPC/SEC Advanced detection with 21-CFR11-Compliant softwareChalk Talk Presenter: – PSS USA Inc
Chalk Talk Presenter: – Agilent Technologies
Manufacturing & Analytical Characterization
11:15 AM – 12:00 PM ET
Characterization of Dextran/Heparin via GPC/SEC Advanced detection with 21-CFR11-Compliant softwareLocation:Spotlight Stage 3, Exhibit Hall A&BChalk Talk Presenter: – PSS USA Inc
Chalk Talk Presenter: – Agilent Technologies
Manufacturing & Analytical Characterization
Derek Lohmann, PhD – PSS USA Inc ### 1778369###Chalk Talk Presenter###VP Sales & Business Development###PSS USA Inc###Chalk Talk Presenter: – PSS USA Inc
### @@@ Lorena Lopez, BSc / MBA – Agilent Technologies ### 1767416###Chalk Talk Presenter###LC Applications Scientist###Agilent Technologies###Chalk Talk Presenter: – Agilent Technologies
### 11:15 AM – 12:00 PM ET
Nitrosamine Risk Management and Analytical TestingChalk Talk Presenter: – Cambrex
Manufacturing & Analytical Characterization
11:15 AM – 12:00 PM ET
Nitrosamine Risk Management and Analytical TestingLocation:Spotlight Stage 2, Exhibit Hall A&BChalk Talk Presenter: – Cambrex
Manufacturing & Analytical Characterization
Caddy Hobbs, PhD (she/her/hers) – Cambrex ### 1807703###Chalk Talk Presenter###Associate Director###Cambrex###Chalk Talk Presenter: – Cambrex
### she/her/hers11:15 AM – 12:00 PM ET
Supporting R&D with Nondilutive Federal FundingChalk Talk Presenter: – EverGlade Consulting
Discovery and Basic Research
11:15 AM – 12:00 PM ET
Supporting R&D with Nondilutive Federal FundingLocation:Spotlight Stage 1, Exhibit Hall A&BChalk Talk Presenter: – EverGlade Consulting
Discovery and Basic Research
Presented By EverGlade Everglade
Stephen Morris, PhD – EverGlade Consulting ### 1778368###Chalk Talk Presenter###Managing Director###EverGlade Consulting###Chalk Talk Presenter: – EverGlade Consulting
### 11:45 AM – 1:30 PM ET
AAPS Student Meet Up
11:45 AM – 1:30 PM ET
AAPS Student Meet UpLocation:North Lobby
12:00 PM – 1:00 PM ET
Developing Sustainable Environments for DE&I Across a Global WorkplaceCareer Center Speaker: – Merck & Co., Inc.
Career Center Speaker: – Merck & Co., Inc.
Career Center Speaker: – Merck & Co., Inc.
Career Center Speaker: – Oral Formulation Sciences, Merck & Co., Inc.
Career Development
12:00 PM – 1:00 PM ET
Developing Sustainable Environments for DE&I Across a Global WorkplaceLocation:360 Stage #3, Exhibit Hall A&BCareer Center Speaker: – Merck & Co., Inc.
Career Center Speaker: – Merck & Co., Inc.
Career Center Speaker: – Merck & Co., Inc.
Career Center Speaker: – Oral Formulation Sciences, Merck & Co., Inc.
Career Development
Stephanie Barrett, PhD – Merck & Co., Inc. ### 466169###Career Center Speaker###Director, Sterile & Specialty Products###Merck & Co., Inc.###Career Center Speaker: – Merck & Co., Inc.
### @@@ Neil Strotman, PhD – Merck & Co., Inc. ### 1650368###Career Center Speaker###Director, Formulations Science###Merck & Co., Inc.###Career Center Speaker: – Merck & Co., Inc.
### @@@ Devin Swiner, PhD (she/her/hers) – Merck & Co., Inc. ### 1767219###Career Center Speaker###Senior Scientist###Merck & Co., Inc.###Career Center Speaker: – Merck & Co., Inc.
### she/her/hers @@@ Alita Miller, MS – Oral Formulation Sciences, Merck & Co., Inc. ### 1808843###Career Center Speaker###Scientist###Oral Formulation Sciences, Merck & Co., Inc.###Career Center Speaker: – Oral Formulation Sciences, Merck & Co., Inc.
### 12:00 PM – 1:00 PM ET
Mass spectrometry Based Characterization of OligonucleotidesPartner Presentation Speaker: – Agilent Technologies
Manufacturing & Analytical Characterization
12:00 PM – 1:00 PM ET
Mass spectrometry Based Characterization of OligonucleotidesLocation:360 Stage #1, Exhibit Hall A&BPartner Presentation Speaker: – Agilent Technologies
Manufacturing & Analytical Characterization
Michael Knierman – Agilent Technologies ### 1743103###Partner Presentation Speaker###Biopharma Workflow Manager###Agilent Technologies###Partner Presentation Speaker: – Agilent Technologies
### 12:00 PM – 2:00 PM ET
The AAPS Journal Editor Strategy Meeting (by invitation only)
12:00 PM – 2:00 PM ET
The AAPS Journal Editor Strategy Meeting (by invitation only)
Location:Executive Boardroom, Westin Boston Seaport District Hotel
12:30 PM – 1:15 PM ET
AAPS Regulatory Sciences Community Membership Meeting Community Leader: – Tolmar, Inc.
12:30 PM – 1:15 PM ET
AAPS Regulatory Sciences Community Membership Meeting Location:Spotlight Stage 2, Exhibit Hall A&BCommunity Leader: – Tolmar, Inc.
Raja B. Velagapudi, PhD – Tolmar, Inc. ### 567542###Community Leader###Sr. Dir., Clinical Development###Tolmar, Inc.###Community Leader: – Tolmar, Inc.
### 12:30 PM – 1:15 PM ET
NextGen – CMC. Innovation, Digitization, Contextualization, and Analytics of Manufacturing DataChalk Talk Presenter: – Mareana, Inc.
Manufacturing & Analytical Characterization
12:30 PM – 1:15 PM ET
NextGen – CMC. Innovation, Digitization, Contextualization, and Analytics of Manufacturing DataLocation:Spotlight Stage 1, Exhibit Hall A&BChalk Talk Presenter: – Mareana, Inc.
Manufacturing & Analytical Characterization
Vishal Prasad – Mareana, Inc. ### 1804060###Chalk Talk Presenter###Founder and CPO###Mareana, Inc.###Chalk Talk Presenter: – Mareana, Inc.
### 12:30 PM – 1:15 PM ET
Sprinkle Formulations: A Convenient Dosing Platform for Special PopulationsChalk Talk Presenter: – Adare Pharma Solutions
Formulation and Delivery
12:30 PM – 1:15 PM ET
Sprinkle Formulations: A Convenient Dosing Platform for Special PopulationsLocation:Spotlight Stage 3, Exhibit Hall A&BChalk Talk Presenter: – Adare Pharma Solutions
Formulation and Delivery
Srinivasan Shanmugam, PhD – Adare Pharma Solutions ### 1473182###Chalk Talk Presenter###Senior Director, Pharmaceutical Sciences, Business Support, and New Technologies###Adare Pharma Solutions###Chalk Talk Presenter: – Adare Pharma Solutions
### 12:30 PM – 1:30 PM ET
FDA Modernization ACT: What's the Future of Current Test SystemsPartner Presentation Speaker: – Lovelace Biomedical
Partner Presentation Speaker: – LifeNet Health
Partner Presentation Speaker: – Emulate
Preclinical Development
12:30 PM – 1:30 PM ET
FDA Modernization ACT: What's the Future of Current Test SystemsLocation:360 Stage #4, Exhibit Hall A&BPartner Presentation Speaker: – Lovelace Biomedical
Partner Presentation Speaker: – LifeNet Health
Partner Presentation Speaker: – Emulate
Preclinical Development
Jake McDonald, PhD – Lovelace Biomedical ### 1044871###Partner Presentation Speaker###VP, Applied Sciences###Lovelace Biomedical###Partner Presentation Speaker: – Lovelace Biomedical
### @@@ Jim McKim, PhD, DABT – LifeNet Health ### 1764086###Partner Presentation Speaker###Executive Director###LifeNet Health###Partner Presentation Speaker: – LifeNet Health
### @@@ Lorna Ewart, PhD – Emulate ### 1764087###Partner Presentation Speaker###Chief Scientific Officer###Emulate###Partner Presentation Speaker: – Emulate
### 12:30 PM – 1:30 PM ET
Mutagenic Impurities Analysis: Response Factor Variation on Quantitative AccuracyPartner Presentation Speaker: – Jordi Labs
Manufacturing & Analytical Characterization
12:30 PM – 1:30 PM ET
Mutagenic Impurities Analysis: Response Factor Variation on Quantitative AccuracyLocation:360 Stage #2, Exhibit Hall A&BPartner Presentation Speaker: – Jordi Labs
Manufacturing & Analytical Characterization
Adam Eason, MSc (he/him/his) – Jordi Labs ### 1807477###Partner Presentation Speaker###Senior Study Director###Jordi Labs###Partner Presentation Speaker: – Jordi Labs
### he/him/his12:30 PM – 1:30 PM ET
Special Poster Collection
12:30 PM – 1:30 PM ET
Special Poster CollectionLocation:Poster Forum #2, Exhibit Hall A&BPoster Collection Host: – Janssen R&D, LLC
Poster Collection Host: – Johnson and Johnson
Gopi Shankar, AAPS Fellow – Janssen R&D, LLC ### 572031###Poster Collection Host###Senior Director###Janssen R&D, LLC###Poster Collection Host: – Janssen R&D, LLC
### @@@ Prathap Nagaraja Shastri, PhD – Johnson and Johnson ### 567445###Poster Collection Host###Scientific Director###Johnson and Johnson ###Poster Collection Host: – Johnson and Johnson
### 1:30 PM – 2:30 PM ET
Equip yourself for independence!Career Center Speaker: – Johnson and Johnson
Career Center Moderator: – Neurocrine Biosciences
Career Center Speaker: – Nimbus Therapeutics
Career Development
1:30 PM – 2:30 PM ET
Equip Yourself for Independence!Location:360 Stage #3, Exhibit Hall A&BCareer Center Speaker: – Johnson and Johnson
Career Center Moderator: – Neurocrine Biosciences
Career Center Speaker: – Nimbus Therapeutics
Career Development
Prathap Nagaraja Shastri, PhD – Johnson and Johnson ### 567445###Career Center Speaker###Scientific Director###Johnson and Johnson ###Career Center Speaker: – Johnson and Johnson
### @@@ Pankajini Mallick, PhD – Neurocrine Biosciences ### 1329420###Career Center Moderator###Principal Scientist, Preclinical Pharmacokinetics | DMPK###Neurocrine Biosciences###Career Center Moderator: – Neurocrine Biosciences
### @@@ Nimita Dave, PhD – Nimbus Therapeutics ### 1650370###Career Center Speaker###Director, Clinical Pharmacology###Nimbus Therapeutics###Career Center Speaker: – Nimbus Therapeutics
### 1:30 PM – 2:30 PM ET
Keynote: COVID-19: A Disruptive Force Transforming Clinical Pharmacology and Medicines DevelopmentKeynote Speaker: – Pfizer
Moderator: – Pfizer Inc.
Clinical Pharmacology
1:30 PM – 2:30 PM ET
Keynote: COVID-19: A Disruptive Force Transforming Clinical Pharmacology and Medicines DevelopmentLocation:151 ABKeynote Speaker: – Pfizer
Moderator: – Pfizer Inc.
Clinical Pharmacology
Brian Corrigan, PhD – Pfizer ### 1595388###Keynote Speaker###Global Head, Clinical Pharmacology###Pfizer###Keynote Speaker: – Pfizer
### @@@ Vaishali Sahasrabudhe, PhD (she/her/hers) – Pfizer Inc. ### 1045004###Moderator###Clinical Pharmacology Therapeutic Area Head for Internal Medicine###Pfizer Inc.###Moderator: – Pfizer Inc.
### she/her/hers1:30 PM – 2:30 PM ET
Keynote: Designing Function-Selective Kinase Inhibitors: Taking an Idea to Clinical Trials Keynote Speaker: – University of Maryland School of Pharmacy
Moderator: – University of North Carolina
Discovery and Basic Research
1:30 PM – 2:30 PM ET
Keynote: Designing Function-Selective Kinase Inhibitors: Taking an Idea to Clinical Trials Location:254 BKeynote Speaker: – University of Maryland School of Pharmacy
Moderator: – University of North Carolina
Discovery and Basic Research
Paul Shapiro, PhD – University of Maryland School of Pharmacy ### 1606391###Keynote Speaker###Professor###University of Maryland School of Pharmacy###Keynote Speaker: – University of Maryland School of Pharmacy
### @@@ Alexander Tropsha, PhD – University of North Carolina ### 1695022###Moderator###KH Lee Distinguished Professor###University of North Carolina ###Moderator: – University of North Carolina
### 1:30 PM – 2:30 PM ET
Keynote: Development of mRNA based Covid Vaccine Keynote Speaker: – Pfizer Inc.
Moderator: – Husson University
Formulation and Delivery – Biomolecular
1:30 PM – 2:30 PM ET
Keynote: Development of mRNA Based Covid Vaccine Location:204 ABKeynote Speaker: – Pfizer Inc.
Moderator: – Husson University
Formulation and Delivery – Biomolecular
Nicholas Warne, PhD – Pfizer Inc. ### 994019###Keynote Speaker###Vice President###Pfizer Inc.###Keynote Speaker: – Pfizer Inc.
### @@@ Shuhua Bai, PhD – Husson University ### 1378203###Moderator###Professor###Husson University###Moderator: – Husson University
### 1:30 PM – 2:30 PM ET
Keynote: Dragons and Invisible Helicopters: Evolution of Analytical TechnologiesKeynote Speaker: – Merck
Moderator: – AbbVie
Manufacturing & Analytical Characterization – Biomolecular
1:30 PM – 2:30 PM ET
Keynote: Dragons and Invisible Helicopters: Evolution of Analytical TechnologiesLocation:205 CKeynote Speaker: – Merck
Moderator: – AbbVie
Manufacturing & Analytical Characterization – Biomolecular
Ian Mangion, PhD – Merck ### 856408###Keynote Speaker###Executive Director###Merck###Keynote Speaker: – Merck
### @@@ Paul Logan Walsh, PhD – AbbVie ### 846991###Moderator###Director###AbbVie###Moderator: – AbbVie
### 1:30 PM – 2:30 PM ET
Keynote: Integrated Risk/Benefit Assessment to Inform Decision Making in Drug Discovery
Preclinical Development – Chemical
1:30 PM – 2:30 PM ET
Keynote: Integrated Risk/Benefit Assessment to Inform Decision Making in Drug Discovery Location:253 CPreclinical Development – Chemical
Thierry Lavé, PhD (he/him/his) – Hoffman-la Roche Inc ### 1417631###Keynote Speaker###Head R&D Academy and Faculty###Hoffman-la Roche Inc###Keynote Speaker: – Hoffman-la Roche Inc
### he/him/his @@@ Christine Bowman, PhD – Genentech ### 1372299###Moderator###Senior Scientist###Genentech###Moderator: – Genentech
### 1:30 PM – 2:30 PM ET
Keynote: Keynote: A Vision for Accelerating Oral Solid Dosage Drug Product Development Using Material Science and SimulationManufacturing & Analytical Characterization – Chemical
1:30 PM – 2:30 PM ET
Keynote: A Vision for Accelerating Oral Solid Dosage Drug Product Development Using Material Science and SimulationLocation:206 ABManufacturing & Analytical Characterization – Chemical
Robert Yule – Sanofi ### 1595391###Keynote Speaker###Head of Operations, Data and Modeling###Sanofi###Keynote Speaker: – Sanofi
### @@@ Sayantan Chattoraj, Ph.D. – GSK ### 828674###Moderator###Director & GSK Fellow, Drug Product Development###GSK###Moderator: – GSK
### 1:30 PM – 2:30 PM ET
Keynote: Oligonucleotides, Where We Started, Where We Stand, and Where We Would Like GoKeynote Speaker: – Pyxant Labs Inc.
Moderator: – Virginia Commonwealth University
Bioanalytics – Chemical
1:30 PM – 2:30 PM ET
Keynote: Oligonucleotides, Where We Started, Where We Stand, and Where We Would Like GoLocation:253 AKeynote Speaker: – Pyxant Labs Inc.
Moderator: – Virginia Commonwealth University
Bioanalytics – Chemical
Troy Voelker, PhD – Pyxant Labs Inc. ### 1447215###Keynote Speaker###Director of Laboratory Operations###Pyxant Labs Inc.###Keynote Speaker: – Pyxant Labs Inc.
### @@@ Matthew S. Halquist, PhD – Virginia Commonwealth University ### 1447055###Moderator###Associate Professor and Laboratory Director###Virginia Commonwealth University###Moderator: – Virginia Commonwealth University
### 1:30 PM – 2:30 PM ET
Keynote: Opportunities and Challenges in Translating Novel Discoveries into Biologic Drugs in R&D: From Oncology to NeurologyKeynote Speaker: – Alector
Moderator: – Repare Therapeutics
Preclinical Development – Biomolecular
1:30 PM – 2:30 PM ET
Keynote: Opportunities and Challenges in Translating Novel Discoveries into Biologic Drugs in R&D: From Oncology to NeurologyLocation:254 AKeynote Speaker: – Alector
Moderator: – Repare Therapeutics
Preclinical Development – Biomolecular
Sara Kenkare-Mitra, PhD – Alector ### 1595386###Keynote Speaker###President, Head of Research & Development###Alector###Keynote Speaker: – Alector
### @@@ Adrian Fretland, PhD – Repare Therapeutics ### 1690833###Moderator###Executive Director, Head of Clinical Pharmacology and Toxicology###Repare Therapeutics###Moderator: – Repare Therapeutics
### 1:30 PM – 2:30 PM ET
Keynote: Prophylactic Therapies in Global Health Applications?Keynote Speaker: – Bill & Melinda Gates Foundation
Moderator: – University of Bath
Formulation and Delivery – Chemical
1:30 PM – 2:30 PM ET
Keynote: Prophylactic Therapies in Global Health Applications?Location:205 ABKeynote Speaker: – Bill & Melinda Gates Foundation
Moderator: – University of Bath
Formulation and Delivery – Chemical
Niya Bowers, PhD – Bill & Melinda Gates Foundation ### 1631286###Keynote Speaker###Senior Program Officer###Bill & Melinda Gates Foundation###Keynote Speaker: – Bill & Melinda Gates Foundation
### @@@ Nikoletta Fotaki, PhD – University of Bath ### 847632###Moderator###Reader in (Bio)Pharmaceutics###University of Bath###Moderator: – University of Bath
### 1:30 PM – 2:30 PM ET
Keynote: Redox Biology and Cancer TherapeuticsKeynote Speaker: – Medical University of South Carolina
Moderator: – University of Charleston
Discovery and Basic Research
1:30 PM – 2:30 PM ET
Keynote: Redox Biology and Cancer TherapeuticsLocation:255Keynote Speaker: – Medical University of South Carolina
Moderator: – University of Charleston
Discovery and Basic Research
Kenneth Tew, PHD, DSc, FASPET – Medical University of South Carolina ### 1596656###Keynote Speaker###Charir Pharmacology###Medical University of South Carolina###Keynote Speaker: – Medical University of South Carolina
### @@@ Tamer E. Fandy, PhD, BCGP, FCP – University of Charleston ### 1378497###Moderator###Professor & Chair, Department of Pharmaceutical & Adminstrative Sciences###University of Charleston###Moderator: – University of Charleston
### 1:30 PM – 2:30 PM ET
Keynote: The Future of Medicine is Here. Are We (Bioanalytically) Ready?Keynote Speaker: – Sana Biotechnology
Moderator: – BioAgilytix Labs
Bioanalytics – Biomolecular
1:30 PM – 2:30 PM ET
Keynote: The Future of Medicine is Here. Are We (Bioanalytically) Ready?Location:253 BKeynote Speaker: – Sana Biotechnology
Moderator: – BioAgilytix Labs
Bioanalytics – Biomolecular
Boris Gorovits, PhD – Sana Biotechnology ### 466045###Keynote Speaker###VP In vitro pharm and bioanalytical ###Sana Biotechnology ###Keynote Speaker: – Sana Biotechnology
### @@@ Lynn Kamen, PhD – BioAgilytix Labs ### 1680382###Moderator###Scientific Officer###BioAgilytix Labs###Moderator: – BioAgilytix Labs
### 1:30 PM – 2:30 PM ET
Long Acting Injectables- Predictive approaches in drug development and manufacturingManufacturing & Analytical Characterization
1:30 PM – 2:00 PM ET
Long Acting Injectables- Predictive approaches in drug development and manufacturingLocation:360 Stage #1, Exhibit Hall A&BManufacturing & Analytical Characterization
Sujatha Sonti, Dr – GSK ### 1743104###Partner Presentation Speaker###VP, Drug Product Development###GSK###Partner Presentation Speaker: – GSK
### @@@ Manish Gupta, PhD – GSK ### 1044965###Partner Presentation Speaker###Senior Director###GSK###Partner Presentation Speaker: – GSK
### @@@ Brian Rhodes, MS – GSK ### 466160###Partner Presentation Speaker###Sr. Director, Process Engineering and Analytics###GSK###Partner Presentation Speaker: – GSK
### 2:00 PM – 3:00 PM ET
Co-processed HPMC–mannitol: A directly compressible excipient for controlled releaseTech Spotlight Speaker: – Roquette America Inc.
Formulation and Delivery
2:00 PM – 3:00 PM ET
Co-processed HPMC–mannitol: A directly compressible excipient for controlled releaseLocation:360 Stage #2, Exhibit Hall A&BTech Spotlight Speaker: – Roquette America Inc.
Formulation and Delivery
Talles Ernica, MS – Roquette America Inc. ### 1743099###Tech Spotlight Speaker###Global Pharma Technical Developer###Roquette America Inc.###Tech Spotlight Speaker: – Roquette America Inc.
### 2:00 PM – 3:00 PM ET
Meet The Employers: Hosted by AstraZeneca
2:00 PM – 3:00 PM ET
Meet The Employer: Hosted by AstraZenecaLocation:Career Development Center, Exhibit Hall A&BCareer Development
2:00 PM – 3:00 PM ET
Serial Two-Photon Plus: Translating Ex Vivo to In Vivo ImagingTech Spotlight Speaker: – TissueVision Inc.
Preclinical Development
2:00 PM – 3:00 PM ET
Serial Two-Photon Plus: Translating Ex Vivo to In Vivo ImagingLocation:360 Stage #4, Exhibit Hall A&BTech Spotlight Speaker: – TissueVision Inc.
Preclinical Development
Stefan Linehan, MS – TissueVision Inc. ### 1764090###Tech Spotlight Speaker###VP of Operations and Development###TissueVision Inc.###Tech Spotlight Speaker: – TissueVision Inc.
### 2:30 PM – 3:00 PM ET
Coffee Break in the Solution Center
2:30 PM – 3:00 PM ET
Coffee Break in the Solution CenterLocation:Exhibit Hall A&B
2:30 PM – 3:30 PM ET
Hot Topic: Emerging Use of Real World Data to Address Data Gaps in Clinical Pharmacology: Opportunities & ChallengesHot Topic Moderator: – Pfizer
Hot Topic Speaker: – Premier Research
Hot Topic Speaker: – Metrum Research Group
Hot Topic Speaker: – Pfizer
Clinical Pharmacology
2:30 PM – 3:30 PM ET
Hot Topic: Emerging Use of Real World Data to Address Data Gaps in Clinical Pharmacology: Opportunities & ChallengesLocation:153 AHot Topic Moderator: – Pfizer
Hot Topic Speaker: – Premier Research
Hot Topic Speaker: – Metrum Research Group
Hot Topic Speaker: – Pfizer
Clinical Pharmacology
Simon Dagenais, PhD, MSc – Pfizer ### 1691797###Hot Topic Moderator###Senior director, RWE COE###Pfizer###Hot Topic Moderator: – Pfizer
### @@@ Abie Ekangaki, PhD – Premier Research ### 1691799###Hot Topic Speaker###Vice President, Statistical Consulting###Premier Research###Hot Topic Speaker: – Premier Research
### @@@ Marc Gastonguay, PhD – Metrum Research Group ### 1779523###Hot Topic Speaker###CEO###Metrum Research Group###Hot Topic Speaker: – Metrum Research Group
### @@@ Simon Dagenais, PhD, MSc – Pfizer ### 1691797###Hot Topic Speaker###Senior director, RWE COE###Pfizer###Hot Topic Speaker: – Pfizer
### 2:30 PM – 3:30 PM ET
Speaker Spotlight: Complex GenericsGovernment Speaker: – US Food and Drug Adminstration
Moderator: – Pfizer Worldwide Research and Development
Formulation and Delivery
2:30 PM – 3:30 PM ET
Speaker Spotlight: Complex GenericsLocation:Spotlight Stage 3, Exhibit Hall A&BGovernment Speaker: – US Food and Drug Adminstration
Moderator: – Pfizer Worldwide Research and Development
Formulation and Delivery
Sam Raney, PhD – US Food and Drug Adminstration ### 604299###Government Speaker###Associate Director for Science###US Food and Drug Adminstration###Government Speaker: – US Food and Drug Adminstration
### @@@ Jaymin C. Shah, PhD – Pfizer Worldwide Research and Development ### 1554431###Moderator###Research Fellow and Head of Topical and Advanced Drug Delivery###Pfizer Worldwide Research and Development###Moderator: – Pfizer Worldwide Research and Development
### 2:30 PM – 3:30 PM ET
Speaker Spotlight: Understanding Clinical Immunogenicity Impact for a Bispecific Antibody AgonistSpotlight Speaker: – Genentech
Moderator: – Janssen R&D / J&J
Bioanalytics – Biomolecular
2:30 PM – 3:30 PM ET
Speaker Spotlight: Understanding Clinical Immunogenicity Impact for a Bispecific Antibody AgonistLocation:Spotlight Stage 2, Exhibit Hall A&BSpotlight Speaker: – Genentech
Moderator: – Janssen R&D / J&J
Bioanalytics – Biomolecular
Yanqiu (Emma) Liu, PhD – Genentech ### 1075489###Spotlight Speaker###Senior Principal Scientist###Genentech###Spotlight Speaker: – Genentech
### @@@ William Hallet, PhD (he/him/his) – Janssen R&D / J&J ### 1723662###Moderator###Associate Scientific Director###Janssen R&D / J&J###Moderator: – Janssen R&D / J&J
### he/him/his2:30 PM – 3:30 PM ET
Special Poster Collection
2:30 PM – 3:30 PM ET
Special Poster CollectionLocation:Poster Forum #2, Exhibit Hall A&BPoster Collection Host: – Purdue University
Tonglei Li, PhD – Purdue University ### 602266###Poster Collection Host###Professor###Purdue University###Poster Collection Host: – Purdue University
### 3:00 PM – 3:45 PM ET
Rapid Fire: Analytical and Predictive Approaches in Drug Development and Manufacturing (BM)Rapid Fire Moderator: – Sanofi
Manufacturing & Analytical Characterization – Biomolecular
3:00 PM – 3:45 PM ET
Rapid Fire: Analytical and Predictive Approaches in Drug Development and Manufacturing (BM)Location:205 CRapid Fire Moderator: – Sanofi
Manufacturing & Analytical Characterization – Biomolecular
Jianmei D. Kochling, PhD, MBA – Sanofi ### 465971###Rapid Fire Moderator###Senior Director###Sanofi###Rapid Fire Moderator: – Sanofi
### 3:00 PM – 3:15 PM ET
Addressing Secondary Interactions in Size Exclusion Chromatography of Protein TherapeuticsLocation:205 CRapid Fire Speaker: – Waters Corporation
Manufacturing & Analytical Characterization – Biomolecular
Lavelay O. Kizekai – Waters Corporation ### 1755686###Rapid Fire Speaker###Sr. Scientist###Waters Corporation###Rapid Fire Speaker: – Waters Corporation
### 3:15 PM – 3:30 PM ET
High Polysorbate 80 in the Formulation Impacts the Structure and Function Assessment of Cation Exchange Fractions of a Monoclonal AntibodyLocation:205 CRapid Fire Speaker: – Merck
Manufacturing & Analytical Characterization – Biomolecular
Kaizhu Guo, PhD – Merck ### 1755923###Rapid Fire Speaker###Senior Scientist###Merck###Rapid Fire Speaker: – Merck
### 3:30 PM – 3:45 PM ET
Multi -Attribute-Monitoring (MAM) of Biopharmaceuticals Using High-Res QTOF Mass SpectrometryLocation:205 CRapid Fire Speaker: – Shimadzu Scientific Instruments Inc - Columbia, MD
Manufacturing & Analytical Characterization – Biomolecular
Mridul Mandal, PhD – Shimadzu Scientific Instruments Inc - Columbia, MD ### 1755679###Rapid Fire Speaker###Market Manager - Pharma/Biopharma###Shimadzu Scientific Instruments Inc - Columbia, MD###Rapid Fire Speaker: – Shimadzu Scientific Instruments Inc - Columbia, MD
### 3:00 PM – 3:45 PM ET
Rapid Fire: Bridging The Cross-Functional Silos To Expedite Compound Progression Into The Clinic (BM)Rapid Fire Moderator: – Albany College of Pharmacy and Health Sciences
Preclinical Development – Biomolecular
3:00 PM – 3:45 PM ET
Rapid Fire: Bridging The Cross-Functional Silos To Expedite Compound Progression Into The Clinic (BM)Location:254 ARapid Fire Moderator: – Albany College of Pharmacy and Health Sciences
Preclinical Development – Biomolecular
HaiAn Zheng, PhD – Albany College of Pharmacy and Health Sciences ### 1755749###Rapid Fire Moderator###Associate Profession###Albany College of Pharmacy and Health Sciences ###Rapid Fire Moderator: – Albany College of Pharmacy and Health Sciences
### 3:00 PM – 3:15 PM ET
Positively Charged Surface in LIGHT Trimers Fused with Fc, a Ligand for Lymphotoxin-b Receptor (LTbR) and HVEM, Caused a Non-specific Interaction with Cells Leading to Fast Systemic Clearance in MiceLocation:254 ARapid Fire Speaker: – Genentech, Inc.
Preclinical Development – Biomolecular
Victor F. Yip, BS – Genentech, Inc. ### 848682###Rapid Fire Speaker###Principal Senior Scientific Researcher###Genentech, Inc.###Rapid Fire Speaker: – Genentech, Inc.
### 3:15 PM – 3:30 PM ET
More than the Sum of Its Parts: In Silico Immunogenicity Risk Assessment for Fusion Proteins and Novel Antibody ModalitiesLocation:254 ARapid Fire Speaker: – EpiVax, Inc.
Preclinical Development – Biomolecular
Frances Terry, MPH – EpiVax, Inc. ### 572017###Rapid Fire Speaker###Director of Analysis###EpiVax, Inc.###Rapid Fire Speaker: – EpiVax, Inc.
### 3:30 PM – 3:45 PM ET
Investigating Protein-Excipient Interactions Using NMR SpectroscopyLocation:254 ARapid Fire Speaker: – Merck & Co. Inc
Preclinical Development – Biomolecular
Jainik PANCHAL, PhD – Merck & Co. Inc ### 1755680###Rapid Fire Speaker###Associate Principal Scientist###Merck & Co. Inc###Rapid Fire Speaker: – Merck & Co. Inc
### 3:00 PM – 3:45 PM ET
Rapid Fire: Oncotargets: Challenges & OpportunitiesRapid Fire Moderator: – Husson University
Discovery and Basic Research
3:00 PM – 3:45 PM ET
Rapid Fire: Oncotargets: Challenges & OpportunitiesLocation:255Rapid Fire Moderator: – Husson University
Discovery and Basic Research
Muhammad D. Hussain, PhD (he/him/his) – Husson University ### 1794283###Rapid Fire Moderator###Professor of Pharmaceutics###Husson University###Rapid Fire Moderator: – Husson University
### he/him/his3:00 PM – 3:15 PM ET
Listeria-Based Vaccine Targeting Interferon-Stimulated Gene 15 for Renal Cell CarcinomaLocation:255Rapid Fire Speaker: – Texas Tech University Health Sciences Center
Discovery and Basic Research
HONG-MY NGUYEN – Texas Tech University Health Sciences Center ### 1689474###Rapid Fire Speaker###Ph.D. Student###Texas Tech University Health Sciences Center###Rapid Fire Speaker: – Texas Tech University Health Sciences Center
### 3:15 PM – 3:30 PM ET
Interaction with Macrophages Alters the Susceptibility of Cancer Cells to FerroptosisLocation:255Rapid Fire Speaker: – Osaka University
Discovery and Basic Research
Yuya Haga, PhD – Osaka University ### 1689734###Rapid Fire Speaker###Assistant Professor###Osaka University###Rapid Fire Speaker: – Osaka University
### 3:30 PM – 3:45 PM ET
Viral Mimicry NanoVaccine Boosting B Immunity to Enhance Anti-cancer EfficacyLocation:255Rapid Fire Speaker: – University of Michigan
Discovery and Basic Research
Chengyi Li, MS – University of Michigan ### 1689490###Rapid Fire Speaker###Graduate Student###University of Michigan###Rapid Fire Speaker: – University of Michigan
### 3:00 PM – 3:45 PM ET
Rapid Fire: Recent Development in Prophylactic Therapies and Vaccines (BM)Rapid Fire Moderator: – Auburn University
Formulation and Delivery – Biomolecular
3:00 PM – 3:45 PM ET
Rapid Fire: Recent Development in Prophylactic Therapies and Vaccines (BM)Location:204 ABRapid Fire Moderator: – Auburn University
Formulation and Delivery – Biomolecular
Jayachandra Babu Ramapuram, PhD (he/him/his) – Auburn University ### 847391###Rapid Fire Moderator###Professor###Auburn University###Rapid Fire Moderator: – Auburn University
### he/him/his3:00 PM – 3:15 PM ET
Towards a Bivalent-Microparticulate 3D-Printed Buccal Film-Based Universal Vaccine Against COVID-19Location:204 ABRapid Fire Speaker: – Mercer University College of Pharmacy
Formulation and Delivery – Biomolecular
Smital R. Patil, Bachelor of Pharmacy – Mercer University College of Pharmacy ### 1045776###Rapid Fire Speaker###Ph.D Candidate###Mercer University College of Pharmacy###Rapid Fire Speaker: – Mercer University College of Pharmacy
### 3:15 PM – 3:30 PM ET
Biotin Nanoparticles as Immune Cell Activator and Protein CarrierLocation:204 ABRapid Fire Speaker: – Duquesne University School of Pharmacy - Graduate School of Pharmaceutical Scien
Formulation and Delivery – Biomolecular
Paul Hartmeier, BA – Duquesne University School of Pharmacy - Graduate School of Pharmaceutical Scien ### 1045918###Rapid Fire Speaker###Graduate Student###Duquesne University School of Pharmacy - Graduate School of Pharmaceutical Scien###Rapid Fire Speaker: – Duquesne University School of Pharmacy - Graduate School of Pharmaceutical Scien
### 3:30 PM – 3:45 PM ET
Redesigning Vaccine Delivery: Microneedle Vaccination for COVID-19 and InfluenzaLocation:204 ABRapid Fire Speaker: – Mercer University
Formulation and Delivery – Biomolecular
Sharon Vijayanand, B. Pharm – Mercer University ### 1045775###Rapid Fire Speaker###Ph.D. Candidate###Mercer University###Rapid Fire Speaker: – Mercer University
### 3:00 PM – 4:00 PM ET
A Look into the Future of BioanalyticsPartner Presentation Speaker: – Q2 Solutions
Partner Presentation Speaker: – Q2 Solutions
Bioanalytics
3:00 PM – 4:00 PM ET
A Look into the Future of BioanalyticsLocation:360 Stage #1, Exhibit Hall A&BPartner Presentation Speaker: – Q2 Solutions
Partner Presentation Speaker: – Q2 Solutions
Bioanalytics
Barry Jones, PhD – Q2 Solutions ### 466060###Partner Presentation Speaker###Director LC-MS Biologics & Biomarkers###Q2 Solutions###Partner Presentation Speaker: – Q2 Solutions
### @@@ Todd Lusk (he/him/his) – Q2 Solutions ### 1743100###Partner Presentation Speaker###Senior Scientist - Assay Development###Q2 Solutions###Partner Presentation Speaker: – Q2 Solutions
### he/him/his3:00 PM – 4:00 PM ET
Career Transitions Between Academia Industry and Regulatory AgencyCareer Center Moderator: – BMS
Career Center Speaker: – Department of Chemical and Biomolecular Engineering University of Maryland
Government Speaker:
Career Center Speaker: – Merck
Career Development
3:00 PM – 4:00 PM ET
Career Transitions Between Academia Industry and Regulatory AgencyLocation:360 Stage #3, Exhibit Hall A&BCareer Center Moderator: – BMS
Career Center Speaker: – Department of Chemical and Biomolecular Engineering University of Maryland
Government Speaker:
Career Center Speaker: – Merck
Career Development
Hiten J. Gutka, PhD – BMS ### 1650366###Career Center Moderator###Sr. Principal Scientist Drug Product Development###BMS###Career Center Moderator: – BMS
### @@@ Deborah S. Goldberg, PhD – Department of Chemical and Biomolecular Engineering University of Maryland ### 1650367###Career Center Speaker###Senior Lecturer Dept. of Chemical Engineering###Department of Chemical and Biomolecular Engineering University of Maryland###Career Center Speaker: – Department of Chemical and Biomolecular Engineering University of Maryland
### @@@ Rohit Kolhatkar ### 1699106###Government Speaker#########Government Speaker:
### @@@ Sachin Lohani, PhD – Merck ### 1477305###Career Center Speaker###Director###Merck###Career Center Speaker: – Merck
### 3:00 PM – 4:00 PM ET
Happy Hour Sponsored by Alturas Analytics
3:00 PM – 4:00 PM ET
Happy Hour Sponsored by Alturas AnalyticsLocation:Booth #631, Exhibit Hall A&B
3:00 PM – 4:00 PM ET
Happy Hour Sponsored by CoreRx
3:00 PM – 4:00 PM ET
Happy Hour Sponsored by CoreRxLocation:Booth #230, Exhibit Hall A&B
3:00 PM – 4:00 PM ET
Happy Hour Sponsored by Gattefossé Corporation
3:00 PM – 4:00 PM ET
Happy Hour Sponsored by Gattefossé Corporation Location:Booth #216, Exhibit Hall A&BSponsored By Gattefossé Corp.
3:00 PM – 4:00 PM ET
Meet The Employers: Hosted by AbbVie
3:00 PM – 4:00 PM ET
Meet The Employer: Hosted by AbbVieLocation:Career Development Center, Exhibit Hall A&BCareer Development
3:00 PM – 4:00 PM ET
Rapid Fire: Analytical and Predictive Approaches in Drug Development and Manufacturing (CE)Rapid Fire Moderator: – Merck & Co., Inc.
Manufacturing & Analytical Characterization – Chemical
3:00 PM – 4:00 PM ET
Rapid Fire: Analytical and Predictive Approaches in Drug Development and Manufacturing (CE)Location:206 ABRapid Fire Moderator: – Merck & Co., Inc.
Manufacturing & Analytical Characterization – Chemical
Rosalind Ang, PhD – Merck & Co., Inc. ### 1762952###Rapid Fire Moderator###Associate Principal Scientist###Merck & Co., Inc.###Rapid Fire Moderator: – Merck & Co., Inc.
### 3:00 PM – 3:15 PM ET
Advanced Microstructure Characterization of Extended-Release Claritin FormulationsLocation:206 ABRapid Fire Speaker: – DigiM Solution LLC
Manufacturing & Analytical Characterization – Chemical
Phillip D. Yawman, BS – DigiM Solution LLC ### 1689842###Rapid Fire Speaker###Senior Application Scientist###DigiM Solution LLC###Rapid Fire Speaker: – DigiM Solution LLC
### 3:15 PM – 3:30 PM ET
Coat Weight and Backing Membrane Effect on Adhesion of PatchesLocation:206 ABRapid Fire Speaker: – Florida A&M University
Manufacturing & Analytical Characterization – Chemical
Oluwaseyi Salau, BS – Florida A&M University ### 1690335###Rapid Fire Speaker###Graduate Student Researcher###Florida A&M University###Rapid Fire Speaker: – Florida A&M University
### 3:30 PM – 3:45 PM ET
Material-Sparing Assessment of the Manufacturability of Long Acting Injectable SuspensionsLocation:206 ABRapid Fire Speaker: – GlaxoSmithKline
Manufacturing & Analytical Characterization – Chemical
Parind Desai, PhD – GlaxoSmithKline ### 1650328###Rapid Fire Speaker###Scientific Leader, GSK Fellow###GlaxoSmithKline###Rapid Fire Speaker: – GlaxoSmithKline
### 3:45 PM – 4:00 PM ET
Potential Impact of the EU TiO2 Food Ban on PharmaceuticalsLocation:206 ABRapid Fire Speaker: – Black Diamond Regulatory Consulting/IPEC-Americas
Manufacturing & Analytical Characterization – Chemical
David R. Schoneker, M.S. – Black Diamond Regulatory Consulting/IPEC-Americas ### 1011741###Rapid Fire Speaker###President/Owner/Consultant & Vice Chair of IPEC-Americas QbD Committee###Black Diamond Regulatory Consulting/IPEC-Americas###Rapid Fire Speaker: – Black Diamond Regulatory Consulting/IPEC-Americas
### 3:00 PM – 4:00 PM ET
Rapid Fire: Beyond Legacy Therapeutics - Navigating the Path Less Traveled (BM)Rapid Fire Moderator: – BioAgilytix Labs
Bioanalytics – Biomolecular
3:00 PM – 4:00 PM ET
Rapid Fire: Beyond Legacy Therapeutics - Navigating the Path Less Traveled (BM)Location:253 BRapid Fire Moderator: – BioAgilytix Labs
Bioanalytics – Biomolecular
Chad J. Briscoe, PhD – BioAgilytix Labs ### 605822###Rapid Fire Moderator###Scientific Officer / VP Business Development Europe###BioAgilytix Labs###Rapid Fire Moderator: – BioAgilytix Labs
### 3:00 PM – 3:15 PM ET
Qualified RT-qPCR Assays to Measure Transgene and Target Gene ExpressionLocation:253 BRapid Fire Speaker: – Sangamo Therapeutics
Bioanalytics – Biomolecular
Yanmei Lu, PhD – Sangamo Therapeutics ### 1650349###Rapid Fire Speaker###VP of Biomarker and BioAnalytical Sciences###Sangamo Therapeutics###Rapid Fire Speaker: – Sangamo Therapeutics
### 3:15 PM – 3:30 PM ET
Assay Optimization to Detect Treatment-Boosted Neutralizing Anti-Transgene Antibodies in PatientsLocation:253 BRapid Fire Speaker: – Sangamo Therapeutics
Bioanalytics – Biomolecular
Joshua Holter – Sangamo Therapeutics ### 1755695###Rapid Fire Speaker###BioAnalytical Scientist###Sangamo Therapeutics###Rapid Fire Speaker: – Sangamo Therapeutics
### 3:30 PM – 3:45 PM ET
Acceptable Level of Precision in qPCR Assay ValidationsLocation:253 BRapid Fire Speaker: – Eurofins-Viracor
Bioanalytics – Biomolecular
Mark C. Wissel, PhD – Eurofins-Viracor ### 1651144###Rapid Fire Speaker###Director, R&D###Eurofins-Viracor###Rapid Fire Speaker: – Eurofins-Viracor
### 3:45 PM – 4:00 PM ET
Detecting Species-Specific Cytosolic Transgene Protein Supporting Liver Gene Therapy StudiesLocation:253 BRapid Fire Speaker: – Sangamo Therapeutics
Bioanalytics – Biomolecular
Joshua Holter – Sangamo Therapeutics ### 1755695###Rapid Fire Speaker###BioAnalytical Scientist###Sangamo Therapeutics###Rapid Fire Speaker: – Sangamo Therapeutics
### 3:00 PM – 4:00 PM ET
Rapid Fire: Beyond Legacy Therapeutics - Navigating the Path Less Traveled (CE)Rapid Fire Moderator: – BioAgilytix
Bioanalytics – Chemical
3:00 PM – 4:00 PM ET
Rapid Fire: Beyond Legacy Therapeutics - Navigating the Path Less Traveled (CE)Location:253 ARapid Fire Moderator: – BioAgilytix
Bioanalytics – Chemical
Amanda Hays, Ph.D. – BioAgilytix ### 1529523###Rapid Fire Moderator###Scientific Officer###BioAgilytix###Rapid Fire Moderator: – BioAgilytix
### 3:00 PM – 3:15 PM ET
Quantitation of Dystrophin and Microdystrophin by A Hybrid LBA/LC-MS AssayLocation:253 ARapid Fire Speaker: – REGENXBIO, Inc.
Bioanalytics – Chemical
Hua Wang, PhD – REGENXBIO, Inc. ### 1447044###Rapid Fire Speaker###Sr Scientist###REGENXBIO, Inc.###Rapid Fire Speaker: – REGENXBIO, Inc.
### 3:15 PM – 3:30 PM ET
The Bioanalysis of ADC Therapeutics in Monkey Serum by IC-LC-MS in the Lead Nomination Stage Location:253 ARapid Fire Speaker: – WuXi AppTec
Bioanalytics – Chemical
Jim Yamashita, PhD – WuXi AppTec ### 1650378###Rapid Fire Speaker###Senior Director, Small Molecule Bioanalysis###WuXi AppTec###Rapid Fire Speaker: – WuXi AppTec
### 3:30 PM ET
Is Hybrid LC-MS/MS Becoming The New Gold Standard? Unique Case Studies Highlighting the Power of Hybrid LCMS – ADCs, MAbs and Other Protein Therapeutics Location:253 ARapid Fire Speaker: – KCAS
Bioanalytics – Chemical
Dawn Dufield, PhD – KCAS ### 466205###Rapid Fire Speaker###Senior Director Biopharma Services - LC-MS/MS###KCAS###Rapid Fire Speaker: – KCAS
### 3:45 PM – 4:00 PM ET
Immunocapture and Tryptic Digest for Quantitation of a Biomarker in Monkey SerumLocation:253 ARapid Fire Speaker: – Bioagilytix
Bioanalytics – Chemical
Christian Smith (he/him/his) – Bioagilytix ### 1791680###Rapid Fire Speaker###Scientist###Bioagilytix###Rapid Fire Speaker: – Bioagilytix
### he/him/his3:00 PM – 4:00 PM ET
Rapid Fire: Bridging The Cross-Functional Silos To Expedite Compound Progression Into The Clinic (CE)Rapid Fire Moderator: – Takeda
Preclinical Development – Chemical
3:00 PM – 4:00 PM ET
Rapid Fire: Bridging The Cross-Functional Silos To Expedite Compound Progression Into The Clinic (CE)Location:253 CRapid Fire Moderator: – Takeda
Preclinical Development – Chemical
Haiqing Wang, PhD – Takeda ### 1650380###Rapid Fire Moderator###Director###Takeda###Rapid Fire Moderator: – Takeda
### 3:00 PM – 3:15 PM ET
Cannabidiol Loaded Extracellular Vesicles Alleviate Paclitaxel Induced Peripheral NeuropathyLocation:253 CRapid Fire Speaker: – Florida A&M University
Preclinical Development – Chemical
Mandip S. Sachdeva, PhD – Florida A&M University ### 848734###Rapid Fire Speaker###Professor###Florida A&M University###Rapid Fire Speaker: – Florida A&M University
### 3:15 PM – 3:30 PM ET
Enabling Preclinical Bioperformance Prediction Through Data AnalyticsLocation:253 CRapid Fire Speaker: – Merck & Co, Inc.
Preclinical Development – Chemical
Pierre Daublain, PhD – Merck & Co, Inc. ### 1755700###Rapid Fire Speaker###Principal Scientist###Merck & Co, Inc.###Rapid Fire Speaker: – Merck & Co, Inc.
### 3:30 PM – 3:45 PM ET
Using the Dynamic Gastric Model (DGM) to Predict Food EffectsLocation:253 CRapid Fire Speaker: – Bioneer A/S
Preclinical Development – Chemical
Matthias M. Knopp, PhD – Bioneer A/S ### 606140###Rapid Fire Speaker###Principal Scientist###Bioneer A/S###Rapid Fire Speaker: – Bioneer A/S
### 3:45 PM – 4:00 PM ET
Small Molecule Crystallographic and Modeling Strategies to Improve SolubilityLocation:253 CRapid Fire Speaker: – Merck
Preclinical Development – Chemical
Tina Xiong, PhD – Merck ### 1755667###Rapid Fire Speaker###Associate Principal Scientist###Merck###Rapid Fire Speaker: – Merck
### 3:00 PM – 4:00 PM ET
Rapid Fire: COVID Pandemic and Beyond: Role of Clinical Pharmacology in Development of Non-COVID and COVID Drugs (BM)Rapid Fire Moderator: – Johnson and Johnson
Clinical Pharmacology – Biomolecular
3:00 PM – 4:00 PM ET
Rapid Fire: COVID Pandemic and Beyond: Role of Clinical Pharmacology in Development of Non-COVID and COVID Drugs (BM)Location:152Rapid Fire Moderator: – Johnson and Johnson
Clinical Pharmacology – Biomolecular
Hardik Mody, PhD – Johnson and Johnson ### 1010836###Rapid Fire Moderator###Principal Scientist###Johnson and Johnson###Rapid Fire Moderator: – Johnson and Johnson
### 3:00 PM – 3:15 PM ET
Clinical Pharmacology in COVID-19 Drug Development: Remaining Agile During a Public Health EmergencyLocation:152Rapid Fire Speaker: – Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, OTS, CDER, FDA
Clinical Pharmacology – Biomolecular
Kellie S. Reynolds, PharmD – Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, OTS, CDER, FDA ### 796154###Rapid Fire Speaker###Division Director###Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, OTS, CDER, FDA###Rapid Fire Speaker: – Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, OTS, CDER, FDA
### 3:15 PM – 3:30 PM ET
Drug Interactions with PaxlovidLocation:152Rapid Fire Speaker: – Pfizer
Clinical Pharmacology – Biomolecular
Bharat Damle, PhD – Pfizer ### 845568###Rapid Fire Speaker###Executive Director###Pfizer###Rapid Fire Speaker: – Pfizer
### 3:30 PM – 3:45 PM ET
Challenges in Dose Adjustment for a SARS COV-2 Variant Based on in-vitro Neutralization DataLocation:152Rapid Fire Speaker: – Regeneron Pharmaceuticals
Clinical Pharmacology – Biomolecular
Kenneth Turner, PhD – Regeneron Pharmaceuticals ### 1650345###Rapid Fire Speaker###Sr Group Director, Clinical Pharmacology###Regeneron Pharmaceuticals###Rapid Fire Speaker: – Regeneron Pharmaceuticals
### 3:45 PM – 4:00 PM ET
Rethinking the Role of Clinical Pharmacology in a Systems Perspective to Accelerate Biologics (mAbs, Cytokine Modulator) Development Location:152Rapid Fire Speaker: – Center for WE-REACH
Clinical Pharmacology – Biomolecular
Rodney J. Ho, Ph.D NAI FAAPS FAAAS – Center for WE-REACH ### 1046065###Rapid Fire Speaker###Executive Director and Professor###Center for WE-REACH###Rapid Fire Speaker: – Center for WE-REACH
### 3:00 PM – 4:00 PM ET
Rapid Fire: COVID Pandemic and Beyond: Role of Clinical Pharmacology in Development of Non-COVID and COVID Drugs (CE)Rapid Fire Moderator: – Agios Pharmaceuticals
Clinical Pharmacology – Chemical
3:00 PM – 4:00 PM ET
Rapid Fire: COVID Pandemic and Beyond: Role of Clinical Pharmacology in Development of Non-COVID and COVID Drugs (CE)Location:151 ABRapid Fire Moderator: – Agios Pharmaceuticals
Clinical Pharmacology – Chemical
Punit Marathe, PhD – Agios Pharmaceuticals ### 1010799###Rapid Fire Moderator###Vice President DMPK-TOX###Agios Pharmaceuticals###Rapid Fire Moderator: – Agios Pharmaceuticals
### 3:00 PM – 3:15 PM ET
19F-NMR as a Tool for Paxlovid ADME Studies Location:151 ABRapid Fire Speaker: – Pfizer
Clinical Pharmacology – Chemical
Arthur Bergman, PhD (he/him/his) – Pfizer ### 1800096###Rapid Fire Speaker###Clinical Pharmacology Group Head - Anti-infectives, Early Clinical Development ###Pfizer###Rapid Fire Speaker: – Pfizer
### he/him/his3:15 PM – 3:30 PM ET
Paxlovid Dose Recommendations in Special PopulationsLocation:151 ABRapid Fire Speaker: – Pfizer
Clinical Pharmacology – Chemical
Donna S. Cox, PhD – Pfizer ### 1755874###Rapid Fire Speaker###Senior Director, Clinical Pharmacology Group Lead; Global Product Development###Pfizer###Rapid Fire Speaker: – Pfizer
### 3:30 PM – 3:45 PM ET
Rapid Repurposing of a QSP Platform to Guide COVID-19 Vaccine DevelopmentLocation:151 ABRapid Fire Speaker: – Certara
Clinical Pharmacology – Chemical
Piet H. van der Graaf, PharmD, PhD – Certara ### 1308013###Rapid Fire Speaker###Senior Vice President QSP###Certara###Rapid Fire Speaker: – Certara
### 3:45 PM – 4:00 PM ET
Rethinking the Role of Clinical Pharmacology in a Systems Perspective to Accelerate Small Molecules (Entry, Protease and Polymerase Inhibitors) Development Location:151 ABRapid Fire Speaker: – University of Washington
Clinical Pharmacology – Chemical
Simone Perazzolo, PhD – University of Washington ### 1695214###Rapid Fire Speaker###Scientist###University of Washington###Rapid Fire Speaker: – University of Washington
### 3:00 PM – 4:00 PM ET
Rapid Fire: Rapid Discovery of Therapeutics: Past Experience and Computational ApproachesRapid Fire Moderator: – Novartis Institutes for Biomedical Research
Discovery and Basic Research
3:00 PM – 4:00 PM ET
Rapid Fire: Rapid Discovery of Therapeutics: Past Experience and Computational ApproachesLocation:254 BRapid Fire Moderator: – Novartis Institutes for Biomedical Research
Discovery and Basic Research
Ryan Polli, PhD – Novartis Institutes for Biomedical Research ### 1777897###Rapid Fire Moderator###Principal Scientist II - Pharmacokinetic Sciences###Novartis Institutes for Biomedical Research###Rapid Fire Moderator: – Novartis Institutes for Biomedical Research
### 3:00 PM – 3:15 PM ET
Deep Learned Screenings of Peptide Vaccines for Exosome-Based Precision DeliveryLocation:254 BRapid Fire Speaker: – University of Florida
Discovery and Basic Research
Zachary Greenberg, MS – University of Florida ### 1328730###Rapid Fire Speaker###Doctoral Student###University of Florida###Rapid Fire Speaker: – University of Florida
### 3:15 PM – 3:30 PM ET
Early Feasibility Assessment of Biotherapeutics Dosing RequirementsLocation:254 BRapid Fire Speaker: – Applied BioMath
Discovery and Basic Research
Fei Hua, PhD – Applied BioMath ### 624501###Rapid Fire Speaker###VP of Modeling and Simulation Services###Applied BioMath###Rapid Fire Speaker: – Applied BioMath
### 3:30 PM – 3:45 PM ET
Personalized Prediction of FDA Approved Drugs with AI/ML for Precision Oncology ApplicationsLocation:254 BDiscovery and Basic Research
Jake Chen ### 1768512###Rapid Fire Speaker#########Rapid Fire Speaker:
### 3:00 PM – 4:00 PM ET
Rapid Fire: Recent Development in Prophylactic Therapies and Vaccines (CE)Rapid Fire Moderator: – Merck & Co., Inc.
Formulation and Delivery – Chemical
3:00 PM – 4:00 PM ET
Rapid Fire: Recent Development in Prophylactic Therapies and Vaccines (CE)Location:205 ABRapid Fire Moderator: – Merck & Co., Inc.
Formulation and Delivery – Chemical
Suman A. Luthra, PhD – Merck & Co., Inc. ### 1689830###Rapid Fire Moderator###Director###Merck & Co., Inc.###Rapid Fire Moderator: – Merck & Co., Inc.
### 3:00 PM – 3:15 PM ET
Enzyme-Responsive Peptide Hydrogels as Long-Acting Injectable Implants for HIV/AIDS PreventionLocation:205 ABRapid Fire Speaker: – Queen's University Belfast
Formulation and Delivery – Chemical
Garry Laverty, MPharm PhD – Queen's University Belfast ### 1755682###Rapid Fire Speaker###Associate Professor in Pharmaceutical Sciences###Queen's University Belfast###Rapid Fire Speaker: – Queen's University Belfast
### 3:15 PM – 3:30 PM ET
Inhaled Clofazimine Particles: An Important Tool Against Mycobacterial Lung InfectionsLocation:205 ABRapid Fire Speaker: – University of Michigan
Formulation and Delivery – Chemical
Ashlee D. Brunaugh, Pharm.D. PhD – University of Michigan ### 1755701###Rapid Fire Speaker###Assistant Professor###University of Michigan###Rapid Fire Speaker: – University of Michigan
### 3:30 PM – 3:45 PM ET
Inhaled Delivery of Lung Cancer Therapeutics for Optimizing Local DosingLocation:205 ABRapid Fire Speaker: – Lonza Pharma & Biotech
Formulation and Delivery – Chemical
David K. Lyon, PhD – Lonza Pharma & Biotech ### 870066###Rapid Fire Speaker###Sr. Fellow, Research (Lonza Bend)###Lonza Pharma & Biotech###Rapid Fire Speaker: – Lonza Pharma & Biotech
### 3:45 PM – 4:00 PM ET
Oral delivery of Amphotericin B by Lipid-Based Drug Delivery SystemsLocation:205 ABRapid Fire Speaker: – University of Copenhagen
Formulation and Delivery – Chemical
Anette Mullertz, PhD – University of Copenhagen ### 466033###Rapid Fire Speaker###Professor###University of Copenhagen###Rapid Fire Speaker: – University of Copenhagen
### 3:00 PM – 4:00 PM ET
Start-up Pavilion Meet & Greet and New England Brewery Tour
3:00 PM – 4:00 PM ET
Start-up Pavilion Meet & Greet and New England Brewery TourLocation:Start-up Pavilion (Aisle 1500), Exhibit Hall A&B
3:30 PM – 4:30 PM ET
A Patient Centric Solution for Development of Oral Dosage FormsPartner Presentation Speaker: – Catalent, Inc.
Formulation and Delivery
3:30 PM – 4:30 PM ET
A Patient Centric Solution for Development of Oral Dosage FormsLocation:360 Stage #2, Exhibit Hall A&BPartner Presentation Speaker: – Catalent, Inc.
Formulation and Delivery
Karunakar Sukuru, PhD – Catalent, Inc. ### 1690085###Partner Presentation Speaker###Vice President- Product Development -Pharma Product Delivery###Catalent, Inc.###Partner Presentation Speaker: – Catalent, Inc.
### 3:30 PM – 4:30 PM ET
Happy Hour Sponsored by WuXi AppTec
3:30 PM – 4:30 PM ET
Happy Hour Sponsored by WuXi AppTecLocation:Booth #723, Exhibit Hall A&B
3:30 PM – 4:30 PM ET
Hot Topic: Learnings From Managing Immunogenicity Risks to Protein Based Therapeutics; Need to Pivot for Cell and Gene Therapies or 1 Size Fits All?Hot Topic Moderator: – Epivax
Preclinical Development – Biomolecular
3:30 PM – 4:30 PM ET
Hot Topic: Learnings From Managing Immunogenicity Risks to Protein Based Therapeutics; Need to Pivot for Cell and Gene Therapies or 1 Size Fits All?Location:153 BCHot Topic Moderator: – Epivax
Preclinical Development – Biomolecular
Amy S. Rosenberg, MD – Epivax ### 567446###Hot Topic Moderator###Senior Director of Immunology ###Epivax###Hot Topic Moderator: – Epivax
### 3:30 PM – 3:45 PM ET
Deimmunization and Immune Tolerance Strategies for Protein Therapeutics: Extension of Principles to Novel Therapeutic Modalities.Location:153 BCHot Topic Speaker: – EpiVax, Inc.
Preclinical Development – Biomolecular
Anne De Groot, MD – EpiVax, Inc. ### 1447113###Hot Topic Speaker###CEO/CSO###EpiVax, Inc.###Hot Topic Speaker: – EpiVax, Inc.
### 3:45 PM – 4:00 PM ET
Preclinical and Clinical Immunogenicity Risk Mitigation and Management for CAR-T TherapiesLocation:153 BCHot Topic Speaker: – Bristol Myers Squibb
Preclinical Development – Biomolecular
Vibha Jawa, Ph.D., FAAPS – Bristol Myers Squibb ### 567586###Hot Topic Speaker###Executive Director###Bristol Myers Squibb###Hot Topic Speaker: – Bristol Myers Squibb
### 4:00 PM – 4:15 PM ET
Enhancing Engraftment of Hematopoietic Stem Cells Using CD117-Saporin Immunotoxin: Advantages in Gene Therapy, Allotransplantation and Tolerance InductionLocation:153 BCGovernment Speaker: – NIAID, NIH
Preclinical Development – Biomolecular
Philip Murphy, MD – NIAID, NIH ### 1686558###Government Speaker###Chief, Laboratory of Molecular Immunology###NIAID, NIH###Government Speaker: – NIAID, NIH
### 4:15 PM – 4:30 PM ET
Panel DiscussionLocation:153 BCHot Topic Moderator: – Epivax
Hot Topic Speaker: – EpiVax, Inc.
Government Speaker: – NIAID, NIH
Hot Topic Speaker: – Bristol Myers Squibb
Preclinical Development – Biomolecular
Amy S. Rosenberg, MD – Epivax ### 567446###Hot Topic Moderator###Senior Director of Immunology ###Epivax###Hot Topic Moderator: – Epivax
### @@@ Anne De Groot, MD – EpiVax, Inc. ### 1447113###Hot Topic Speaker###CEO/CSO###EpiVax, Inc.###Hot Topic Speaker: – EpiVax, Inc.
### @@@ Philip Murphy, MD – NIAID, NIH ### 1686558###Government Speaker###Chief, Laboratory of Molecular Immunology###NIAID, NIH###Government Speaker: – NIAID, NIH
### @@@ Vibha Jawa, Ph.D., FAAPS – Bristol Myers Squibb ### 567586###Hot Topic Speaker###Executive Director###Bristol Myers Squibb###Hot Topic Speaker: – Bristol Myers Squibb
### 3:30 PM – 4:30 PM ET
Special Poster Collection
3:30 PM – 4:30 PM ET
Special Poster CollectionLocation:Poster Forum #2, Exhibit Hall A&BPoster Collection Host: – AstraZeneca
Poster Collection Host: – AstraZeneca Pharmaceuticals
Annette Bak, PhD, MBA, FAAPS (she/her/hers) – AstraZeneca ### 466184###Poster Collection Host###Executive Director###AstraZeneca###Poster Collection Host: – AstraZeneca
### she/her/hers @@@ Wenzhan Yang, PhD – AstraZeneca Pharmaceuticals ### 1755694###Poster Collection Host###Associate Principal Scientist###AstraZeneca Pharmaceuticals###Poster Collection Host: – AstraZeneca Pharmaceuticals
### 3:30 PM – 4:30 PM ET
Using HME for Low-Cost, High-Volume, Excipient-Enabled Antimalarials for Underserved PopulationsPartner Presentation Speaker: – Queen’s University Belfast
Partner Presentation Speaker: – Rondol Industrie
Partner Presentation Speaker: – BASF Corporation
Formulation and Delivery
3:30 PM – 4:30 PM ET
Using HME for Low-Cost, High-Volume, Excipient-Enabled Antimalarials for Underserved PopulationsLocation:360 Stage #4, Exhibit Hall A&BPartner Presentation Speaker: – Queen’s University Belfast
Partner Presentation Speaker: – Rondol Industrie
Partner Presentation Speaker: – BASF Corporation
Formulation and Delivery
Gavin P. Andrews, PhD (he/him/his) – Queen’s University Belfast ### 602480###Partner Presentation Speaker###Professor Pharmaceutical Engineering###Queen’s University Belfast###Partner Presentation Speaker: – Queen’s University Belfast
### he/him/his @@@ Victoire de Margerie, PhD – Rondol Industrie ### 1743102###Partner Presentation Speaker###Executive Chairman###Rondol Industrie###Partner Presentation Speaker: – Rondol Industrie
### @@@ Lindsay M. Johnson, PhD – BASF Corporation ### 1137450###Partner Presentation Speaker###Global Technical Marketing Manager###BASF Corporation###Partner Presentation Speaker: – BASF Corporation
### 3:45 PM – 4:45 PM ET
Happy Hour Sponsored by Adare Pharma Solutions
3:45 PM – 4:45 PM ET
Happy Hour Sponsored by Adare Pharma SolutionsLocation:Booth #929, Exhibit Halls A & BSponsored By Adare Pharma
3:45 PM – 4:45 PM ET
Happy Hour Sponsored by Boston Analytical
3:45 PM – 4:45 PM ET
Happy Hour Sponsored by Boston AnalyticalLocation:Booth #1209, Exhibit Hall A&BSponsored By Boston Analytical
4:00 PM – 5:00 PM ET
AAPS Pharmacometrics Community Membership Meeting
4:00 PM – 5:00 PM ET
AAPS Pharmacometrics Community Membership Meeting Location:Spotlight Stage 1, Exhibit Hall A&B
Dipti Pawaskar ### 1779176###Community Leader#########Community Leader:
### 4:00 PM – 5:00 PM ET
AAPS Women in Pharmaceutical Science Community Membership Meeting Community Leader: – PPD Laboratories
4:00 PM – 5:00 PM ET
AAPS Women in Pharmaceutical Science Community Membership Meeting Location:Spotlight Stage 2, Exhibit Hall A&BCommunity Leader: – PPD Laboratories
Amy Lavelle, PhD (she/her/hers) – PPD Laboratories ### 802454###Community Leader###Director###PPD Laboratories###Community Leader: – PPD Laboratories
### she/her/hers5:00 PM – 6:00 PM ET
AAPS Biomarkers & Precision Medicine Community Membership MeetingCommunity Leader: – BioAgilytix
5:00 PM – 6:00 PM ET
AAPS Biomarkers & Precision Medicine Community Membership MeetingLocation:253 BCommunity Leader: – BioAgilytix
Amanda Hays, Ph.D. – BioAgilytix ### 1529523###Community Leader###Scientific Officer###BioAgilytix###Community Leader: – BioAgilytix
### 5:00 PM – 6:00 PM ET
AAPS Gene & Cell Therapy Products Community Membership MeetingCommunity Leader: – Johnson and Johnson
5:00 PM – 6:00 PM ET
AAPS Gene & Cell Therapy Products Community Membership MeetingLocation:253 ACommunity Leader: – Johnson and Johnson
Prathap Nagaraja Shastri, PhD – Johnson and Johnson ### 567445###Community Leader###Scientific Director###Johnson and Johnson ###Community Leader: – Johnson and Johnson
### 5:00 PM – 6:00 PM ET
AAPS Global Health Community Membership MeetingCommunity Leader: – Bill & Melinda Gates Medical Research Institute
5:00 PM – 6:00 PM ET
AAPS Global Health Community Membership MeetingLocation:255Community Leader: – Bill & Melinda Gates Medical Research Institute
Joleen T. White, PhD – Bill & Melinda Gates Medical Research Institute ### 627094###Community Leader###Head of Bioassay Development and Operations###Bill & Melinda Gates Medical Research Institute###Community Leader: – Bill & Melinda Gates Medical Research Institute
### 5:00 PM – 6:00 PM ET
AAPS In Vitro Release & Dissolution Testing Community Membership MeetingCommunity Leader: – Merck & Co., Inc.
5:00 PM – 6:00 PM ET
AAPS In Vitro Release & Dissolution Testing Community Membership MeetingLocation:253 CCommunity Leader: – Merck & Co., Inc.
Andre Hermans, PhD – Merck & Co., Inc. ### 624038###Community Leader###Director###Merck & Co., Inc.###Community Leader: – Merck & Co., Inc.
### 5:00 PM – 6:00 PM ET
AAPS Inhalation & Nasal Community Membership MeetingCommunity Leader: – St. John's University
5:00 PM – 6:00 PM ET
AAPS Inhalation & Nasal Community Membership MeetingLocation:153 ACommunity Leader: – St. John's University
Vivek Gupta, PhD – St. John's University ### 604838###Community Leader###Associate Professor, Pharmaceutical Sciences###St. John's University###Community Leader: – St. John's University
### 5:00 PM – 6:00 PM ET
AAPS Oral Biopharmaceutics & Absorption Modeling Community Membership MeetingCommunity Leader: – University of Bath
5:00 PM – 6:00 PM ET
AAPS Oral Biopharmaceutics & Absorption Modeling Community Membership MeetingLocation:254 BCommunity Leader: – University of Bath
Nikoletta Fotaki, PhD – University of Bath ### 847632###Community Leader###Reader in (Bio)Pharmaceutics###University of Bath###Community Leader: – University of Bath
### 5:00 PM – 6:00 PM ET
AAPS Protein Purification, Storage, Transportation, and Drug-Device Combination Community Membership MeetingCommunity Leader: – Drug Product Development / Bristol Myers Squibb
5:00 PM – 6:00 PM ET
AAPS Protein Purification, Storage, Transportation, and Drug-Device Combination Community Membership MeetingLocation:254 ACommunity Leader: – Drug Product Development / Bristol Myers Squibb
Mary E. Krause, Ph.D. – Drug Product Development / Bristol Myers Squibb ### 893994###Community Leader###Principal Scientist###Drug Product Development / Bristol Myers Squibb###Community Leader: – Drug Product Development / Bristol Myers Squibb
### 5:00 PM – 6:00 PM ET
AAPS Stability Community Membership Meeting
5:00 PM – 6:00 PM ET
AAPS Stability Community Membership MeetingLocation:153 BC
5:00 PM – 6:00 PM ET
AAPS Sterile Products Community Membership MeetingCommunity Leader: – Merck & Co., Inc.,
5:00 PM – 6:00 PM ET
AAPS Sterile Products Community Membership MeetingLocation:152Community Leader: – Merck & Co., Inc.,
Smeet Deshmukh, Ph.D. – Merck & Co., Inc., ### 803606###Community Leader###Principal Scientist###Merck & Co., Inc.,###Community Leader: – Merck & Co., Inc.,
### 5:00 PM – 6:00 PM ET
AAPS Therapeutic Product Immunogenicity Community Membership MeetingCommunity Leader: – Eli Lilly and Company
5:00 PM – 6:00 PM ET
AAPS Therapeutic Product Immunogenicity Community Membership MeetingLocation:151 ABCommunity Leader: – Eli Lilly and Company
Yi Wen, PhD – Eli Lilly and Company ### 1011767###Community Leader###Director###Eli Lilly and Company###Community Leader: – Eli Lilly and Company
### 5:00 PM – 7:00 PM ET
University of Kansas Pharmaceutical Chemistry Alumni Reception (Invitation Only)
5:00 PM – 7:00 PM ET
University of Kansas Pharmaceutical Chemistry Alumni Reception (Invitation Only)Location:Alcott Room, Westin Boston Seaport District Hotel
5:00 PM – 7:00 PM ET
University of Michigan College of Pharmacy Alumni and Friends Reception
5:00 PM – 7:00 PM ET
University of Michigan College of Pharmacy Alumni and Friends ReceptionLocation:Burroughs Room, Westin Boston Seaport District Hotel
5:30 PM – 7:30 PM ET
Minnesota Alumni Reception
5:30 PM – 7:30 PM ET
Minnesota Alumni ReceptionLocation:Douglas Room, Westin Boston Seaport District Hotel
5:30 PM – 7:30 PM ET
University at Buffalo, School of Pharmacy and Pharmaceutical Sciences, Alumni Reception
5:30 PM – 7:30 PM ET
University at Buffalo, School of Pharmacy and Pharmaceutical Sciences, Alumni ReceptionLocation:Lewis Room, Westin Boston Seaport District Hotel
5:30 PM – 7:30 PM ET
University of Texas - Austin, College of Pharmacy Alumni & Friends Reception
5:30 PM – 7:30 PM ET
University of Texas - Austin, College of Pharmacy Alumni & Friends ReceptionLocation:Fanueil Room, Westin Boston Seaport District Hotel
5:30 PM – 7:30 PM ET
University of Wisconsin-Madison Alumni & Friends Reception
5:30 PM – 7:30 PM ET
University of Wisconsin-Madison Alumni & Friends ReceptionLocation:Mediterranean Room, Renaissance
5:30 PM – 8:00 PM ET
University of Utah Pharmaceutics & Pharmaceutical Chemistry/Molecular Pharmaceutics Alumni Event
5:30 PM – 8:00 PM ET
University of Utah Pharmaceutics & Pharmaceutical Chemistry/Molecular Pharmaceutics Alumni EventLocation:Griffin Room, Westin Boston Seaport District Hotel
6:00 PM – 8:00 PM ET
2022 AAPS OSU Alumni and Friends Reception (Invitation Only)
6:00 PM – 8:00 PM ET
2022 AAPS OSU Alumni and Friends Reception (Invitation Only)Location:The Committee, 50 Northern Ave, Boston, MA 02210
6:00 PM – 8:00 PM ET
Purdue University College of Pharmacy Alumni and Friends Reception
6:00 PM – 8:00 PM ET
Purdue University College of Pharmacy Alumni and Friends ReceptionLocation:City Tap House Boston, 10 Boston Wharf Rd, Boston, MA 02210
6:00 PM – 8:00 PM ET
St. John's College of Pharmacy and Health Sciences
6:00 PM – 8:00 PM ET
St. John's College of Pharmacy and Health Sciences Location:Atlantic 3, Renaissance Boston Waterfront
6:00 PM – 9:00 PM ET
Vietnamese Association of Pharmaceutical Scientists
6:00 PM – 9:00 PM ET
Vietnamese Association of Pharmaceutical Scientists
Location:Phở Pasteur, 682 Washington St, Boston, MA, 02111
7:00 PM – 9:00 PM ET
President's Reception (by invitation only)
7:00 PM – 9:00 PM ET
President's Reception (by invitation only)Location:New England Aquarium
- Tuesday, October 18, 2022
7:00 AM – 8:30 AM ET
Mentoring Breakfast
7:00 AM – 8:30 AM ET
Mentoring BreakfastLocation:Harbor 1&2, Westin Boston Seaport District Hotel
7:30 AM – 5:00 PM ET
Registration Hours
7:30 AM – 5:00 PM ET
Registration Hours
Location:North Lobby
7:30 AM – 5:00 PM ET
Speaker Ready Room
7:30 AM – 5:00 PM ET
Speaker Ready Room
Location:252 AB
8:30 AM – 9:00 AM ET
Prologue: Advancements in Translational PK/PD Approaches Towards Novel Biologic ModalitiesPrologue Speaker: – Johnson and Johnson
Preclinical Development – Biomolecular
8:30 AM – 9:00 AM ET
Prologue: Advancements in Translational PK/PD Approaches Towards Novel Biologic ModalitiesLocation:254 APrologue Speaker: – Johnson and Johnson
Preclinical Development – Biomolecular
Prathap Nagaraja Shastri, PhD – Johnson and Johnson ### 567445###Prologue Speaker###Scientific Director###Johnson and Johnson ###Prologue Speaker: – Johnson and Johnson
### 8:30 AM – 9:00 AM ET
Prologue: Application of PBPK Modeling to Support Dose Selection in Underrepresented PopulationsPrologue Speaker: – University of Florida
Clinical Pharmacology – Biomolecular
8:30 AM – 9:00 AM ET
Prologue: Application of PBPK Modeling to Support Dose Selection in Underrepresented PopulationsLocation:152Prologue Speaker: – University of Florida
Clinical Pharmacology – Biomolecular
Rodrigo Cristofoletti, PhD – University of Florida ### 1650917###Prologue Speaker###Assistant Professor ###University of Florida###Prologue Speaker: – University of Florida
### 8:30 AM – 9:00 AM ET
Prologue: Current Status and Gaps in Predicting the Food EffectPrologue Speaker: – Daiichi Sankyo, Inc.
Preclinical Development – Chemical
8:30 AM – 9:00 AM ET
Prologue: Current Status and Gaps in Predicting the Food EffectLocation:253 CPrologue Speaker: – Daiichi Sankyo, Inc.
Preclinical Development – Chemical
Xinyuan Zhang, PhD – Daiichi Sankyo, Inc. ### 567518###Prologue Speaker###Director###Daiichi Sankyo, Inc.###Prologue Speaker: – Daiichi Sankyo, Inc.
### 8:30 AM – 9:00 AM ET
Prologue: Developmental Challenges with Antibody-Drug Conjugates Prologue Speaker: – Merck
Manufacturing & Analytical Characterization – Biomolecular
8:30 AM – 9:00 AM ET
Prologue: Developmental Challenges with Antibody-Drug Conjugates Location:205 CPrologue Speaker: – Merck
Manufacturing & Analytical Characterization – Biomolecular
Manoj Charati, PhD – Merck ### 1666037###Prologue Speaker###Principal Scientist###Merck###Prologue Speaker: – Merck
### 8:30 AM – 9:00 AM ET
Prologue: Patient Centric Bioanalysis: Where We’ve Been and Where We’re GoingPrologue Speaker: – Bill & Melinda Gates Medical Research Institute
Bioanalytics – Chemical
8:30 AM – 9:00 AM ET
Prologue: Patient Centric Bioanalysis: Where We’ve Been and Where We’re GoingLocation:253 APrologue Speaker: – Bill & Melinda Gates Medical Research Institute
Bioanalytics – Chemical
Joleen T. White, PhD – Bill & Melinda Gates Medical Research Institute ### 627094###Prologue Speaker###Head of Bioassay Development and Operations###Bill & Melinda Gates Medical Research Institute###Prologue Speaker: – Bill & Melinda Gates Medical Research Institute
### 8:30 AM – 9:00 AM ET
Prologue: PBPK/PBBM to Inform the Bioequivalence Safe Space, Food Effects, and pH-Mediated DDIsPrologue Speaker: – Pharmaceutical Sciences, Merck & Co., Inc., Rahway, NJ USA
Clinical Pharmacology – Chemical
8:30 AM – 9:00 AM ET
Prologue: PBPK/PBBM to Inform the Bioequivalence Safe Space, Food Effects, and pH-Mediated DDIsLocation:151 ABPrologue Speaker: – Pharmaceutical Sciences, Merck & Co., Inc., Rahway, NJ USA
Clinical Pharmacology – Chemical
Tycho Heimbach, PhD – Pharmaceutical Sciences, Merck & Co., Inc., Rahway, NJ USA ### 1329525###Prologue Speaker###Senior Principal Scientist/Director###Pharmaceutical Sciences, Merck & Co., Inc., Rahway, NJ USA###Prologue Speaker: – Pharmaceutical Sciences, Merck & Co., Inc., Rahway, NJ USA
### 8:30 AM – 9:00 AM ET
Prologue: Practical Considerations for Implementing Biomarkers in Clinical Trials, Challenges and OpportunitiesPrologue Speaker: – Dewpoint Therapeutics
Bioanalytics – Biomolecular
8:30 AM – 9:00 AM ET
Prologue: Practical Considerations for Implementing Biomarkers in Clinical Trials, Challenges and OpportunitiesLocation:253 BPrologue Speaker: – Dewpoint Therapeutics
Bioanalytics – Biomolecular
Lakshmi Amaravadi, PhD – Dewpoint Therapeutics ### 567500###Prologue Speaker###SVP, Head of Preclinical Development & Translational Medicine###Dewpoint Therapeutics###Prologue Speaker: – Dewpoint Therapeutics
### 8:30 AM – 9:00 AM ET
Prologue: Regulation of Cannabinoids for Histone Modification in Resistant Breast CancerPrologue Speaker: – Florida A&M University
Discovery and Basic Research
8:30 AM – 9:00 AM ET
Prologue: Regulation of Cannabinoids for Histone Modification in Resistant Breast CancerLocation:255Prologue Speaker: – Florida A&M University
Discovery and Basic Research
Mandip S. Sachdeva, PhD – Florida A&M University ### 848734###Prologue Speaker###Professor###Florida A&M University###Prologue Speaker: – Florida A&M University
### 8:30 AM – 9:00 AM ET
Prologue: Rethinking ASD Particle Architecture and Performance Utilizing Advances in Engineering Technologies Prologue Speaker: – Merck & Co., Inc.
Formulation and Delivery – Chemical
8:30 AM – 9:00 AM ET
Prologue: Rethinking ASD Particle Architecture and Performance Utilizing Advances in Engineering Technologies Location:205 ABPrologue Speaker: – Merck & Co., Inc.
Formulation and Delivery – Chemical
Luke Schenck – Merck & Co., Inc. ### 604981###Prologue Speaker###Principal Scientist###Merck & Co., Inc.###Prologue Speaker: – Merck & Co., Inc.
### 8:30 AM – 9:00 AM ET
Prologue: Science-Based Formulation and Process Development of Biologicals: Physical Chemical and Analytical AspectsPrologue Speaker: – Abbvie
Formulation and Delivery – Biomolecular
8:30 AM – 9:00 AM ET
Prologue: Science-Based Formulation and Process Development of Biologicals: Physical Chemical and Analytical AspectsLocation:204 ABPrologue Speaker: – Abbvie
Formulation and Delivery – Biomolecular
Evgenyi Shalaev, PhD – Abbvie ### 624499###Prologue Speaker###Distinguished Research Fellow###Abbvie###Prologue Speaker: – Abbvie
### 8:30 AM – 9:00 AM ET
Prologue: The Microbiome in Pharmaceutical Development and DiseasePrologue Speaker: – University of Illinois Chicago
Discovery and Basic Research
8:30 AM – 9:00 AM ET
Prologue: The Microbiome in Pharmaceutical Development and DiseaseLocation:254 BPrologue Speaker: – University of Illinois Chicago
Discovery and Basic Research
Matthew Henke, PhD – University of Illinois Chicago ### 1695109###Prologue Speaker###Assistant Professor###University of Illinois Chicago###Prologue Speaker: – University of Illinois Chicago
### 8:30 AM – 4:30 PM ET
Coffee Station
8:30 AM – 4:30 PM ET
Coffee StationLocation:Booth #1344, Exhibit Hall A&B
8:30 AM – 4:30 PM ET
Free Professional Headshots
8:30 AM – 4:30 PM ET
Free Professional HeadshotsLocation:Career Development Center, Exhibit Hall A&B
8:30 AM – 4:30 PM ET
LinkedIn Profile Critiques & Resume Reviews
8:30 AM – 4:30 PM ET
LinkedIn Profile Critiques & Resume ReviewsLocation:Career Development Center, Exhibit Hall A&B
8:30 AM – 5:00 PM ET
Solution Center Hours & Poster Presentations
8:30 AM – 5:00 PM ET
Solution Center Hours & Poster Presentations
Location:Exhibit Hall A&B
9:00 AM – 10:00 AM ET
Hot Topic: Phase Appropriate Design Controls for Combination Products during Clinical DevelopmentHot Topic Speaker: – Pharmalytik
Hot Topic Speaker: – Merck & Co., Inc.
Hot Topic Speaker: – Takeda
Hot Topic Moderator: – Takeda Pharmaceutical Company Limited
Manufacturing & Analytical Characterization – Chemical
9:00 AM – 10:00 AM ET
Hot Topic: Phase Appropriate Design Controls for Combination Products during Clinical DevelopmentLocation:153 AHot Topic Speaker: – Pharmalytik
Hot Topic Speaker: – Merck & Co., Inc.
Hot Topic Speaker: – Takeda
Hot Topic Moderator: – Takeda Pharmaceutical Company Limited
Manufacturing & Analytical Characterization – Chemical
Kim Huynh-Ba, MS, PMP, FAAPS – Pharmalytik ### 636579###Hot Topic Speaker###Managing Director###Pharmalytik###Hot Topic Speaker: – Pharmalytik
### @@@ Jiaying Shen, PhD – Merck & Co., Inc. ### 980258###Hot Topic Speaker###Distinguished Scientist, Research Sciences, Device Development###Merck & Co., Inc.###Hot Topic Speaker: – Merck & Co., Inc.
### @@@ Gretchen Vandal, MS, MBA – Takeda ### 1650360###Hot Topic Speaker###Executive Director, Global Regulatory Affairs – Head of Devices, Digital and Combination Products###Takeda###Hot Topic Speaker: – Takeda
### @@@ Shrinivas (Cheenu) Murti, PhD, MBA – Takeda Pharmaceutical Company Limited ### 720714###Hot Topic Moderator###Head, CMC Business Process Excellence & Systems###Takeda Pharmaceutical Company Limited###Hot Topic Moderator: – Takeda Pharmaceutical Company Limited
### 9:00 AM – 10:00 AM ET
Overcoming Today's Pharmaceutical Formulation Challenges with Aprecia's In-Blister ManufacturingFormulation and Delivery
9:00 AM – 10:00 AM ET
Overcoming Today's Pharmaceutical Formulation Challenges with In-Blister ManufacturingLocation:360 Stage #1, Exhibit Hall A&BFormulation and Delivery
Michael Gosselin, PhD – Aprecia ### 1743108###Tech Spotlight Speaker###Vice President of Pharmaceutical Development###Aprecia###Tech Spotlight Speaker: – Aprecia
### 9:00 AM – 10:00 AM ET
Promoting Yourself and Increasing Your Visibility in the WorkplaceCareer Center Moderator: – Duquesne University
Career Center Moderator: – AAPS
Career Center Speaker: – Bristol-Myers Squibb
Career Center Speaker: – Immunologix Laboratories
Career Development
9:00 AM – 10:00 AM ET
Promoting Yourself and Increasing Your Visibility in the WorkplaceLocation:360 Stage #3, Exhibit Hall A&BCareer Center Moderator: – Duquesne University
Career Center Moderator: – AAPS
Career Center Speaker: – Bristol-Myers Squibb
Career Center Speaker: – Immunologix Laboratories
Career Development
Mustafa Bookwala, M.S. – Duquesne University ### 1377263###Career Center Moderator###Ph.D. Candidate###Duquesne University###Career Center Moderator: – Duquesne University
### @@@ Stacey Axler – AAPS ### 1535109###Career Center Moderator###Community Manager###AAPS###Career Center Moderator: – AAPS
### @@@ Binodh S. DeSilva, PhD – Bristol-Myers Squibb ### 527148###Career Center Speaker###Vice President###Bristol-Myers Squibb###Career Center Speaker: – Bristol-Myers Squibb
### @@@ Lauren Stevenson, PhD – Immunologix Laboratories ### 802379###Career Center Speaker###Chief Scientific Officer###Immunologix Laboratories###Career Center Speaker: – Immunologix Laboratories
### 9:00 AM – 10:30 AM ET
Symposium: Epigenetic Drug Targets and Epigenetic ModifiersModerator: – Florida A&M University
Discovery and Basic Research
9:00 AM – 10:30 AM ET
Symposium: Epigenetic Drug Targets and Epigenetic ModifiersLocation:255Moderator: – Florida A&M University
Discovery and Basic Research
Mandip S. Sachdeva, PhD – Florida A&M University ### 848734###Moderator###Professor###Florida A&M University###Moderator: – Florida A&M University
### 9:00 AM – 9:30 AM ET
Non-Enzymatic Post-Translational Modifications and Their Effects on ChromatinLocation:255Speaker: – University of Arizona
Discovery and Basic Research
James Galligan, PhD – University of Arizona ### 1676332###Speaker###Assistant Professor###University of Arizona###Speaker: – University of Arizona
### 9:30 AM – 10:00 AM ET
Epigenetic Reprogramming in Carcinogenesis by Dietary Phytochemicals in Cancer PreventionLocation:255Speaker: – Rutgers University
Discovery and Basic Research
Ah-Ng Tony Kong, PhD – Rutgers University ### 604777###Speaker###Distinguished Professor, Glaxo Endowed Chair in Pharmaceutics; Graduate Director###Rutgers University ###Speaker: – Rutgers University
### 10:00 AM – 10:30 AM ET
Reciprocal MicroRNA-mRNA Pairings as Precision Biomarkers and Novel Drug Targets in Aggressive Prostate CancersLocation:255Speaker: – University of Maryland Eastern Shore School of Pharmacy
Discovery and Basic Research
Bi-Dar (Peter) Wang – University of Maryland Eastern Shore School of Pharmacy ### 1695111###Speaker###Associate Professor###University of Maryland Eastern Shore School of Pharmacy###Speaker: – University of Maryland Eastern Shore School of Pharmacy
### 9:00 AM – 10:30 AM ET
Symposium: Microbiome: Impact in Pharmaceutical Development and DiseaseModerator: – University of Illinois Chicago
Discovery and Basic Research
9:00 AM – 10:30 AM ET
Symposium: Microbiome: Impact in Pharmaceutical Development and DiseaseLocation:254 BModerator: – University of Illinois Chicago
Discovery and Basic Research
Matthew Henke, PhD – University of Illinois Chicago ### 1695109###Moderator###Assistant Professor###University of Illinois Chicago###Moderator: – University of Illinois Chicago
### 9:00 AM – 9:30 AM ET
Therapeutic Potential of the Gut Microbiota in Neurologic DiseaseLocation:254 BSpeaker: – Harvard Medical School/ Brigham & Women's Hospital
Discovery and Basic Research
Laura M. Cox, PhD – Harvard Medical School/ Brigham & Women's Hospital ### 1680384###Speaker###Assistant Professor###Harvard Medical School/ Brigham & Women's Hospital###Speaker: – Harvard Medical School/ Brigham & Women's Hospital
### 9:30 AM – 10:00 AM ET
Microbial Diversity as a Tool for Metabolism ResearchLocation:254 BSpeaker: – Pennsylvania State University
Discovery and Basic Research
Jordan Bisanz, PhD – Pennsylvania State University ### 1699109###Speaker###Assistant Professor###Pennsylvania State University###Speaker: – Pennsylvania State University
### 10:00 AM – 10:30 AM ET
Bugs, Drugs, and Autoimmunity: The Impact of the Gut Microbiome on the Treatment of Rheumatic DiseaseLocation:254 BSpeaker: – University of California, San Francisco
Discovery and Basic Research
Renuka Nayak, MD, PhD – University of California, San Francisco ### 1688946###Speaker###Assistant Professor###University of California, San Francisco###Speaker: – University of California, San Francisco
### 9:00 AM – 10:30 AM ET
Symposium: Novel Manufacturing Approaches in Pharmaceuticals and Biopharmaceuticals (BM)Manufacturing & Analytical Characterization – Biomolecular
9:00 AM – 10:30 AM ET
Symposium: Novel Manufacturing Approaches in Pharmaceuticals and Biopharmaceuticals (BM)Location:205 CManufacturing & Analytical Characterization – Biomolecular
Manoj Charati, PhD – Merck ### 1666037###Moderator###Principal Scientist###Merck###Moderator: – Merck
### 9:00 AM – 9:30 AM ET
Evaluation of New Drying Technologies for a mAb FormulationLocation:205 CManufacturing & Analytical Characterization – Biomolecular
Yuan Chen, PhD – AstraZeneca ### 1346614###Speaker###Senior Scientist###AstraZeneca###Speaker: – AstraZeneca
### 9:30 AM – 10:00 AM ET
Understanding Phase Behavior and Adsorption of Monoclonal Antibodies and Surfactants During Formulation Processing Location:205 CSpeaker: – Bristol Myers Squibb
Manufacturing & Analytical Characterization – Biomolecular
Ankit D. Kanthe, PhD – Bristol Myers Squibb ### 1446462###Speaker###Scientist###Bristol Myers Squibb###Speaker: – Bristol Myers Squibb
### 10:00 AM – 10:30 AM ET
Evolving Manufacturing Controls for Cell Therapy ProductsLocation:205 CSpeaker: – Philadelphia College of Pharmacy and Science
Manufacturing & Analytical Characterization – Biomolecular
Allison E. Radwick, Ph.D. – Philadelphia College of Pharmacy and Science ### 1650343###Speaker###Adjunct Faculty###Philadelphia College of Pharmacy and Science###Speaker: – Philadelphia College of Pharmacy and Science
### 9:00 AM – 10:30 AM ET
Symposium: Novel Manufacturing Approaches in Pharmaceuticals and Biopharmaceuticals (CE)Manufacturing & Analytical Characterization – Chemical
9:00 AM – 10:30 AM ET
Symposium: Novel Manufacturing Approaches in Pharmaceuticals and Biopharmaceuticals (CE)Location:206 ABManufacturing & Analytical Characterization – Chemical
Maria Cruanes, PhD Chemistry (she/her/hers) – Organon ### 1680406###Moderator###Director Analytical Chemistry ###Organon###Moderator: – Organon
### she/her/hers9:00 AM – 9:30 AM ET
Oral Granules as Pediatric Formulations?Location:206 ABSpeaker: – Vertex Pharmaceuticals Inc.
Manufacturing & Analytical Characterization – Chemical
Eleni Dokou, PhD (she/her/hers) – Vertex Pharmaceuticals Inc. ### 1680408###Speaker###Vice President###Vertex Pharmaceuticals Inc.###Speaker: – Vertex Pharmaceuticals Inc.
### she/her/hers9:30 AM – 10:00 AM ET
Machine Learning Assisted Optimization of Chemical ReactionsLocation:206 ABManufacturing & Analytical Characterization – Chemical
Kehua Yin – GSK ### 1650321###Speaker###Investigator###GSK###Speaker: – GSK
### 10:00 AM – 10:30 AM ET
Understanding the Sources of Error in PAT Methods That Monitor Continuous ProcessesLocation:206 ABSpeaker: – University of Puerto Rico Mayaguez
Manufacturing & Analytical Characterization – Chemical
Rodolfo J. Romanach, PhD – University of Puerto Rico Mayaguez ### 825188###Speaker###Professor of Chemistry###University of Puerto Rico Mayaguez###Speaker: – University of Puerto Rico Mayaguez
### 9:00 AM – 11:00 AM ET
Symposium: Advances in Engineering Technologies for Drug Substance and Enabling Drug Product (BM)Formulation and Delivery – Biomolecular
9:00 AM – 11:00 AM ET
Symposium: Advances in Engineering Technologies for Drug Substance and Enabling Drug Product (BM)Location:204 ABFormulation and Delivery – Biomolecular
Evgenyi Shalaev, PhD – Abbvie ### 624499###Moderator###Distinguished Research Fellow###Abbvie###Moderator: – Abbvie
### 9:00 AM – 9:30 AM ET
Understanding Mechanisms When Considering Alternative Surfactants in Biologic FormulationLocation:204 ABSpeaker: – IFF Pharma Solutions
Formulation and Delivery – Biomolecular
Susan Jordan, PhD – IFF Pharma Solutions ### 1302240###Speaker###Technical Fellow###IFF Pharma Solutions###Speaker: – IFF Pharma Solutions
### 9:30 AM – 10:00 AM ET
Enabling Solid-State Biological Products Through Advanced Engineering and CharacterizationLocation:204 ABSpeaker: – Merck & Co., Inc.
Formulation and Delivery – Biomolecular
Jing Ling, PhD – Merck & Co., Inc. ### 1650352###Speaker###Associate Principal Scientist###Merck & Co., Inc.###Speaker: – Merck & Co., Inc.
### 10:00 AM – 10:30 AM ET
Enabling Solid-State Biological Products Through Advanced Engineering and CharacterizationLocation:204 ABSpeaker: – College of Pharmacy, University of Minnesota
Formulation and Delivery – Biomolecular
Raj Suryanarayanan, PhD, MPharm, MSc – College of Pharmacy, University of Minnesota ### 466096###Speaker###Professor & Endowed Chair###College of Pharmacy, University of Minnesota###Speaker: – College of Pharmacy, University of Minnesota
### 10:30 AM – 11:00 AM ET
Enabling Solid-State Biological Products Through Advanced Engineering and CharacterizationLocation:204 ABSpeaker: – Purdue University
Formulation and Delivery – Biomolecular
Eric J. Munson, PhD, FAAPS – Purdue University ### 856795###Speaker###Professor###Purdue University###Speaker: – Purdue University
### 9:00 AM – 11:00 AM ET
Symposium: Advances in Engineering Technologies for Drug Substance and Enabling Drug Product (CE)Moderator: – Merck & Co., Inc.
Formulation and Delivery – Chemical
9:00 AM – 11:00 AM ET
Symposium: Advances in Engineering Technologies for Drug Substance and Enabling Drug Product (CE)Location:205 ABModerator: – Merck & Co., Inc.
Formulation and Delivery – Chemical
Luke Schenck – Merck & Co., Inc. ### 604981###Moderator###Principal Scientist###Merck & Co., Inc.###Moderator: – Merck & Co., Inc.
### 9:00 AM – 9:30 AM ET
Combining Crystal Structure Prediction with Formulation Technologies to De-Risk Solid Dosage DevelopmentLocation:205 ABSpeaker: – MilliporeSigma
Formulation and Delivery – Chemical
Gudrun Birk, PhD (she/her/hers) – MilliporeSigma ### 604429###Speaker###Head of Controlled Release, Senior Manager###MilliporeSigma###Speaker: – MilliporeSigma
### she/her/hers9:30 AM – 10:00 AM ET
In vitro and in Silico Modeling for Amorphous Solid DispersionsLocation:205 ABFormulation and Delivery – Chemical
Bart Hens, PharmD, PhD – Pfizer UK ### 1791678###Speaker###Biopharmaceutics Scientist/ Drug Product Design Biomodeler###Pfizer UK###Speaker: – Pfizer UK
### 10:00 AM – 10:30 AM ET
The Impact of Liquid-Liquid Phase Separation on Amorphous Solid Dispersions PerformanceLocation:205 ABSpeaker: – Purdue University
Formulation and Delivery – Chemical
Lynne S. Taylor, PhD – Purdue University ### 465958###Speaker###Professor###Purdue University###Speaker: – Purdue University
### 10:30 AM – 11:00 AM ET
3D PrintingLocation:205 ABFormulation and Delivery – Chemical
Alvaro Goyanes, PhD – FabRx ### 605229###Speaker###CEO and Co-founder###FabRx###Speaker: – FabRx
### 9:00 AM – 11:00 AM ET
Symposium: Breaking Through Barriers in Preclinical Development To Improve Clinical Translation (BM)Preclinical Development – Biomolecular
9:00 AM – 11:00 AM ET
Symposium: Breaking Through Barriers in Preclinical Development To Improve Clinical Translation (BM)Location:254 APreclinical Development – Biomolecular
Nagendra V. Chemuturi, GDMPK – Takeda ### 1010805###Moderator###Scientific Director Research###Takeda###Moderator: – Takeda
### 9:00 AM – 9:30 AM ET
QSP Model of AAV Based Gene Therapy for Clinical ApplicationsLocation:254 APreclinical Development – Biomolecular
Jatin Narula, PhD – Pfizer ### 857254###Speaker###Senior Principal Scientist###Pfizer###Speaker: – Pfizer
### 9:30 AM – 10:00 AM ET
Gene Efficiency Factor and its Application in the Development of Viral-Mediated in vivo Gene TherapyLocation:254 ASpeaker: – NewGround Pharmaceutical Consulting
Preclinical Development – Biomolecular
Chee Meng Ng, PharmD, PhD, FCP – NewGround Pharmaceutical Consulting ### 1650379###Speaker###Managing Director###NewGround Pharmaceutical Consulting###Speaker: – NewGround Pharmaceutical Consulting
### 10:00 AM – 10:30 AM ET
Challenges and Opportunities of Oncology CAR Cell Therapy FIH Dose SelectionLocation:254 APreclinical Development – Biomolecular
Haiqing Wang, PhD – Takeda ### 1650380###Speaker###Director###Takeda###Speaker: – Takeda
### 10:30 AM – 11:00 AM ET
Retrospective Look at Translational Considerations for T-cell RedirectorsLocation:254 ASpeaker: – Janssen Research and Development, LLC
Preclinical Development – Biomolecular
Nirav Shah, PhD – Janssen Research and Development, LLC ### 1650377###Speaker###Senior Scientist###Janssen Research and Development, LLC###Speaker: – Janssen Research and Development, LLC
### 9:00 AM – 11:00 AM ET
Symposium: Breaking Through Barriers in Preclinical Development To Improve Clinical Translation (CE)Moderator: – Merck & Co., Inc.
Preclinical Development – Chemical
9:00 AM – 11:00 AM ET
Symposium: Breaking Through Barriers in Preclinical Development To Improve Clinical Translation (CE)Location:253 CModerator: – Merck & Co., Inc.
Preclinical Development – Chemical
Yasuhiro Tsume, PhD – Merck & Co., Inc. ### 583852###Moderator###Scientist###Merck & Co., Inc.###Moderator: – Merck & Co., Inc.
### 9:00 AM – 9:30 AM ET
Physiological Considerations Around Food Effects On Oral Drug BioavailabilityLocation:253 CSpeaker: – AbbVie Deutschland GmbH & Co. KG
Preclinical Development – Chemical
Mirko Koziolek, PhD – AbbVie Deutschland GmbH & Co. KG ### 1664098###Speaker###Principal Research Scientist I###AbbVie Deutschland GmbH & Co. KG###Speaker: – AbbVie Deutschland GmbH & Co. KG
### 9:30 AM – 10:00 AM ET
Applications of Physiologically Based Biopharmaceutics Modeling and Simulation in Oral Drug DevelopmentLocation:253 CPreclinical Development – Chemical
Aishwarya R – Pfizer ### 1650325###Speaker###Biopharmaceutics Scientist###Pfizer###Speaker: – Pfizer
### 10:00 AM – 10:30 AM ET
In vitro Methodologies for Evaluating Food Effects on Intraluminal Drug Disposition: Possibilities and GapsLocation:253 CSpeaker: – Department of Pharmacy
National and Kapodistrian University of Athens
Preclinical Development – Chemical
Christos Reppas, PhD – Department of Pharmacy
National and Kapodistrian University of Athens ### 571995###Speaker###Professor in Pharmaceutics###Department of Pharmacy
National and Kapodistrian University of Athens###Speaker: – Department of Pharmacy
National and Kapodistrian University of Athens
### 10:30 AM – 11:00 AM ET
Got Hungry? Can Predict Food Effects in Preclinical and Clinical?Location:253 CPreclinical Development – Chemical
Brian Booth, PhD – FDA ### 576429###Speaker###Director, DCP I###FDA###Speaker: – FDA
### 9:00 AM – 11:00 AM ET
Symposium: Model Informed Drug Development (MIDD): Role in Dose Selection, Vulnerable Populations, and Biowaivers (BM)Clinical Pharmacology – Biomolecular
9:00 AM – 11:00 AM ET
Symposium: Model Informed Drug Development (MIDD): Role in Dose Selection, Vulnerable Populations, and BiowaiversLocation:152Clinical Pharmacology – Biomolecular
Rodrigo Cristofoletti, PhD – University of Florida ### 1650917###Moderator###Assistant Professor ###University of Florida###Moderator: – University of Florida
### 9:00 AM – 9:30 AM ET
WAPPS-Hemo Modelling on a Global Scale to Dose Optimize Clotting Factor (Biomolecule) Prophylaxis in Hemophilia PatientsLocation:152Speaker: – University of Waterloo, School of Pharmacy
Clinical Pharmacology – Biomolecular
Andrea Edginton, PhD – University of Waterloo, School of Pharmacy ### 603955###Speaker###Professor, Hallman Director###University of Waterloo, School of Pharmacy###Speaker: – University of Waterloo, School of Pharmacy
### 9:30 AM – 10:00 AM ET
MIDD Using PK/PD Modeling with Discrete Outcomes in Dose Selection for Biomolecules - General ConsiderationsLocation:152Clinical Pharmacology – Biomolecular
Serge Guzy, PhD – UF ### 1663981###Speaker###Courtesy Professor###UF###Speaker: – UF
### 10:00 AM – 10:30 AM ET
Modeling Informed Pre-Clinical to Clinical PK/PD Translation for siRNA TherapeuticsLocation:152Speaker: – Janssen Research & Development, LLC
Clinical Pharmacology – Biomolecular
Vivaswath S. Ayyar, PhD – Janssen Research & Development, LLC ### 1650347###Speaker###Senior Scientist###Janssen Research & Development, LLC###Speaker: – Janssen Research & Development, LLC
### 10:30 AM – 11:00 AM ET
Modeling and Simulation to Fill the Knowledge Gap in Pregnancy and LactationLocation:152Speaker: – University of Pittsburgh
Clinical Pharmacology – Biomolecular
Nupur Chaphekar, MS – University of Pittsburgh ### 1446978###Speaker###Graduate Student###University of Pittsburgh###Speaker: – University of Pittsburgh
### 9:00 AM – 11:00 AM ET
Symposium: Model Informed Drug Development (MIDD): Role in Dose Selection, Vulnerable Populations, and Biowaivers (CE)Clinical Pharmacology – Chemical
9:00 AM – 11:00 AM ET
Symposium: Model Informed Drug Development (MIDD): Role in Dose Selection, Vulnerable Populations, and BiowaiversLocation:151 ABClinical Pharmacology – Chemical
Tycho Heimbach, PhD – Pharmaceutical Sciences, Merck & Co., Inc., Rahway, NJ USA ### 1329525###Moderator###Senior Principal Scientist/Director###Pharmaceutical Sciences, Merck & Co., Inc., Rahway, NJ USA###Moderator: – Pharmaceutical Sciences, Merck & Co., Inc., Rahway, NJ USA
### 9:00 AM – 9:30 AM ET
Prospective Prediction of Food Effect Using PBPK Modeling: Is the Science On Par with Expectations?Location:151 ABSpeaker: – Pfizer Worldwide R&D
Clinical Pharmacology – Chemical
Ravi Shanker, PhD – Pfizer Worldwide R&D ### 1792082###Speaker###Senior Research Fellow###Pfizer Worldwide R&D###Speaker: – Pfizer Worldwide R&D
### 9:30 AM – 10:00 AM ET
Applying MIDD Paradigm to Inform Clinical Relevance of Dissolution SpecificationsLocation:151 ABClinical Pharmacology – Chemical
Mohamed-Eslam F. Mohamed, PhD, FCP – AbbVie ### 602556###Speaker###Director, Clinical Pharmacology and Pharmacometrics###AbbVie###Speaker: – AbbVie
### 10:00 AM – 10:30 AM ET
Applications of PBPK for Virtual BE Assessment of Dermal ProductsLocation:151 ABClinical Pharmacology – Chemical
Sebastian Polak, PhD – Certara UK ### 602670###Speaker###Senior Scientific Advisor###Certara UK###Speaker: – Certara UK
### 10:30 AM – 11:00 AM ET
Physiologically-Based Pharmacokinetic Modeling to Support BE and Products ApprovalLocation:151 ABGovernment Speaker: – US Food and Drug Adminstration
Clinical Pharmacology – Chemical
Eleftheria Tsakalozou, PhD – US Food and Drug Adminstration ### 1044996###Government Speaker###Staff Fellow###US Food and Drug Adminstration###Government Speaker: – US Food and Drug Adminstration
### 9:00 AM – 11:00 AM ET
Symposium: Sample Challenges, Yet Opportunities (BM)Bioanalytics – Biomolecular
9:00 AM – 11:00 AM ET
Symposium: Sample Challenges, Yet Opportunities (BM)Location:253 BBioanalytics – Biomolecular
Christian Braithwaite, M.S. – BioAgilytix ### 607032###Moderator###Manager II###BioAgilytix###Moderator: – BioAgilytix
### 9:00 AM – 9:30 AM ET
Overcoming Challenges to Profile ctDNA for Monitoring Tumor EvolutionLocation:253 BBioanalytics – Biomolecular
Anup Madan, PhD – PPD ### 1663785###Speaker###Director, Lab###PPD###Speaker: – PPD
### 9:30 AM – 10:00 AM ET
Considerations for Obtaining High-Quality PBMCs in Global Rare Disease Clinical TrialsLocation:253 BSpeaker: – Passage Bio, Inc
Bioanalytics – Biomolecular
Karen J. Quadrini, PhD – Passage Bio, Inc ### 604596###Speaker###Associate Director, Biomarkers and Precision Medicine###Passage Bio, Inc###Speaker: – Passage Bio, Inc
### 10:00 AM – 10:30 AM ET
Use of Tissue Biopsies to Improve Clinical TrialsLocation:253 BBioanalytics – Biomolecular
Keith Wharton, Jr., MD PhD FCAP – Ultivue, Inc. ### 1691762###Speaker###Vice President Medical Director###Ultivue, Inc.###Speaker: – Ultivue, Inc.
### 10:30 AM – 11:00 AM ET
Exosomes-Based Biomarkers: Challenges and the Promise of Cell Specificity and Multi Marker Approach Location:253 BBioanalytics – Biomolecular
Erez Eitan, PhD – NeuroDex Inc ### 1699107###Speaker###Chief scientific officer ###NeuroDex Inc###Speaker: – NeuroDex Inc
### 9:00 AM – 11:00 AM ET
Symposium: Sample Challenges, Yet Opportunities (CE)Moderator: – Virginia Commonwealth University
Bioanalytics – Chemical
9:00 AM – 11:00 AM ET
Symposium: Sample Challenges, Yet Opportunities (CE)Location:253 AModerator: – Virginia Commonwealth University
Bioanalytics – Chemical
Matthew S. Halquist, PhD – Virginia Commonwealth University ### 1447055###Moderator###Associate Professor and Laboratory Director###Virginia Commonwealth University###Moderator: – Virginia Commonwealth University
### 9:00 AM – 9:30 AM ET
XpressCollect: Enabling Home Collection for High-Throughput Diagnostics and SurveillanceLocation:253 ASpeaker: – Quantigen BioSciences
Bioanalytics – Chemical
Doug Rains (he/him/his) – Quantigen BioSciences ### 1755947###Speaker###Chief Scientific Officer###Quantigen BioSciences###Speaker: – Quantigen BioSciences
### he/him/his9:30 AM – 10:00 AM ET
Use of Volumetric Absorptive Microsampling in Remote / Hybrid Clinical TrialsLocation:253 ASpeaker: – Neoteryx, Part of the Trajan Family
Bioanalytics – Chemical
James Rudge, PhD – Neoteryx, Part of the Trajan Family ### 1663790###Speaker###Technical Director###Neoteryx, Part of the Trajan Family###Speaker: – Neoteryx, Part of the Trajan Family
### 10:00 AM – 10:30 AM ET
Microsampling and its Integration into Modeling in Long-Acting HIV ProgramsLocation:253 ASpeaker: – Merck & Co., Inc.
Bioanalytics – Chemical
Ryan Vargo, Ph.D – Merck & Co., Inc. ### 1651141###Speaker###Sr. Director###Merck & Co., Inc.###Speaker: – Merck & Co., Inc.
### 10:30 AM – 11:00 AM ET
Adopting Patient Centric Sampling for Routine Clinical Tests Location:253 ASpeaker: – Eli Lilly and Company
Bioanalytics – Chemical
Enaksha Wickremsinhe, PhD – Eli Lilly and Company ### 627103###Speaker###Senior Director###Eli Lilly and Company###Speaker: – Eli Lilly and Company
### 9:00 AM – 4:00 PM ET
Career Fair
9:00 AM – 4:00 PM ET
Career FairLocation:Career Development Center, Exhibit Hall A&B
9:30 AM – 10:00 AM ET
Coffee Break in the Solution Center
9:30 AM – 10:00 AM ET
Coffee Break in the Solution CenterLocation:Exhibit Hall A&B
9:30 AM – 10:30 AM ET
Platform Usage to Support Advanced Drug ModalitiesPartner Presentation Speaker: – BioAgilytix
Bioanalytics
9:30 AM – 10:30 AM ET
Platform Usage to Support Advanced Drug ModalitiesLocation:360 Stage #2, Exhibit Hall A&BPartner Presentation Speaker: – BioAgilytix
Bioanalytics
Jim McNally, PhD – BioAgilytix ### 1137442###Partner Presentation Speaker###Chief Scientific Officer###BioAgilytix###Partner Presentation Speaker: – BioAgilytix
### 9:30 AM – 10:30 AM ET
Speaker Spotlight: Gene Therapy Delivery Using Recombinant Adeno-Associated VirusSpotlight Speaker: – UMass Chan Medical School
Moderator: – Husson University
Formulation and Delivery
9:30 AM – 10:30 AM ET
Speaker Spotlight: Gene Therapy Delivery Using Recombinant Adeno-Associated VirusLocation:Spotlight Stage 3, Exhibit Hall A&BSpotlight Speaker: – UMass Chan Medical School
Moderator: – Husson University
Formulation and Delivery
Dan Wang, PhD – UMass Chan Medical School ### 1730309###Spotlight Speaker###Assistant Professor###UMass Chan Medical School###Spotlight Speaker: – UMass Chan Medical School
### @@@ Tianzhi Yang, PhD – Husson University ### 606403###Moderator###Professor of Pharmaceutical Sciences###Husson University###Moderator: – Husson University
### 9:30 AM – 10:30 AM ET
Speaker Spotlight: New Tools for Pharmaceutical Research Based on Tetrazine LigationModerator: – Adesis Inc.
Spotlight Speaker: – University of Delaware
Discovery and Basic Research
9:30 AM – 10:30 AM ET
Speaker Spotlight: New Tools for Pharmaceutical Research Based on Tetrazine LigationLocation:Spotlight Stage 1, Exhibit Hall A&BModerator: – Adesis Inc.
Spotlight Speaker: – University of Delaware
Discovery and Basic Research
Zhenzhen Dong, PhD (she/her/hers) – Adesis Inc. ### 1773700###Moderator###Associate Director###Adesis Inc.###Moderator: – Adesis Inc.
### she/her/hers @@@ Joseph Fox, PhD – University of Delaware ### 1773701###Spotlight Speaker###Professor###University of Delaware###Spotlight Speaker: – University of Delaware
### 9:30 AM – 10:30 AM ET
Speaker Spotlight: Post-Pandemic Configurations for Regulated BioanalysisModerator: – Bristol Myers Squibb
Bioanalytics
9:30 AM – 10:30 AM ET
Speaker Spotlight: Post-Pandemic Configurations for Regulated BioanalysisLocation:Spotlight Stage 2, Exhibit Hall A&BModerator: – Bristol Myers Squibb
Bioanalytics
HsinPin Ho, PhD – Bristol Myers Squibb ### 1466231###Moderator###Principal Scientist###Bristol Myers Squibb###Moderator: – Bristol Myers Squibb
### 9:30 AM – 10:00 AM ET
Regulated Bioanalysis in a Post-Pandemic WorldLocation:Spotlight Stage 2, Exhibit Hall A&BSpotlight Speaker: – Bristol-Myers Squibb Company
Bioanalytics
Jim Shen, PhD – Bristol-Myers Squibb Company ### 754507###Spotlight Speaker###Senior Director, Head of Regulated Bioanalysis & Operations###Bristol-Myers Squibb Company###Spotlight Speaker: – Bristol-Myers Squibb Company
### 10:00 AM – 10:30 AM ET
How the Pandemic Changed Lab-Based Bioanalytics to a New Normal: New (and Ongoing) ConsiderationsLocation:Spotlight Stage 2, Exhibit Hall A&BSpotlight Speaker: – Novartis Institutes for BioMedical Research, Inc.
Bioanalytics
Ann Brown, BS – Novartis Institutes for BioMedical Research, Inc. ### 1741077###Spotlight Speaker###Principle Scientist###Novartis Institutes for BioMedical Research, Inc.###Spotlight Speaker: – Novartis Institutes for BioMedical Research, Inc.
### 9:30 AM – 10:30 AM ET
The Evolution of Separations and Sample Preparation Technologies for BiopharmaPartner Presentation Speaker: – Phenomenex
Bioanalytics
9:30 AM – 10:30 AM ET
The Evolution of Separations and Sample Preparation Technologies for BiopharmaLocation:360 Stage #4, Exhibit Hall A&BPartner Presentation Speaker: – Phenomenex
Bioanalytics
John C. Gebler, PhD – Phenomenex ### 1778367###Partner Presentation Speaker###Director, Strategic Biopharma Business Dev###Phenomenex###Partner Presentation Speaker: – Phenomenex
### 10:30 AM – 11:30 AM ET
Design Your Career Board of DirectorsCareer Center Speaker: – Susan Morris Coaching
Career Development
10:30 AM – 11:30 AM ET
Design Your Career Board of DirectorsLocation:360 Stage #3, Exhibit Hall A&BCareer Center Speaker: – Susan Morris Coaching
Career Development
Susan Morris, M.Ed., CPCC, ACC – Susan Morris Coaching ### 1023071###Career Center Speaker###President###Susan Morris Coaching###Career Center Speaker: – Susan Morris Coaching
### 10:30 AM – 11:30 AM ET
Exploring Protein Degrader Drug Delivery ChallengesPartner Presentation Speaker: – Catalent
Preclinical Development
10:30 AM – 11:30 AM ET
Exploring Protein Degrader Drug Delivery ChallengesLocation:360 Stage #1, Exhibit Hall A&BPartner Presentation Speaker: – Catalent
Preclinical Development
Nathan Bennette, M.S. – Catalent ### 1743101###Partner Presentation Speaker###Director, Scientific Advisory###Catalent###Partner Presentation Speaker: – Catalent
### 10:30 AM – 11:30 AM ET
Special Poster Collection
10:30 AM – 11:30 AM ET
Special Poster CollectionLocation:Poster Forum #2, Exhibit Hall A&BPoster Collection Host: – Attralus, Inc.
Poster Collection Host: – Mercer University
Andrew Vick, Ph.D. – Attralus, Inc. ### 1140814###Poster Collection Host###Head of Toxicology, Drug Disposition, and PKPD###Attralus, Inc.###Poster Collection Host: – Attralus, Inc.
### @@@ Amruta A. Dandekar, B.Tech (she/her/hers) – Mercer University ### 1689916###Poster Collection Host###Ph.D. Candidate###Mercer University###Poster Collection Host: – Mercer University
### she/her/hers11:00 AM – 12:00 PM ET
New functional polyvinyl alcohol grade for optimized amorphous solid dispersionsPartner Presentation Speaker: – MilliporeSigma
Formulation and Delivery
11:00 AM – 12:00 PM ET
New functional polyvinyl alcohol grade for optimized amorphous solid dispersionsLocation:360 Stage #4, Exhibit Hall A&BPartner Presentation Speaker: – MilliporeSigma
Formulation and Delivery
Thomas Kipping, PhD – MilliporeSigma ### 604723###Partner Presentation Speaker###Head of Drug Carriers###MilliporeSigma###Partner Presentation Speaker: – MilliporeSigma
### 11:00 AM – 12:00 PM ET
Working with a CDMO to accelerate Lead to FIH journeyPartner Presentation Speaker: – Syngene International Limited
Formulation and Delivery
11:00 AM – 12:00 PM ET
Working with a CDMO to accelerate Lead to FIH journeyLocation:360 Stage #2, Exhibit Hall A&BPartner Presentation Speaker: – Syngene International Limited
Formulation and Delivery
Purushottam Singnurkar, PhD (he/him/his) – Syngene International Limited ### 635968###Partner Presentation Speaker###Associate Vice President & Head, Formulations###Syngene International Limited###Partner Presentation Speaker: – Syngene International Limited
### he/him/his11:00 AM – 1:30 PM ET
Dedicated Solution Center Hours
11:00 AM – 1:30 PM ET
Dedicated Solution Center HoursLocation:Exhibit Hall A&B
11:15 AM – 12:00 PM ET
AAPS Excipients Community Membership MeetingCommunity Leader: – Symbiotix
11:15 AM – 12:00 PM ET
AAPS Excipients Community Membership MeetingLocation:Spotlight Stage 1, Exhibit Hall A&BCommunity Leader: – Symbiotix
Allison E. Radwick, PhD – Symbiotix ### 1650343###Community Leader###Associate Medical Director###Symbiotix###Community Leader: – Symbiotix
### 11:15 AM – 12:00 PM ET
Combined In-Silico & Experimental Approach for Solid Form Crystallization DevelopmentChalk Talk Presenter: – J-Star Research Inc.
Chalk Talk Presenter: – J-Star Research Inc.
Formulation and Delivery
11:15 AM – 12:00 PM ET
Combined In-Silico & Experimental Approach for Solid Form Crystallization DevelopmentLocation:Spotlight Stage 3, Exhibit Hall A&BChalk Talk Presenter: – J-Star Research Inc.
Chalk Talk Presenter: – J-Star Research Inc.
Formulation and Delivery
Presented By J-Star Research
Yuriy Abramov, PhD – J-Star Research Inc. ### 1778370###Chalk Talk Presenter###Executive Director of Computational Chemistry and Data Science###J-Star Research Inc.###Chalk Talk Presenter: – J-Star Research Inc.
### @@@ Harsh Shah, PhD – J-Star Research Inc. ### 1446577###Chalk Talk Presenter###Senior Scientist###J-Star Research Inc.###Chalk Talk Presenter: – J-Star Research Inc.
### 11:15 AM – 12:00 PM ET
Improving oral absorption to rapidly advance early phase compoundsChalk Talk Presenter: – Lonza Small Molecules
Formulation and Delivery
11:15 AM – 12:00 PM ET
Improving oral absorption to rapidly advance early phase compoundsLocation:Spotlight Stage 2, Exhibit Hall A&BChalk Talk Presenter: – Lonza Small Molecules
Formulation and Delivery
Deanna M. Mudie, PhD – Lonza Small Molecules ### 602666###Chalk Talk Presenter###Sr. Principal Engineer R&D###Lonza Small Molecules###Chalk Talk Presenter: – Lonza Small Molecules
### 12:00 PM – 1:00 PM ET
Exploring Ways to Maintain your Network and Keep It AliveCareer Center Speaker: – Pharmalytik
Career Center Speaker: – Sanofi
Career Center Moderator: – Pharmalytik
Career Development
12:00 PM – 1:00 PM ET
Exploring Ways to Maintain Your Network and Keep It AliveLocation:360 Stage #3, Exhibit Hall A&BCareer Center Speaker: – Pharmalytik
Career Center Speaker: – Sanofi
Career Center Moderator: – Pharmalytik
Career Development
Kim Huynh-Ba, MS, PMP, FAAPS – Pharmalytik ### 636579###Career Center Speaker###Managing Director###Pharmalytik###Career Center Speaker: – Pharmalytik
### @@@ Jianmei D. Kochling, PhD, MBA – Sanofi ### 465971###Career Center Speaker###Senior Director###Sanofi###Career Center Speaker: – Sanofi
### @@@ Kim Huynh-Ba, MS, PMP, FAAPS – Pharmalytik ### 636579###Career Center Moderator###Managing Director###Pharmalytik###Career Center Moderator: – Pharmalytik
### 12:00 PM – 1:00 PM ET
Online Amino Acid Analysis for Spend Media ControlPartner Presentation Speaker: – Agilent Technologies
Manufacturing & Analytical Characterization
12:00 PM – 1:00 PM ET
Online Amino Acid Analysis for Spend Media ControlLocation:360 Stage #1, Exhibit Hall A&BPartner Presentation Speaker: – Agilent Technologies
Manufacturing & Analytical Characterization
Lorena Lopez, BSc / MBA – Agilent Technologies ### 1767416###Partner Presentation Speaker###LC Applications Scientist###Agilent Technologies###Partner Presentation Speaker: – Agilent Technologies
### 12:30 PM – 1:15 PM ET
AAPS Topical and Transdermal Community Membership MeetingCommunity Leader: – Solaris Pharma Corporation
12:30 PM – 1:15 PM ET
AAPS Topical and Transdermal Community Membership MeetingLocation:Spotlight Stage 1, Exhibit Hall A&BCommunity Leader: – Solaris Pharma Corporation
Lakshmi Raghavan, PhD – Solaris Pharma Corporation ### 1718883###Community Leader###Founder & President###Solaris Pharma Corporation###Community Leader: – Solaris Pharma Corporation
### 12:30 PM – 1:15 PM ET
Liposome formulation in cancer immunotherapy and challenges on early-stage developmentChalk Talk Presenter: – FUJIFILM Pharmaceuticals U.S.A., Inc.
Formulation and Delivery
12:30 PM – 1:15 PM ET
Liposome formulation in cancer immunotherapy and challenges on early-stage developmentLocation:Spotlight Stage 3, Exhibit Hall A&BChalk Talk Presenter: – FUJIFILM Pharmaceuticals U.S.A., Inc.
Formulation and Delivery
Presented By FUJIFILM Pharm.
Naoki Yamada, MS – FUJIFILM Pharmaceuticals U.S.A., Inc. ### 1377184###Chalk Talk Presenter###Director Strategy and Operation###FUJIFILM Pharmaceuticals U.S.A., Inc.###Chalk Talk Presenter: – FUJIFILM Pharmaceuticals U.S.A., Inc.
### 12:30 PM – 1:15 PM ET
Speaker Spotlight: Ask A RegulatorBioanalytics
12:30 PM – 1:15 PM ET
Speaker Spotlight: Ask A RegulatorLocation:Spotlight Stage 2, Exhibit Hall A&BBioanalytics
Brian Booth, PhD – FDA ### 576429###Spotlight Speaker###Director, DCP I###FDA###Spotlight Speaker: – FDA
### 12:30 PM – 1:30 PM ET
Oligonucleotide Analysis: How You Can Go Faster and Further?Partner Presentation Speaker: – Waters Corp.
Manufacturing & Analytical Characterization
12:30 PM – 1:30 PM ET
Oligonucleotide Analysis: How You Can Go Faster and Further?Location:360 Stage #4, Exhibit Hall A&BPartner Presentation Speaker: – Waters Corp.
Manufacturing & Analytical Characterization
Andrew Argo, MSc (he/him/his) – Waters Corp. ### 1777504###Partner Presentation Speaker###Sr. Global Marketing Manager###Waters Corp.###Partner Presentation Speaker: – Waters Corp.
### he/him/his12:30 PM – 1:30 PM ET
Solubility Enhancement Technology to Develop Particle-Engineered Free-Flowing Amorphous Solid DispersionPartner Presentation Speaker: – Evonik Corporation
Formulation and Delivery
12:30 PM – 1:30 PM ET
Solubility Enhancement Technology to Develop Particle-Engineered Free-Flowing Amorphous Solid DispersionLocation:360 Stage #2, Exhibit Hall A&BPartner Presentation Speaker: – Evonik Corporation
Formulation and Delivery
Mohammed Irfan Syed, M.S. – Evonik Corporation ### 1446733###Partner Presentation Speaker###Associate Director FAS Lab###Evonik Corporation###Partner Presentation Speaker: – Evonik Corporation
### 12:30 PM – 1:30 PM ET
Special Poster Collection
12:30 PM – 1:30 PM ET
Special Poster CollectionLocation:Poster Forum #2, Exhibit Hall A&BPoster Collection Host: – OnKure Therapeutics
Kevin Litwiler, PhD (he/him/his) – OnKure Therapeutics ### 803611###Poster Collection Host###Senior Vice President###OnKure Therapeutics###Poster Collection Host: – OnKure Therapeutics
### he/him/his1:30 PM – 2:30 PM ET
Keynote: Applications of MIDD for Dose Selection, Specific Populations, and Beyond: The Advantages of BracketingKeynote Speaker: – Certara
Moderator: – Pfizer Inc.
Clinical Pharmacology
1:30 PM – 2:30 PM ET
Keynote: Applications of MIDD for Dose Selection, Specific Populations, and Beyond: The Advantages of BracketingLocation:151 ABKeynote Speaker: – Certara
Moderator: – Pfizer Inc.
Clinical Pharmacology
Julie Bullock, PharmD – Certara ### 1595389###Keynote Speaker###Global Head of Clinical Pharmacology & Translational Medicine###Certara###Keynote Speaker: – Certara
### @@@ Vaishali Sahasrabudhe, PhD (she/her/hers) – Pfizer Inc. ### 1045004###Moderator###Clinical Pharmacology Therapeutic Area Head for Internal Medicine###Pfizer Inc.###Moderator: – Pfizer Inc.
### she/her/hers1:30 PM – 2:30 PM ET
Keynote: Challenges and Opportunities in the ADC Manufacturing Keynote Speaker: – Genentech, Inc.
Moderator: – Merck
Manufacturing & Analytical Characterization – Biomolecular
1:30 PM – 2:30 PM ET
Keynote: Challenges and Opportunities in the ADC Manufacturing Location:205 CKeynote Speaker: – Genentech, Inc.
Moderator: – Merck
Manufacturing & Analytical Characterization – Biomolecular
Sreedhara Alavattam, PhD (he/him/his) – Genentech, Inc. ### 803605###Keynote Speaker###Distinguished Scientist###Genentech, Inc.###Keynote Speaker: – Genentech, Inc.
### he/him/his @@@ Manoj Charati, PhD – Merck ### 1666037###Moderator###Principal Scientist###Merck###Moderator: – Merck
### 1:30 PM – 2:30 PM ET
Keynote: Fluidic Processes for Bottom-Up Engineering of Particles to Enable Drug Product PerformanceKeynote Speaker: – MIT
Moderator: – Pfizer Worldwide Research and Development
Formulation and Delivery – Chemical
1:30 PM – 2:30 PM ET
Keynote: Fluidic Processes for Bottom-Up Engineering of Particles to Enable Drug Product PerformanceLocation:205 ABKeynote Speaker: – MIT
Moderator: – Pfizer Worldwide Research and Development
Formulation and Delivery – Chemical
Patrick Doyle, PhD – MIT ### 1602135###Keynote Speaker###Professor###MIT###Keynote Speaker: – MIT
### @@@ Jaymin C. Shah, PhD – Pfizer Worldwide Research and Development ### 1554431###Moderator###Research Fellow and Head of Topical and Advanced Drug Delivery###Pfizer Worldwide Research and Development###Moderator: – Pfizer Worldwide Research and Development
### 1:30 PM – 2:30 PM ET
Keynote: From preclinical to clinical drug product development- a path for smooth transitionKeynote Speaker: – Simulations Plus, Inc.
Moderator: – Genentech
Preclinical Development – Biomolecular
1:30 PM – 2:30 PM ET
Keynote: From Preclinical to Clinical Drug Product Development- A Path for Smooth TransitionLocation:254 AKeynote Speaker: – Simulations Plus, Inc.
Moderator: – Genentech
Preclinical Development – Biomolecular
Sandra Suarez-Sharp, PhD – Simulations Plus, Inc. ### 1447017###Keynote Speaker###Vice President, Regulatory Affairs###Simulations Plus, Inc.###Keynote Speaker: – Simulations Plus, Inc.
### @@@ Christine Bowman, PhD – Genentech ### 1372299###Moderator###Senior Scientist###Genentech###Moderator: – Genentech
### 1:30 PM – 2:30 PM ET
Keynote: Gut Bugs and Fecal Transplants: Experience Over a Decade of Clinical Microbiome ResearchKeynote Speaker: – Lifespan Physician Group
Moderator: – University of Illinois Chicago
Discovery and Basic Research
1:30 PM – 2:30 PM ET
Keynote: Gut Bugs and Fecal Transplants: Experience Over a Decade of Clinical Microbiome ResearchLocation:254 BKeynote Speaker: – Lifespan Physician Group
Moderator: – University of Illinois Chicago
Discovery and Basic Research
Colleen R. Kelly, MD – Lifespan Physician Group ### 1602081###Keynote Speaker###Gastroenterologist###Lifespan Physician Group###Keynote Speaker: – Lifespan Physician Group
### @@@ Richard A. Gemeinhart, PhD (he/him/his) – University of Illinois Chicago ### 1378471###Moderator###Professor and Associate Vice Chancellor for Research###University of Illinois Chicago###Moderator: – University of Illinois Chicago
### he/him/his1:30 PM – 2:30 PM ET
Keynote: How Lyndra Is Working to 'Reinvent Medicine for a Healthier WorldModerator: – Organon
Keynote Speaker: – Lyndra Therapeutics Inc.
Manufacturing & Analytical Characterization – Chemical
1:30 PM – 2:30 PM ET
Keynote: How Lyndra Is Working to 'Reinvent Medicine for a Healthier WorldLocation:206 ABModerator: – Organon
Keynote Speaker: – Lyndra Therapeutics Inc.
Manufacturing & Analytical Characterization – Chemical
Maria Cruanes, PhD Chemistry (she/her/hers) – Organon ### 1680406###Moderator###Director Analytical Chemistry ###Organon###Moderator: – Organon
### she/her/hers @@@ Patricia Hurter, PhD (she/her/hers) – Lyndra Therapeutics Inc. ### 1595392###Keynote Speaker###CEO###Lyndra Therapeutics Inc.###Keynote Speaker: – Lyndra Therapeutics Inc.
### she/her/hers1:30 PM – 2:30 PM ET
Keynote: Keys to Improving Clinical Predictability via Preclinical DevelopmentKeynote Speaker: – UCSF School of Pharmacy
Moderator: – Exelixis
Preclinical Development – Chemical
1:30 PM – 2:30 PM ET
Keynote: Keys to Improving Clinical Predictability via Preclinical DevelopmentLocation:253 CKeynote Speaker: – UCSF School of Pharmacy
Moderator: – Exelixis
Preclinical Development – Chemical
Leslie Z. Benet, PhD – UCSF School of Pharmacy ### 466000###Keynote Speaker###Professor###UCSF School of Pharmacy###Keynote Speaker: – UCSF School of Pharmacy
### @@@ Jae H. Chang, PhD – Exelixis ### 1010871###Moderator###Head of Drug Discovery Sciences###Exelixis###Moderator: – Exelixis
### 1:30 PM – 2:30 PM ET
Keynote: Preparing for the Renaissance of the Dried Microsample: Lessons Learned in Newborn Screening
Bioanalytics – Chemical
1:30 PM – 2:30 PM ET
Keynote: Preparing for the Renaissance of the Dried Microsample: Lessons Learned in Newborn ScreeningLocation:253 ABioanalytics – Chemical
Donald Chace, MSFS PhD FAACC – Capitainer AB ### 1602080###Keynote Speaker###Senior Application and Product Specialist###Capitainer AB###Keynote Speaker: – Capitainer AB
### @@@ Matthew S. Halquist, PhD – Virginia Commonwealth University ### 1447055###Moderator###Associate Professor and Laboratory Director###Virginia Commonwealth University###Moderator: – Virginia Commonwealth University
### 1:30 PM – 2:30 PM ET
Keynote: Surrogate Matrices – A Creative Solution to Scarcity, or Simply Sound Science?Keynote Speaker: – Immunologix Laboratories
Moderator: – BioAgilytix
Bioanalytics – Biomolecular
1:30 PM – 2:30 PM ET
Keynote: Surrogate Matrices – A Creative Solution to Scarcity, or Simply Sound Science?Location:253 BKeynote Speaker: – Immunologix Laboratories
Moderator: – BioAgilytix
Bioanalytics – Biomolecular
Lauren Stevenson, PhD – Immunologix Laboratories ### 802379###Keynote Speaker###Chief Scientific Officer###Immunologix Laboratories###Keynote Speaker: – Immunologix Laboratories
### @@@ Amanda Hays, Ph.D. – BioAgilytix ### 1529523###Moderator###Scientific Officer###BioAgilytix###Moderator: – BioAgilytix
### 1:30 PM – 2:30 PM ET
Keynote: Targeting Epigenetic Regulator Mutations in CancerKeynote Speaker: – Mayo Clinic
Moderator: – University of Charleston
Discovery and Basic Research
1:30 PM – 2:30 PM ET
Keynote: Targeting Epigenetic Regulator Mutations in CancerLocation:255Keynote Speaker: – Mayo Clinic
Moderator: – University of Charleston
Discovery and Basic Research
Keith D. Robertson, PhD – Mayo Clinic ### 1602082###Keynote Speaker###Professor, Molecular Pharmacology and Experimental Therapeutics###Mayo Clinic###Keynote Speaker: – Mayo Clinic
### @@@ Tamer E. Fandy, PhD, BCGP, FCP – University of Charleston ### 1378497###Moderator###Professor & Chair, Department of Pharmaceutical & Adminstrative Sciences###University of Charleston###Moderator: – University of Charleston
### 1:30 PM – 2:30 PM ET
Quality attributes and characterization of gene vectors using light scatteringPartner Presentation Speaker: – Wyatt Technology
Bioanalytics
1:30 PM – 2:30 PM ET
Quality attributes and characterization of gene vectors using light scatteringLocation:360 Stage #1, Exhibit Hall A&BPartner Presentation Speaker: – Wyatt Technology
Bioanalytics
John Champagne, PhD – Wyatt Technology ### 1743098###Partner Presentation Speaker###Senior Application Scientist & Northeast Regional Manager###Wyatt Technology###Partner Presentation Speaker: – Wyatt Technology
### 1:30 PM – 2:30 PM ET
Strategies for a Successful Job InterviewCareer Center Moderator: – Nimbus Therapeutics
Career Center Speaker: – Hughes and Associates
Career Center Speaker: – AbbVie, Inc.
Career Development
1:30 PM – 2:30 PM ET
Strategies for a Successful Job InterviewLocation:360 Stage #3, Exhibit Hall A&BCareer Center Moderator: – Nimbus Therapeutics
Career Center Speaker: – Hughes and Associates
Career Center Speaker: – AbbVie, Inc.
Career Development
Nimita Dave, PhD – Nimbus Therapeutics ### 1650370###Career Center Moderator###Director, Clinical Pharmacology###Nimbus Therapeutics###Career Center Moderator: – Nimbus Therapeutics
### @@@ Jay Chapman, BS – Hughes and Associates ### 1650371###Career Center Speaker###Executive Director###Hughes and Associates###Career Center Speaker: – Hughes and Associates
### @@@ Patrick J. Marroum, PhD – AbbVie, Inc. ### 602558###Career Center Speaker###Distinguished Research Fellow###AbbVie, Inc.###Career Center Speaker: – AbbVie, Inc.
### 2:00 PM – 3:00 PM ET
Design and Manufacturing of Polymeric Long-Acting Injectable ProductsPartner Presentation Speaker: – Evonik
Formulation and Delivery
2:00 PM – 3:00 PM ET
Design and Manufacturing of Polymeric Long-Acting Injectable ProductsLocation:360 Stage #2, Exhibit Hall A&BPartner Presentation Speaker: – Evonik
Formulation and Delivery
Tom Tice, PhD – Evonik ### 1072987###Partner Presentation Speaker###Senior Director###Evonik###Partner Presentation Speaker: – Evonik
### 2:00 PM – 3:00 PM ET
Exponentially Expanding Science: Regulatory Acceptance and Use Cases for PBPKPreclinical Development
2:00 PM – 3:00 PM ET
Lost in translation? Predict first-in-human PK with Simcyp DiscoveryLocation:360 Stage #4, Exhibit Hall A&BPreclinical Development
Hannah Jones, PhD – Certara ### 1764091###Partner Presentation Speaker###Senior Vice President, Head of PBPK Consulting Services###Certara###Partner Presentation Speaker: – Certara
### 2:30 PM – 3:00 PM ET
Coffee Break in the Solution Center
2:30 PM – 3:00 PM ET
Coffee Break in the Solution CenterLocation:Exhibit Hall A&B
2:30 PM – 3:30 PM ET
Hot Topic: The Potential Dark Side of AI for Drug DiscoveryHot Topic Speaker: – Collaborations Pharmaceuticals, Inc.
Hot Topic Moderator: – University of Charleston
Discovery and Basic Research
2:30 PM – 3:30 PM ET
Hot Topic: The Potential Dark Side of AI for Drug DiscoveryLocation:153 AHot Topic Speaker: – Collaborations Pharmaceuticals, Inc.
Hot Topic Moderator: – University of Charleston
Discovery and Basic Research
Sean Ekins, PhD, DSc – Collaborations Pharmaceuticals, Inc. ### 1650348###Hot Topic Speaker###CEO###Collaborations Pharmaceuticals, Inc.###Hot Topic Speaker: – Collaborations Pharmaceuticals, Inc.
### @@@ Tamer E. Fandy, PhD, BCGP, FCP – University of Charleston ### 1378497###Hot Topic Moderator###Professor & Chair, Department of Pharmaceutical & Adminstrative Sciences###University of Charleston###Hot Topic Moderator: – University of Charleston
### 2:30 PM – 3:30 PM ET
Speaker Spotlight: Addressing the Gaps in Human PK and DDI PredictionSpotlight Speaker: – Pfizer Inc
Moderator: – Schrodinger, Inc. USA
Preclinical Development
2:30 PM – 3:30 PM ET
Speaker Spotlight: Addressing the Gaps in Human PK and DDI PredictionLocation:Spotlight Stage 1, Exhibit Hall A&BSpotlight Speaker: – Pfizer Inc
Moderator: – Schrodinger, Inc. USA
Preclinical Development
Li Di, PhD – Pfizer Inc ### 653545###Spotlight Speaker###Research Fellow###Pfizer Inc###Spotlight Speaker: – Pfizer Inc
### @@@ Naveen Thakral, PhD – Schrodinger, Inc. USA ### 1664123###Moderator###Director, Pharmaceutical Sciences###Schrodinger, Inc. USA###Moderator: – Schrodinger, Inc. USA
### 2:30 PM – 3:30 PM ET
Speaker Spotlight: Extrapolating Efficacy from Adults to PediatricsSpotlight Speaker: – University of Maryland
Moderator: – Tolmar, Inc.
Clinical Pharmacology – Chemical
2:30 PM – 3:30 PM ET
Speaker Spotlight: Extrapolating Efficacy from Adults to PediatricsLocation:Spotlight Stage 2, Exhibit Hall A&BSpotlight Speaker: – University of Maryland
Moderator: – Tolmar, Inc.
Clinical Pharmacology – Chemical
Joga Gobburu, PhD, MBA – University of Maryland ### 1075542###Spotlight Speaker###Professor###University of Maryland###Spotlight Speaker: – University of Maryland
### @@@ Raja B. Velagapudi, PhD – Tolmar, Inc. ### 567542###Moderator###Sr. Dir., Clinical Development###Tolmar, Inc.###Moderator: – Tolmar, Inc.
### 2:30 PM – 3:30 PM ET
Speaker Spotlight: Phase Appropriate Design Controls for Combination Products During Clinical DevelopmentSpotlight Speaker: – Takeda Pharmaceutical Company Limited
Moderator: – Pharmalytik
Manufacturing & Analytical Characterization – Chemical
2:30 PM – 3:30 PM ET
Speaker Spotlight: Phase Appropriate Design Controls for Combination Products During Clinical DevelopmentLocation:Spotlight Stage 3, Exhibit Hall A&BSpotlight Speaker: – Takeda Pharmaceutical Company Limited
Moderator: – Pharmalytik
Manufacturing & Analytical Characterization – Chemical
Shrinivas (Cheenu) Murti, PhD, MBA – Takeda Pharmaceutical Company Limited ### 720714###Spotlight Speaker###Head, CMC Business Process Excellence & Systems###Takeda Pharmaceutical Company Limited###Spotlight Speaker: – Takeda Pharmaceutical Company Limited
### @@@ Kim Huynh-Ba, MS, PMP, FAAPS – Pharmalytik ### 636579###Moderator###Managing Director###Pharmalytik###Moderator: – Pharmalytik
### 2:30 PM – 3:30 PM ET
Taste of Boston: Food Tour
2:30 PM – 3:30 PM ET
Taste of Boston: Food TourLocation:Exhibit Hall A&B
3:00 PM – 3:45 PM ET
Rapid Fire: Advances in Engineering Technologies For Drug Substance and Enabling Drug Product (BM)Rapid Fire Moderator: – Merck & Co., Inc.
Formulation and Delivery – Biomolecular
3:00 PM – 3:45 PM ET
Rapid Fire: Advances in Engineering Technologies For Drug Substance and Enabling Drug Product (BM)Location:204 ABRapid Fire Moderator: – Merck & Co., Inc.
Formulation and Delivery – Biomolecular
Suman A. Luthra, PhD – Merck & Co., Inc. ### 1689830###Rapid Fire Moderator###Director###Merck & Co., Inc.###Rapid Fire Moderator: – Merck & Co., Inc.
### 3:00 PM – 3:15 PM ET
CARTs: A New Vehicle for Nucleic Acid DeliveryLocation:204 ABRapid Fire Speaker: – Evonik North America, Vancouver
Formulation and Delivery – Biomolecular
Zahra Merchant, PhD – Evonik North America, Vancouver ### 1792340###Rapid Fire Speaker###Senior Scientist: Research, Development and Innovation###Evonik North America, Vancouver###Rapid Fire Speaker: – Evonik North America, Vancouver
### 3:15 PM – 3:30 PM ET
Antimicrobial Peptide, Nisin ZP, as an Inhaled Therapeutic for NSCLCLocation:204 ABRapid Fire Speaker: – St. John's University
Formulation and Delivery – Biomolecular
Suyash M. Patil – St. John's University ### 1755691###Rapid Fire Speaker###Doctoral Candidate###St. John's University###Rapid Fire Speaker: – St. John's University
### 3:00 PM – 3:45 PM ET
Rapid Fire: Microbiome: Impact in Pharmaceutical Development and DiseaseRapid Fire Moderator: – AbbVie
Discovery and Basic Research
3:00 PM – 3:45 PM ET
Rapid Fire: Microbiome: Impact in Pharmaceutical Development and DiseaseLocation:254 BRapid Fire Moderator: – AbbVie
Discovery and Basic Research
Maya Lipert, PhD – AbbVie ### 1611945###Rapid Fire Moderator###Principal Scientist I###AbbVie###Rapid Fire Moderator: – AbbVie
### 3:00 PM – 3:15 PM ET
Macropinocytosis Route for Drug Delivery: An Unexplored Avenue with Prospects and ChallengesLocation:254 BRapid Fire Speaker: – University of Toledo
Discovery and Basic Research
Rabin Neupane, MS – University of Toledo ### 1689551###Rapid Fire Speaker###Graduate Assistant###University of Toledo###Rapid Fire Speaker: – University of Toledo
### 3:15 PM – 3:30 PM ET
Developing a Dual Prodrug for Triggered Antibiotic ActivationLocation:254 BRapid Fire Speaker: – University of Otago
Discovery and Basic Research
Catherine L. Ross, BPharm – University of Otago ### 1690019###Rapid Fire Speaker###PhD Student ###University of Otago###Rapid Fire Speaker: – University of Otago
### 3:30 PM – 3:45 PM ET
Utilizing Tiny-TIM to Assess the Food Effect on the Absorption of Orally Administered DrugsLocation:254 BRapid Fire Speaker: – Genentech, Inc.
Discovery and Basic Research
Jia Liu, BS – Genentech, Inc. ### 1689653###Rapid Fire Speaker######Genentech, Inc.###Rapid Fire Speaker: – Genentech, Inc.
### 3:00 PM – 3:45 PM ET
Rapid Fire: Novel Manufacturing Approaches in Pharmaceuticals and Biopharmaceuticals (BM)Rapid Fire Moderator: – Pfizer
Manufacturing & Analytical Characterization – Biomolecular
3:00 PM – 3:45 PM ET
Rapid Fire: Novel Manufacturing Approaches in Pharmaceuticals and Biopharmaceuticals (BM)Location:205 CRapid Fire Moderator: – Pfizer
Manufacturing & Analytical Characterization – Biomolecular
Jay Jukyung Kang, PhD – Pfizer ### 1755672###Rapid Fire Moderator###Senior Scientist###Pfizer###Rapid Fire Moderator: – Pfizer
### 3:00 PM – 3:15 PM ET
Development Challenges and Lessons Learned During Development of Bispecific MoleculesLocation:205 CRapid Fire Speaker: – Pfizer
Manufacturing & Analytical Characterization – Biomolecular
Jay Jukyung Kang, PhD – Pfizer ### 1755672###Rapid Fire Speaker###Senior Scientist###Pfizer###Rapid Fire Speaker: – Pfizer
### 3:15 PM – 3:30 PM ET
Evaluation of a Commercial Alpha Kit for Detecting and Quantitating RVLP in In-Process and DS SamplesLocation:205 CRapid Fire Speaker: – Merck & Co., Inc.
Manufacturing & Analytical Characterization – Biomolecular
Rosalind Ang, PhD – Merck & Co., Inc. ### 1762952###Rapid Fire Speaker###Associate Principal Scientist###Merck & Co., Inc.###Rapid Fire Speaker: – Merck & Co., Inc.
### 3:30 PM – 3:45 PM ET
Fractionation of LNP-Nucleic Acid Drug Products Using Solid-Phase ExtractionLocation:205 CRapid Fire Speaker: – Waters Corporation
Manufacturing & Analytical Characterization – Biomolecular
Bonnie A. Alden – Waters Corporation ### 1755688###Rapid Fire Speaker###Principal Scientist###Waters Corporation###Rapid Fire Speaker: – Waters Corporation
### 3:00 PM – 4:00 PM ET
Early CMC Development Strategies to Support Late-Stage SuccessPartner Presentation Speaker: – Societal CDMO
Partner Presentation Speaker: – Societal CDMO
Manufacturing & Analytical Characterization
3:00 PM – 4:00 PM ET
Early CMC Development Strategies to Support Late-Stage SuccessLocation:360 Stage #1, Exhibit Hall A&BPartner Presentation Speaker: – Societal CDMO
Partner Presentation Speaker: – Societal CDMO
Manufacturing & Analytical Characterization
Neha Shah, Ph.D. – Societal CDMO ### 1743105###Partner Presentation Speaker###Director, Product Development###Societal CDMO###Partner Presentation Speaker: – Societal CDMO
### @@@ Kiran Pedada, Ph.D. – Societal CDMO ### 1743106###Partner Presentation Speaker###Associate Director, Analytical Development###Societal CDMO###Partner Presentation Speaker: – Societal CDMO
### 3:00 PM – 4:00 PM ET
Happy Hour Sponsored by Flow Sciences, Inc.
3:00 PM – 4:00 PM ET
Happy Hour Sponsored by Flow Sciences, Inc.Location:Booth #1310, Exhibit Halls A&BSponsored By Flow Sciences
3:00 PM – 4:00 PM ET
Happy Hour Sponsored by Prolytix
3:00 PM – 4:00 PM ET
Happy Hour Sponsored by ProlytixLocation:Booth #1246, Exhibit Hall A&B
3:00 PM – 4:00 PM ET
Rapid Fire: Advances in Engineering Technologies For Drug Substance and Enabling Drug Product (CE)Rapid Fire Moderator: – Merck & Co., Inc.
Formulation and Delivery – Chemical
3:00 PM – 4:00 PM ET
Rapid Fire: Advances in Engineering Technologies For Drug Substance and Enabling Drug Product (CE)Location:205 ABRapid Fire Moderator: – Merck & Co., Inc.
Formulation and Delivery – Chemical
Ashish Punia, PhD – Merck & Co., Inc. ### 1378020###Rapid Fire Moderator###Associate Principal Scientist###Merck & Co., Inc.###Rapid Fire Moderator: – Merck & Co., Inc.
### 3:00 PM – 3:15 PM ET
Aqueous Eye Drop Microsuspension Delivers Therapeutic Drug Concentrations to RetinaLocation:205 ABRapid Fire Speaker: – University of Iceland
Formulation and Delivery – Chemical
Thorsteinn Loftsson, PhD, FAAPS – University of Iceland ### 602997###Rapid Fire Speaker###Professor###University of Iceland###Rapid Fire Speaker: – University of Iceland
### 3:15 PM – 3:30 PM ET
Development of Reentry Vehicles and Payloads for In-Orbit Drug DevelopmentLocation:205 ABRapid Fire Speaker: – Varda Space Industries
Formulation and Delivery – Chemical
Jordan Croom, M.S. – Varda Space Industries ### 1755702###Rapid Fire Speaker###Head of Mechanisms###Varda Space Industries###Rapid Fire Speaker: – Varda Space Industries
### 3:30 PM – 3:45 PM ET
Unified Physical Property Estimation Relationships (UPPER)Location:205 ABRapid Fire Speaker: – University of Arizona, College of Pharmacy
Formulation and Delivery – Chemical
Samuel H. Yalkowsky, Ph.D., FAAPS – University of Arizona, College of Pharmacy ### 623865###Rapid Fire Speaker###Professor of Pharmaceutics###University of Arizona, College of Pharmacy###Rapid Fire Speaker: – University of Arizona, College of Pharmacy
### 3:45 PM – 4:00 PM ET
Leveraging Co-Precipitated Amorphous Dispersions as Alternatives to Spray Drying ChallengesLocation:205 ABRapid Fire Speaker: – Merck & Co., Inc.
Formulation and Delivery – Chemical
Marina Solomos, PhD – Merck & Co., Inc. ### 1755668###Rapid Fire Speaker###Senior Scientist###Merck & Co., Inc.###Rapid Fire Speaker: – Merck & Co., Inc.
### 3:00 PM – 4:00 PM ET
Rapid Fire: Breaking Through Barriers in Preclinical Development To Improve Clinical Translation (BM)Rapid Fire Moderator: – Janssen Research and Development, LLC
Preclinical Development – Biomolecular
3:00 PM – 4:00 PM ET
Rapid Fire: Breaking Through Barriers in Preclinical Development To Improve Clinical Translation (BM)Location:254 ARapid Fire Moderator: – Janssen Research and Development, LLC
Preclinical Development – Biomolecular
Nirav Shah, PhD – Janssen Research and Development, LLC ### 1650377###Rapid Fire Moderator###Senior Scientist###Janssen Research and Development, LLC###Rapid Fire Moderator: – Janssen Research and Development, LLC
### 3:00 PM – 3:15 PM ET
Pharmacokinetics/Pharmacodynamics Model to Predict the Therapeutic Index of Bispecific AntibodyLocation:254 ARapid Fire Speaker: – Genentech, Inc.
Preclinical Development – Biomolecular
Ran Li, PhD – Genentech, Inc. ### 1755671###Rapid Fire Speaker###Principal Scientist###Genentech, Inc.###Rapid Fire Speaker: – Genentech, Inc.
### 3:15 PM – 3:30 PM ET
Assays for Assessment of Anti-Drug Antibody Against STK-001 in SerumLocation:254 ARapid Fire Speaker: – Stoke Therapeutics
Preclinical Development – Biomolecular
Yanyan Cui, PhD – Stoke Therapeutics ### 1755692###Rapid Fire Speaker###Principal Scientist###Stoke Therapeutics###Rapid Fire Speaker: – Stoke Therapeutics
### 3:30 PM – 3:45 PM ET
A Mechanistic Ocular PK/PD Model with Systemic Target-Mediated Drug Disposition to Predict Human PK for Intravitreally Administered Anti-Tie2 AgonistLocation:254 ARapid Fire Speaker: – Genentech, Inc.
Preclinical Development – Biomolecular
Paulina Jakubiak, PhD – Genentech, Inc. ### 1690752###Rapid Fire Speaker###Scientist###Genentech, Inc.###Rapid Fire Speaker: – Genentech, Inc.
### 3:45 PM – 4:00 PM ET
Modeling Gastrointestinal Motility: The Multiple Moving Plug ModelLocation:254 ARapid Fire Speaker: – Intellipharm, LLC
Preclinical Development – Biomolecular
Kevin C. Johnson, PhD – Intellipharm, LLC ### 1755685###Rapid Fire Speaker###Pres.###Intellipharm, LLC###Rapid Fire Speaker: – Intellipharm, LLC
### 3:00 PM – 4:00 PM ET
Rapid Fire: Breaking Through Barriers in Preclinical Development To Improve Clinical Translation (CE)Rapid Fire Moderator: – Novartis
Preclinical Development – Chemical
3:00 PM – 4:00 PM ET
Rapid Fire: Breaking Through Barriers in Preclinical Development To Improve Clinical Translation (CE)Location:253 CRapid Fire Moderator: – Novartis
Preclinical Development – Chemical
Steven W. Louie, M.S. – Novartis ### 1328552###Rapid Fire Moderator###Senior Principal Scientist###Novartis###Rapid Fire Moderator: – Novartis
### 3:00 PM – 3:15 PM ET
Differential Effects of Metformin-Mediated BSEP Repression on Pharmacokinetics in HumansLocation:253 CRapid Fire Speaker: – University of Maryland School of Pharmacy
Preclinical Development – Chemical
James E. Polli, Ph.D., FAAPS – University of Maryland School of Pharmacy ### 605881###Rapid Fire Speaker###Professor###University of Maryland School of Pharmacy###Rapid Fire Speaker: – University of Maryland School of Pharmacy
### 3:15 PM – 3:30 PM ET
SRS-Microscopy and Deep-Learning: Novel Approach for Evaluation of Topical BioequivalenceLocation:253 CRapid Fire Speaker: – Harvard Medical School / Massachusetts General Hospital
Preclinical Development – Chemical
Fotis Iliopoulos, MPharm, PhD – Harvard Medical School / Massachusetts General Hospital ### 1689946###Rapid Fire Speaker###Research Fellow###Harvard Medical School / Massachusetts General Hospital###Rapid Fire Speaker: – Harvard Medical School / Massachusetts General Hospital
### 3:30 PM – 3:45 PM ET
Modeling Concentration-Dependent RBC-Partitioning for Human PK Prediction of SubasumstatLocation:253 CRapid Fire Speaker: – Takeda Development Corporation Americas
Preclinical Development – Chemical
Priyanka R. Kulkarni, PhD – Takeda Development Corporation Americas ### 1755699###Rapid Fire Speaker###Research Scientist II###Takeda Development Corporation Americas###Rapid Fire Speaker: – Takeda Development Corporation Americas
### 3:45 PM – 4:00 PM ET
Improving Brain Penetration Prediction via PBPK ModelingLocation:253 CRapid Fire Speaker: – Genentech
Preclinical Development – Chemical
Christine Bowman, PhD – Genentech ### 1372299###Rapid Fire Speaker###Senior Scientist###Genentech###Rapid Fire Speaker: – Genentech
### 3:00 PM – 4:00 PM ET
Rapid Fire: Epigenetic Drug Targets and Epigenetic ModifiersRapid Fire Moderator: – OnKure Therapeutics
Discovery and Basic Research
3:00 PM – 4:00 PM ET
Rapid Fire: Epigenetic Drug Targets and Epigenetic ModifiersLocation:255Rapid Fire Moderator: – OnKure Therapeutics
Discovery and Basic Research
Kevin Litwiler, PhD (he/him/his) – OnKure Therapeutics ### 803611###Rapid Fire Moderator###Senior Vice President###OnKure Therapeutics###Rapid Fire Moderator: – OnKure Therapeutics
### he/him/his3:00 PM – 3:15 PM ET
Piperlongumine Reverses EGFR Resistance as Adjuvant Treatment in NSCLC CellsLocation:255Rapid Fire Speaker: – MCPHS
Discovery and Basic Research
Shail Rakesh Modi, PhD – MCPHS ### 1378365###Rapid Fire Speaker###PhD Student###MCPHS###Rapid Fire Speaker: – MCPHS
### 3:15 PM – 3:30 PM ET
Prenatal E-Cigarette Use Disrupts Postnatal Blood-Brain Barrier (BBB) Integrity and Worsens Ischemic Stroke Outcomes- Implications on Brain Drug DeliveryLocation:255Rapid Fire Speaker: – Texas Tech University Health Sciences Center
Discovery and Basic Research
Sabrina Rahman Archie, MS – Texas Tech University Health Sciences Center ### 1377642###Rapid Fire Speaker###PhD Candidate###Texas Tech University Health Sciences Center###Rapid Fire Speaker: – Texas Tech University Health Sciences Center
### 3:30 PM – 3:45 PM ET
Vocacapsaicin (formerly CA-008): A Water-Soluble Prodrug for Rapid Release of Capsaicin for the Treatment of Post-Surgical PainLocation:255Rapid Fire Speaker: – Concentric Analgesics, Inc.
Discovery and Basic Research
Tarra Knotts, PhD (she/her/hers) – Concentric Analgesics, Inc. ### 1689703###Rapid Fire Speaker###Director of Nonclinical and Clinical Pharmacology###Concentric Analgesics, Inc.###Rapid Fire Speaker: – Concentric Analgesics, Inc.
### she/her/hers3:45 PM – 4:00 PM ET
Pharmacokinetic-Pharmacodynamic Modeling of the Antinociceptive Effect of Mitragynine, the Most Abundant Kratom Alkaloid in MiceLocation:255Rapid Fire Speaker: – University of Florida
Discovery and Basic Research
Abhisheak Sharma, MPharm, PhD (he/him/his) – University of Florida ### 603332###Rapid Fire Speaker###Research Assistant Professor and Assistant Director
###University of Florida###Rapid Fire Speaker: – University of Florida
### he/him/his3:00 PM – 4:00 PM ET
Rapid Fire: Model Informed Drug Development (MIDD): Role in Dose Selection, Vulnerable Populations, and Biowaivers (BM)Rapid Fire Moderator: – Kura Oncology
Clinical Pharmacology – Biomolecular
3:00 PM – 4:00 PM ET
Rapid Fire: Model Informed Drug Development (MIDD): Role in Dose Selection, Vulnerable Populations, and Biowaivers (BM)Location:152Rapid Fire Moderator: – Kura Oncology
Clinical Pharmacology – Biomolecular
Amitava Mitra, PhD – Kura Oncology ### 465957###Rapid Fire Moderator###Clinical Pharmacology###Kura Oncology###Rapid Fire Moderator: – Kura Oncology
### 3:00 PM – 3:15 PM ET
Assessing Food Impact on Bioequivalence Using Physiologically-Based Pharmacokinetic ModelingLocation:152Rapid Fire Speaker: – U.S. Food & Drug Administration
Clinical Pharmacology – Biomolecular
Fang Wu, PhD – U.S. Food & Drug Administration ### 604099###Rapid Fire Speaker###Senior Pharmacologist###U.S. Food & Drug Administration###Rapid Fire Speaker: – U.S. Food & Drug Administration
### 3:15 PM – 3:30 PM ET
First-in-Patient Dose Prediction for Adeno-Associated Virus-Mediated Hemophilia Gene TherapyLocation:152Rapid Fire Speaker: – Daiichi Sankyo Inc.
Clinical Pharmacology – Biomolecular
Peng Zou, PhD – Daiichi Sankyo Inc. ### 844096###Rapid Fire Speaker###Clinical Pharmacologist###Daiichi Sankyo Inc.###Rapid Fire Speaker: – Daiichi Sankyo Inc.
### 3:30 PM – 3:45 PM ET
Streamlined Pathways to Clinical Success through Integrated ModellingLocation:152Rapid Fire Speaker: – SEDA Pharmaceutical Development Services
Clinical Pharmacology – Biomolecular
Jake Dickinson, BSc (Hons) – SEDA Pharmaceutical Development Services ### 1378051###Rapid Fire Speaker###Senior Modeller###SEDA Pharmaceutical Development Services###Rapid Fire Speaker: – SEDA Pharmaceutical Development Services
### 3:45 PM – 4:00 PM ET
PK/PD and First-In Human Dosing Considerations for Cellular TherapiesLocation:152Rapid Fire Speaker: – Johnson and Johnson
Clinical Pharmacology – Biomolecular
Hardik Mody, PhD – Johnson and Johnson ### 1010836###Rapid Fire Speaker###Principal Scientist###Johnson and Johnson###Rapid Fire Speaker: – Johnson and Johnson
### 3:00 PM – 4:00 PM ET
Rapid Fire: Model Informed Drug Development (MIDD): Role in Dose Selection, Vulnerable Populations, and Biowaivers (CE)Rapid Fire Moderator: – Agios Pharmaceuticals
Clinical Pharmacology – Chemical
3:00 PM – 4:00 PM ET
Rapid Fire: Model Informed Drug Development (MIDD): Role in Dose Selection, Vulnerable Populations, and Biowaivers (CE)Location:151 ABRapid Fire Moderator: – Agios Pharmaceuticals
Clinical Pharmacology – Chemical
Punit Marathe, PhD – Agios Pharmaceuticals ### 1010799###Rapid Fire Moderator###Vice President DMPK-TOX###Agios Pharmaceuticals###Rapid Fire Moderator: – Agios Pharmaceuticals
### 3:00 PM – 3:15 PM ET
A Novel Mechanistic Model for Drug Release from PLGA ImplantsLocation:151 ABRapid Fire Speaker: – Certara UK (Simcyp Division)
Clinical Pharmacology – Chemical
Santosh Kumar Puttrevu, PhD – Certara UK (Simcyp Division) ### 844155###Rapid Fire Speaker###Research Scientist II###Certara UK (Simcyp Division)###Rapid Fire Speaker: – Certara UK (Simcyp Division)
### 3:15 PM – 3:30 PM ET
Application of Modeling and Simulation in Long Acting Injectable Product DevelopmentLocation:151 ABRapid Fire Speaker: – Simulations Plus, Inc.
Clinical Pharmacology – Chemical
Viera Lukacova, PhD – Simulations Plus, Inc. ### 1689910###Rapid Fire Speaker###Chief Scientist###Simulations Plus, Inc.###Rapid Fire Speaker: – Simulations Plus, Inc.
### 3:30 PM – 3:45 PM ET
Supporting Biowaivers with PBPK Virtual Bioequivalence: Importance of Within-Subject VariabilityLocation:151 ABRapid Fire Speaker: – Certara / University of Manchester
Clinical Pharmacology – Chemical
Amin Rostami-Hodjegan, PharmD, PhD – Certara / University of Manchester ### 465985###Rapid Fire Speaker###Director of CAPKR and Chief Scientific Officer###Certara / University of Manchester ###Rapid Fire Speaker: – Certara / University of Manchester
### 3:45 PM – 4:00 PM ET
No Polysorbate 80 Effect on Human Intestinal Drug PermeabilityLocation:151 ABRapid Fire Speaker: – University of Maryland School of Pharmacy
Clinical Pharmacology – Chemical
James E. Polli, Ph.D., FAAPS – University of Maryland School of Pharmacy ### 605881###Rapid Fire Speaker###Professor###University of Maryland School of Pharmacy###Rapid Fire Speaker: – University of Maryland School of Pharmacy
### 3:00 PM – 4:00 PM ET
Rapid Fire: Novel Manufacturing Approaches in Pharmaceuticals and Biopharmaceuticals (CE)Rapid Fire Moderator: – Karuna Therapeutics Inc.
Manufacturing & Analytical Characterization – Chemical
3:00 PM – 4:00 PM ET
Rapid Fire: Novel Manufacturing Approaches in Pharmaceuticals and Biopharmaceuticals (CE)Location:206 ABRapid Fire Moderator: – Karuna Therapeutics Inc.
Manufacturing & Analytical Characterization – Chemical
Praveen Kandi, PhD – Karuna Therapeutics Inc. ### 1765981###Rapid Fire Moderator###Director, Formulation Development, CMC & Preclinical###Karuna Therapeutics Inc.###Rapid Fire Moderator: – Karuna Therapeutics Inc.
### 3:00 PM – 3:15 PM ET
A QbD Approach for Continuous Crystallization and Filtration DevelopmentLocation:206 ABRapid Fire Speaker: – CONTINUUS Pharm
Manufacturing & Analytical Characterization – Chemical
Qinglin Su, PhD – CONTINUUS Pharm ### 1755673###Rapid Fire Speaker###Assoc. Director, MS&T###CONTINUUS Pharm###Rapid Fire Speaker: – CONTINUUS Pharm
### 3:15 PM – 3:30 PM ET
Investigating Excipient Induced Recrystallization of Spray Dried Intermediates in TabletsLocation:206 ABRapid Fire Speaker: – Merck & Co.
Manufacturing & Analytical Characterization – Chemical
Haichen Nie, PhD – Merck & Co. ### 1690377###Rapid Fire Speaker###Associate Principal Scientist###Merck & Co.###Rapid Fire Speaker: – Merck & Co.
### 3:30 PM – 3:45 PM ET
Transformational Conical Mill Screens Improve Efficiencies Without Affecting Validated ProcessesLocation:206 ABRapid Fire Speaker: – Quadro Engineering
Manufacturing & Analytical Characterization – Chemical
Wilf Sanguesa, P.Eng. – Quadro Engineering ### 605369###Rapid Fire Speaker###Pharma Research & Technology Manager###Quadro Engineering###Rapid Fire Speaker: – Quadro Engineering
### 3:45 PM – 4:00 PM ET
Manufacture of Mini-Tablets with High Drug Loading ContentLocation:206 ABSpeaker: – University of Chemistry and Technology Prague
Manufacturing & Analytical Characterization – Chemical
Frantisek Stepanek, PhD (he/him/his) – University of Chemistry and Technology Prague ### 1377223###Speaker###Professor###University of Chemistry and Technology Prague###Speaker: – University of Chemistry and Technology Prague
### he/him/his3:00 PM – 4:00 PM ET
Rapid Fire: Sample Challenges, Yet Opportunities (BM)Rapid Fire Moderator: – Biotech
Bioanalytics – Biomolecular
3:00 PM – 4:00 PM ET
Rapid Fire: Sample Challenges, Yet Opportunities (BM)Location:253 BRapid Fire Moderator: – Biotech
Bioanalytics – Biomolecular
Mark Ma, MD (he/him/his) – Biotech ### 1792079###Rapid Fire Moderator###VP, Head of Translational Clinical Sciences###Biotech###Rapid Fire Moderator: – Biotech
### he/him/his3:00 PM – 3:15 PM ET
Does Covid Infection Change our Immune Robustness Baseline ?Location:253 BRapid Fire Speaker: – SymphonyTech Biologucs
Bioanalytics – Biomolecular
Narendra Chirmule, Dr. – SymphonyTech Biologucs ### 516216###Rapid Fire Speaker###CEO###SymphonyTech Biologucs###Rapid Fire Speaker: – SymphonyTech Biologucs
### 3:15 PM – 3:30 PM ET
Novel Pharmacokinetic and Hematological Monitoring Methods Validated for Gene/Cell TherapiesLocation:253 BRapid Fire Speaker: – Frontage Laboratories, Inc.
Bioanalytics – Biomolecular
Bin Xu, PhD – Frontage Laboratories, Inc. ### 1653890###Rapid Fire Speaker###Director###Frontage Laboratories, Inc.###Rapid Fire Speaker: – Frontage Laboratories, Inc.
### 3:30 PM – 3:45 PM ET
A Total ADA Assay and Pre-Existing Antibodies to AAV9Location:253 BRapid Fire Speaker: – Eli Lilly and Company
Bioanalytics – Biomolecular
Yi Wen, PhD – Eli Lilly and Company ### 1011767###Rapid Fire Speaker###Director###Eli Lilly and Company###Rapid Fire Speaker: – Eli Lilly and Company
### 3:45 PM – 4:00 PM ET
Overcoming Challenges of Quantifying Protein Expression for Gene TherapyLocation:253 BRapid Fire Speaker: – Sangamo Therapeutics
Bioanalytics – Biomolecular
Jing Hu, PhD – Sangamo Therapeutics ### 1010831###Rapid Fire Speaker###Scientist###Sangamo Therapeutics###Rapid Fire Speaker: – Sangamo Therapeutics
### 3:00 PM – 4:00 PM ET
Rapid Fire: Sample Challenges, Yet Opportunities (CE)Rapid Fire Moderator: – Novartis
Bioanalytics – Chemical
3:00 PM – 4:00 PM ET
Rapid Fire: Sample Challenges, Yet Opportunities (CE)Location:253 ARapid Fire Moderator: – Novartis
Bioanalytics – Chemical
Wenkui Li, Ph.D – Novartis ### 602507###Rapid Fire Moderator###Director###Novartis###Rapid Fire Moderator: – Novartis
### 3:00 PM – 3:15 PM ET
Evaluation of Tasso-M20 Microsampling in Support of Clinical PK StudiesLocation:253 ARapid Fire Speaker: – Merck & Co Inc
Bioanalytics – Chemical
Huizhi Xie – Merck & Co Inc ### 1755674###Rapid Fire Speaker###Principle Scientist###Merck & Co Inc###Rapid Fire Speaker: – Merck & Co Inc
### 3:15 PM – 3:30 PM ET
Applying a Novel Patient-Centric Sampling Approach in Islatravir Clinical TrialsLocation:253 ARapid Fire Speaker: – Merck & Co Inc
Bioanalytics – Chemical
Li Sun, PhD – Merck & Co Inc ### 1302253###Rapid Fire Speaker###Principal Scientist###Merck & Co Inc###Rapid Fire Speaker: – Merck & Co Inc
### 3:30 PM – 3:45 PM ET
System Optimization to Mitigate Signal Suppression While Autonomously Running Multiple LC/MS/MS Methods in for SiRNAs, Peptides and Small Molecules in SequenceLocation:253 ARapid Fire Speaker: – Q2 Solutions
Bioanalytics – Chemical
Todd Lusk – Q2 Solutions ### 1689809###Rapid Fire Speaker###Senior Scientist###Q2 Solutions###Rapid Fire Speaker: – Q2 Solutions
### 3:45 PM – 4:00 PM ET
The ICH Process and the M10 JourneyLocation:253 ARapid Fire Speaker: – Merck & Co. Inc.
Bioanalytics – Biomolecular
Faye Vazvaei, M.S. – Merck & Co. Inc. ### 1529547###Rapid Fire Speaker###Executive Director###Merck & Co. Inc.###Rapid Fire Speaker: – Merck & Co. Inc.
### 3:00 PM – 4:00 PM ET
Scientist to Executive - Transition beyond PhD and 1st job,Career Center Moderator: – Sandoz, Inc.
Career Center Speaker: – Tergus Pharma, LLC
Career Center Speaker: – Longview Leader Corp
Career Development
3:00 PM – 4:00 PM ET
Scientist to Executive - Transition beyond PhD and 1st job,Location:360 Stage #3, Exhibit Hall A&BCareer Center Moderator: – Sandoz, Inc.
Career Center Speaker: – Tergus Pharma, LLC
Career Center Speaker: – Longview Leader Corp
Career Development
Prasad N. Tata – Sandoz, Inc. ### 1000523###Career Center Moderator###Clinical Development###Sandoz, Inc.###Career Center Moderator: – Sandoz, Inc.
### @@@ Vijendra Nalamothu, PhD – Tergus Pharma, LLC ### 604096###Career Center Speaker###Chairman & CEO###Tergus Pharma, LLC###Career Center Speaker: – Tergus Pharma, LLC
### @@@ Kurt Nielsen, PhD (he/him/his) – Longview Leader Corp ### 1804447###Career Center Speaker###Senior Advisor and Co-Founder###Longview Leader Corp###Career Center Speaker: – Longview Leader Corp
### he/him/his3:30 PM – 4:30 PM ET
Elimination of Titanium Dioxide from Film Coating-Challenges and OpportunitiesPartner Presentation Speaker: – ColorCon
Partner Presentation Speaker: – Colorcon
Manufacturing & Analytical Characterization
3:30 PM – 4:30 PM ET
Elimination of Titanium Dioxide from Film Coating-Challenges and OpportunitiesLocation:360 Stage #4, Exhibit Hall A&BPartner Presentation Speaker: – ColorCon
Partner Presentation Speaker: – Colorcon
Manufacturing & Analytical Characterization
Manish Ghimire, PhD – ColorCon ### 848929###Partner Presentation Speaker###Product Development Manager###ColorCon###Partner Presentation Speaker: – ColorCon
### @@@ Laura Scattergood (she/her/hers) – Colorcon ### 848338###Partner Presentation Speaker###Technical Manager###Colorcon###Partner Presentation Speaker: – Colorcon
### she/her/hers3:30 PM – 4:30 PM ET
Happy Hour Sponsored by Luminex
3:30 PM – 4:30 PM ET
Happy Hour Sponsored by Luminex a Diasorin CompanyLocation:Booth #1457, Exhibit Halls A&B
3:30 PM – 4:30 PM ET
Hot Topic: Novel-Approaches to Accelerate Access of Complex Locally-Acting Products to PatientsGovernment Speaker: – US Food and Drug Adminstration
Preclinical Development – Chemical
3:30 PM – 4:30 PM ET
Hot Topic: Novel-Approaches to Accelerate Access of Complex Locally-Acting Products to PatientsLocation:153 BCGovernment Speaker: – US Food and Drug Adminstration
Preclinical Development – Chemical
Priyanka Ghosh, PhD – US Food and Drug Adminstration ### 584219###Government Speaker###Pharmacologist###US Food and Drug Adminstration###Government Speaker: – US Food and Drug Adminstration
### 3:30 PM – 3:50 PM ET
Advancements in the in vitro Characterization Methodologies for Alternative BE Approaches of Locally Acting Complex Drug ProductsLocation:153 BCGovernment Speaker: – US Food and Drug Administration
Preclinical Development – Chemical
Ahmed Zidan, PhD – US Food and Drug Administration ### 1446962###Government Speaker###Senior Staff Fellow (Pharmacologist)###US Food and Drug Administration###Government Speaker: – US Food and Drug Administration
### 3:50 PM – 4:10 PM ET
Mechanistic Modeling and Simulation Approaches for Performance Prediction of Locally Acting Complex Drug ProductsLocation:153 BCGovernment Speaker: – US Food and Drug Adminstration
Preclinical Development – Chemical
Eleftheria Tsakalozou, PhD – US Food and Drug Adminstration ### 1044996###Government Speaker###Staff Fellow###US Food and Drug Adminstration###Government Speaker: – US Food and Drug Adminstration
### 4:10 PM – 4:30 PM ET
Panel DiscussionLocation:153 BCGovernment Speaker: – US Food and Drug Adminstration
Government Speaker: – US Food and Drug Administration
Hot Topic Speaker: – Merck & Co., Inc.
Hot Topic Speaker: – Schrodinger, Inc. USA
Preclinical Development – Chemical
Sam Raney, PhD – US Food and Drug Adminstration ### 604299###Government Speaker###Associate Director for Science###US Food and Drug Adminstration###Government Speaker: – US Food and Drug Adminstration
### @@@ Andrew Babiskin, PhD – US Food and Drug Administration ### 584226###Government Speaker###Lead Chemist###US Food and Drug Administration###Government Speaker: – US Food and Drug Administration
### @@@ Stephanie Barrett, PhD – Merck & Co., Inc. ### 466169###Hot Topic Speaker###Director, Sterile & Specialty Products###Merck & Co., Inc.###Hot Topic Speaker: – Merck & Co., Inc.
### @@@ Naveen Thakral, PhD – Schrodinger, Inc. USA ### 1664123###Hot Topic Speaker###Director, Pharmaceutical Sciences###Schrodinger, Inc. USA###Hot Topic Speaker: – Schrodinger, Inc. USA
### 3:30 PM – 4:30 PM ET
Important Role of UGTs in Drug Metabolism and Drug-Drug InteractionsPartner Presentation Speaker: – Sekisui XenoTech, LLC
Preclinical Development
3:30 PM – 4:30 PM ET
Important Role of UGTs in Drug Metabolism and Drug-Drug InteractionsLocation:360 Stage #2, Exhibit Hall A&BPartner Presentation Speaker: – Sekisui XenoTech, LLC
Preclinical Development
Maciej Czerwinski, PhD – Sekisui XenoTech, LLC ### 1092611###Partner Presentation Speaker###Director, Scientific Consulting###Sekisui XenoTech, LLC###Partner Presentation Speaker: – Sekisui XenoTech, LLC
### 3:30 PM – 4:30 PM ET
Special Poster Collection
3:30 PM – 4:30 PM ET
Special Poster CollectionLocation:Poster Forum #2, Exhibit Hall A&BPoster Collection Host: – Rutgers University
Patrick J. Sinko, PhD – Rutgers University ### 602328###Poster Collection Host###Distinguished Professor###Rutgers University###Poster Collection Host: – Rutgers University
### 3:45 PM – 4:45 PM ET
Happy Hour Sponsored by Agilent Technologies
3:45 PM – 4:45 PM ET
Happy Hour Sponsored by Agilent TechnologiesLocation:Booth #1021, Exhibit Hall A&B
3:45 PM – 4:45 PM ET
Happy Hour Sponsored by COREALIS Pharma Inc.
3:45 PM – 4:45 PM ET
Happy Hour Sponsored by COREALIS Pharma Inc.Location:Booth #916, Exhibit Halls A & BSponsored By COREALIS Pharma
5:00 PM – 6:00 PM ET
AAPS Bioanalytical Community Membership MeetingCommunity Leader: – Labcorp
5:00 PM – 6:00 PM ET
AAPS Bioanalytical Community Membership MeetingLocation:253 ACommunity Leader: – Labcorp
Stephanie Cape, PhD (she/her/hers) – Labcorp ### 627114###Community Leader###Head of R&D - Scientific Affairs, Clinical Trials Testing Solutions###Labcorp###Community Leader: – Labcorp
### she/her/hers5:00 PM – 6:00 PM ET
AAPS Bioequivalence and Bioavailability Science Community Membership Meeting Community Leader: – Sandoz, Inc.
5:00 PM – 6:00 PM ET
AAPS Bioequivalence and Bioavailability Science Community Membership Meeting Location:253 BCommunity Leader: – Sandoz, Inc.
Prasad N. Tata – Sandoz, Inc. ### 1000523###Community Leader###Clinical Development###Sandoz, Inc.###Community Leader: – Sandoz, Inc.
### 5:00 PM – 6:00 PM ET
AAPS Chemistry, Manufacturing, & Controls (CMC) Membership MeetingCommunity Leader: – Pharmalytik
5:00 PM – 6:00 PM ET
AAPS Chemistry, Manufacturing, & Controls (CMC) Membership MeetingLocation:254 BCommunity Leader: – Pharmalytik
Kim Huynh-Ba, MS, PMP, FAAPS – Pharmalytik ### 636579###Community Leader###Managing Director###Pharmalytik###Community Leader: – Pharmalytik
### 5:00 PM – 6:00 PM ET
AAPS Nanotechnology Community Membership MeetingCommunity Leader: – Florida A&M University
5:00 PM – 6:00 PM ET
AAPS Nanotechnology Community Membership MeetingLocation:255Community Leader: – Florida A&M University
Mandip S. Sachdeva, PhD – Florida A&M University ### 848734###Community Leader###Professor###Florida A&M University###Community Leader: – Florida A&M University
### 5:00 PM – 6:00 PM ET
AAPS Pharmaceutical Discovery & Preclinical Development Community Membership MeetingCommunity Leader: – Bristol Myers Squibb
5:00 PM – 6:00 PM ET
AAPS Pharmaceutical Discovery & Preclinical Development Community Membership MeetingLocation:254 ACommunity Leader: – Bristol Myers Squibb
Vibha Jawa, PhD – Bristol Myers Squibb ### 567586###Community Leader###Executive Director###Bristol Myers Squibb###Community Leader: – Bristol Myers Squibb
### 5:00 PM – 6:00 PM ET
AAPS Pharmacokinetics, Pharmacodynamics, & Drug Metabolism Community Membership MeetingCommunity Leader: – Nimbus Therapeutics
5:00 PM – 6:00 PM ET
AAPS Pharmacokinetics, Pharmacodynamics, & Drug Metabolism Community Membership MeetingLocation:253 CCommunity Leader: – Nimbus Therapeutics
Nimita Dave, PhD – Nimbus Therapeutics ### 1650370###Community Leader###Director, Clinical Pharmacology###Nimbus Therapeutics###Community Leader: – Nimbus Therapeutics
### 5:00 PM – 7:00 PM ET
PhRMA Foundation (Invitation Only)
5:00 PM – 7:00 PM ET
PhRMA FoundationLocation:Bullfinch Room, Westin Boston Seaport District Hotel
5:30 PM – 7:00 PM ET
Sustaining Sponsor Reception
5:30 PM – 7:00 PM ET
Sustaining Sponsor ReceptionLocation:Marina 1, Westin Boston Seaport District Hotel
6:00 PM – 9:00 PM ET
2022 Simulations Plus Annual User Forum (Invitation Only)
6:00 PM – 9:00 PM ET
2022 Simulations Plus Annual User Forum (Invitation Only)Location:Douglas Room, Westin Boston Seaport District Hotel
6:00 PM – 9:30 PM ET
American Association of Indian Pharmaceutical Scientist (AAiPS)-Annual Meeting
6:00 PM – 9:30 PM ET
American Association of Indian Pharmaceutical Scientist (AAiPS)-Annual MeetingLocation:Maharaja Restaurant, 57 JFK Street, Cambridge, MA
- Wednesday, October 19, 2022
7:30 AM – 8:30 AM ET
Women in PharmSci Breakfast
7:30 AM – 8:30 AM ET
Women in PharmSci BreakfastLocation:Pavilion, Westin Boston Seaport District Hotel
7:30 AM – 2:30 PM ET
Registration Hours
7:30 AM – 2:30 PM ET
Registration Hours
Location:North Lobby
7:30 AM – 5:00 PM ET
Speaker Ready Room
7:30 AM – 5:00 PM ET
Speaker Ready Room
Location:252 AB
8:30 AM – 9:00 AM ET
Prologue: Biomarkers in Cancer Immunotherapy – a Clinical Pharmacology PerspectiveGovernment Speaker: – U.S. Food and Drug Administration
Clinical Pharmacology – Biomolecular
8:30 AM – 9:00 AM ET
Prologue: Biomarkers in Cancer Immunotherapy – a Clinical Pharmacology PerspectiveLocation:152Government Speaker: – U.S. Food and Drug Administration
Clinical Pharmacology – Biomolecular
Xiaofei Wang, PhD – U.S. Food and Drug Administration ### 1010812###Government Speaker###Pharmacologist###U.S. Food and Drug Administration###Government Speaker: – U.S. Food and Drug Administration
### 8:30 AM – 9:00 AM ET
Prologue: Biomarkers in Drug Development: Overview, Progress and ChallengesPrologue Speaker: – Astellas
Clinical Pharmacology – Chemical
8:30 AM – 9:00 AM ET
Prologue: Biomarkers in Drug Development: Overview, Progress and ChallengesLocation:151 ABPrologue Speaker: – Astellas
Clinical Pharmacology – Chemical
Gurunadh Chichili, PhD – Astellas ### 1686444###Prologue Speaker###Senior Director###Astellas###Prologue Speaker: – Astellas
### 8:30 AM – 9:00 AM ET
Prologue: Cell-Inspired Strategies for Precision Therapy and Drug DeliveryPrologue Speaker: – University of Illinois Chicago
Discovery and Basic Research
8:30 AM – 9:00 AM ET
Prologue: Cell-Inspired Strategies for Precision Therapy and Drug DeliveryLocation:254 BPrologue Speaker: – University of Illinois Chicago
Discovery and Basic Research
Zongmin Zhao, PhD – University of Illinois Chicago ### 1680386###Prologue Speaker###Assistant Professor###University of Illinois Chicago###Prologue Speaker: – University of Illinois Chicago
### 8:30 AM – 9:00 AM ET
Prologue: Challenges and Opportunities for Worldwide Analytical Procedure ManagementPrologue Speaker: – Organon
Manufacturing & Analytical Characterization – Biomolecular
8:30 AM – 9:00 AM ET
Prologue: Challenges and Opportunities for Worldwide Analytical Procedure ManagementLocation:205 CPrologue Speaker: – Organon
Manufacturing & Analytical Characterization – Biomolecular
Christine M V Moore, PhD – Organon ### 1688936###Prologue Speaker###Executive Director###Organon###Prologue Speaker: – Organon
### 8:30 AM – 9:00 AM ET
Prologue: Complexities in Defining/Designing Bioanalytical Strategies to Characterize Pharmacokinetics for CGT
Bioanalytics – Biomolecular
8:30 AM – 9:00 AM ET
Prologue: Complexities in Defining/Designing Bioanalytical Strategies to Characterize Pharmacokinetics for CGTLocation:253 BBioanalytics – Biomolecular
Hiroshi Sugimoto, PhD – Takeda ### 604730###Prologue Speaker###Associate Director###Takeda###Prologue Speaker: – Takeda
### 8:30 AM – 9:00 AM ET
Prologue: Drug Hunters as Project ChampionsPrologue Speaker: – Drug Hunter Inc.
Preclinical Development – Chemical
8:30 AM – 9:00 AM ET
Prologue: Drug Hunters as Project ChampionsLocation:253 CPrologue Speaker: – Drug Hunter Inc.
Preclinical Development – Chemical
Dennis X. Hu, PhD – Drug Hunter Inc. ### 1664126###Prologue Speaker###CEO###Drug Hunter Inc.###Prologue Speaker: – Drug Hunter Inc.
### 8:30 AM – 9:00 AM ET
Prologue: Industry Perspectives in Continuous Manufacturing Prologue Speaker: – Merck & Co., Inc.
Manufacturing & Analytical Characterization
8:30 AM – 9:00 AM ET
Prologue: Industry Perspectives in Continuous Manufacturing Location:206 ABPrologue Speaker: – Merck & Co., Inc.
Manufacturing & Analytical Characterization
Robert F. Meyer, PhD – Merck & Co., Inc. ### 1666085###Prologue Speaker###Senior Principal Scientist###Merck & Co., Inc.###Prologue Speaker: – Merck & Co., Inc.
### 8:30 AM – 9:00 AM ET
Prologue: Modulation of Tumor Microenvironment for Immunotherapy: Focused on Lipid Nanoparticle-Based Gene Delivery StrategiesPrologue Speaker: – Spark Therapeutics
Formulation and Delivery – Biomolecular
8:30 AM – 9:00 AM ET
Prologue: Modulation of Tumor Microenvironment for Immunotherapy: Focused on Lipid Nanoparticle-Based Gene Delivery StrategiesLocation:204 ABPrologue Speaker: – Spark Therapeutics
Formulation and Delivery – Biomolecular
Yun Liu, PhD – Spark Therapeutics ### 1464109###Prologue Speaker###Research Scientist###Spark Therapeutics###Prologue Speaker: – Spark Therapeutics
### 8:30 AM – 9:00 AM ET
Prologue: Overcoming Pitfalls in Moving Compounds From Preclinical Development to the Clinic: Examples From Bench to BedsidePrologue Speaker: – Janssen R&D
Preclinical Development – Biomolecular
8:30 AM – 9:00 AM ET
Prologue: Overcoming Pitfalls in Moving Compounds From Preclinical Development to the Clinic: Examples From Bench to BedsideLocation:254 APrologue Speaker: – Janssen R&D
Preclinical Development – Biomolecular
Weirong Wang, PhD – Janssen R&D ### 567485###Prologue Speaker###Senior Scientific Director###Janssen R&D###Prologue Speaker: – Janssen R&D
### 8:30 AM – 9:00 AM ET
Prologue: Patient-Centric Drug Formulation and Delivery Prologue Speaker: – University of Southern Denmark
Formulation and Delivery – Chemical
8:30 AM – 9:00 AM ET
Prologue: Patient-Centric Drug Formulation and Delivery Location:205 ABPrologue Speaker: – University of Southern Denmark
Formulation and Delivery – Chemical
Rene Holm, PhD – University of Southern Denmark ### 846278###Prologue Speaker###Professor###University of Southern Denmark###Prologue Speaker: – University of Southern Denmark
### 8:30 AM – 9:00 AM ET
Prologue: Recent Progress in Protein DegradationPrologue Speaker: – Pfizer
Discovery and Basic Research
8:30 AM – 9:00 AM ET
Prologue: Recent Progress in Protein DegradationLocation:255Prologue Speaker: – Pfizer
Discovery and Basic Research
Adam M. Gilbert, PhD – Pfizer ### 1695211###Prologue Speaker###Executive Director###Pfizer###Prologue Speaker: – Pfizer
### 8:30 AM – 9:00 AM ET
Prologue: Rising to the Challenge: Advances in Mass Spectrometry Enabling the Future of Biomarker and Biotherapeutic AnalysisPrologue Speaker: – BioAgilytix Labs
Bioanalytics – Chemical
8:30 AM – 9:00 AM ET
Prologue: Rising to the Challenge: Advances in Mass Spectrometry Enabling the Future of Biomarker and Biotherapeutic AnalysisLocation:253 APrologue Speaker: – BioAgilytix Labs
Bioanalytics – Chemical
Chad J. Briscoe, PhD – BioAgilytix Labs ### 605822###Prologue Speaker###Scientific Officer / VP Business Development Europe###BioAgilytix Labs###Prologue Speaker: – BioAgilytix Labs
### 8:30 AM – 1:00 PM ET
Free Professional Headshots
8:30 AM – 1:00 PM ET
Free Professional HeadshotsLocation:Career Development Center, Exhibit Hall A&B
8:30 AM – 1:00 PM ET
LinkedIn Profile Critiques & Resume Reviews
8:30 AM – 1:00 PM ET
LinkedIn Profile Critiques & Resume ReviewsLocation:Career Development Center, Exhibit Hall A&B
8:30 AM – 1:30 PM ET
Solution Center Hours & Poster Presentations
8:30 AM – 1:30 PM ET
Solution Center Hours & Poster PresentationsLocation:Exhibit Hall A&B
9:00 AM – 10:00 AM ET
Development of robust, sensitive LC-MS/MS workflows for metabolites and oligonucleotidesTech Spotlight Speaker: – SCIEX
Partner Presentation Speaker: – Sciex
Discovery and Basic Research
9:00 AM – 10:00 AM ET
Development of robust, sensitive LC-MS/MS workflows for metabolites and oligonucleotidesLocation:360 Stage #1, Exhibit Hall A&BTech Spotlight Speaker: – SCIEX
Partner Presentation Speaker: – Sciex
Discovery and Basic Research
Remco van Soest, MS – SCIEX ### 1743112###Tech Spotlight Speaker###Staff Biopharma Quant Applications Scientist###SCIEX###Tech Spotlight Speaker: – SCIEX
### @@@ Rahul Baghla, M.Pharm, MBA (he/him/his) – Sciex ### 1767288###Partner Presentation Speaker###Manager, Pharma Applications###Sciex###Partner Presentation Speaker: – Sciex
### he/him/his9:00 AM – 10:00 AM ET
Hot Topic: PBPK Modeling: Exponentially Expanding ScienceModerator: – Tolmar, Inc.
Clinical Pharmacology – Chemical
9:00 AM – 10:00 AM ET
Hot Topic: PBPK Modeling: Exponentially Expanding ScienceLocation:153 AModerator: – Tolmar, Inc.
Clinical Pharmacology – Chemical
Raja B. Velagapudi, PhD – Tolmar, Inc. ### 567542###Moderator###Sr. Dir., Clinical Development###Tolmar, Inc.###Moderator: – Tolmar, Inc.
### 9:00 AM – 9:30 AM ET
Scemblix: Use of PBPK Models In Lieu of Clinical TrialsLocation:153 AHot Topic Moderator: – Tolmar, Inc.
Hot Topic Speaker: – Novartis Institutes for Biomedical Research
Clinical Pharmacology – Chemical
Raja B. Velagapudi, PhD – Tolmar, Inc. ### 567542###Hot Topic Moderator###Sr. Dir., Clinical Development###Tolmar, Inc.###Hot Topic Moderator: – Tolmar, Inc.
### @@@ Heidi J. Einolf, PhD (she/her/hers) – Novartis Institutes for Biomedical Research ### 1795010###Hot Topic Speaker###Executive Director###Novartis Institutes for Biomedical Research###Hot Topic Speaker: – Novartis Institutes for Biomedical Research
### she/her/hers9:30 AM – 10:00 AM ET
Applications and Regulatory Acceptance of PBPK ModelingLocation:153 AHot Topic Speaker: – Certara
Clinical Pharmacology – Chemical
Hannah Jones, PhD – Certara ### 1764091###Hot Topic Speaker###Senior Vice President, Head of PBPK Consulting Services###Certara###Hot Topic Speaker: – Certara
### 9:00 AM – 10:00 AM ET
Symposium: Cross-Modality and Modality Agnostic Approaches to Development and Manufacturing 2Moderator: – Merck & Co., Inc.
Manufacturing & Analytical Characterization
9:00 AM – 10:00 AM ET
Symposium: Cross-Modality and Modality Agnostic Approaches to Development and Manufacturing 2Location:206 ABModerator: – Merck & Co., Inc.
Manufacturing & Analytical Characterization
Robert F. Meyer, PhD – Merck & Co., Inc. ### 1666085###Moderator###Senior Principal Scientist###Merck & Co., Inc.###Moderator: – Merck & Co., Inc.
### 9:00 AM – 9:30 AM ET
Advances in the Application of Continuous Manufacturing at Eli LillyLocation:206 ABSpeaker: – Eli Lilly and Company
Manufacturing & Analytical Characterization
Wyatt Roth, PhD – Eli Lilly and Company ### 796051###Speaker###Senior Director###Eli Lilly and Company###Speaker: – Eli Lilly and Company
### 9:30 AM – 10:00 AM ET
Modernization of Pharmaceutical Manufacturing Through Adoption of Advanced ManufacturingLocation:206 ABGovernment Speaker: – US FOOD AND DRUG ADMINISTRATION
Manufacturing & Analytical Characterization
Sau Lee, PhD – US FOOD AND DRUG ADMINISTRATION ### 603104###Government Speaker###Deputy Director of Science###US FOOD AND DRUG ADMINISTRATION###Government Speaker: – US FOOD AND DRUG ADMINISTRATION
### 9:00 AM – 10:00 AM ET
The Science of Belonging for STEM WomenCareer Center Speaker: – Susan Morris Coaching
Career Center Speaker: – Thriving Though Adversity Coaching
Career Development
9:00 AM – 10:00 AM ET
The Science of Belonging for STEM WomenLocation:360 Stage #3, Exhibit Hall A&BCareer Center Speaker: – Susan Morris Coaching
Career Center Speaker: – Thriving Though Adversity Coaching
Career Development
Susan Morris, M.Ed., CPCC, ACC – Susan Morris Coaching ### 1023071###Career Center Speaker###President###Susan Morris Coaching###Career Center Speaker: – Susan Morris Coaching
### @@@ Lara S. Kallander, PhD, MAPP, ACC – Thriving Though Adversity Coaching ### 1650333###Career Center Speaker###Founder###Thriving Though Adversity Coaching###Career Center Speaker: – Thriving Though Adversity Coaching
### 9:00 AM – 10:30 AM ET
Symposium: Overcoming Pitfalls in Moving Compounds From Preclinical Development to the Clinic: Examples From Bench to Bedside (CE)Moderator: – Drug Hunter Inc.
Preclinical Development – Chemical
9:00 AM – 10:30 AM ET
Symposium: Overcoming Pitfalls in Moving Compounds From Preclinical Development to the Clinic: Examples From Bench to Bedside (CE)Location:253 CModerator: – Drug Hunter Inc.
Preclinical Development – Chemical
Dennis X. Hu, PhD – Drug Hunter Inc. ### 1664126###Moderator###CEO###Drug Hunter Inc.###Moderator: – Drug Hunter Inc.
### 9:00 AM – 9:30 AM ET
Challenges in Development of a Small Peptide-Based Therapeutic Targeting CNSLocation:253 CPreclinical Development – Chemical
Mikhail Lomonosov, PhD – Ovoca Bio ### 1650362###Speaker###Head of Research###Ovoca Bio###Speaker: – Ovoca Bio
### 9:30 AM – 10:00 AM ET
RP-6306: Preclinical Experiences Delivering a Bioavailable and Selective PKMYT1 InhibitorLocation:253 CSpeaker: – Repare Therapeutics
Preclinical Development – Chemical
Robert Papp, MSc – Repare Therapeutics ### 1664127###Speaker###Director - DMPK###Repare Therapeutics###Speaker: – Repare Therapeutics
### 10:00 AM – 10:30 AM ET
Navigating the Pain Points in Discovery & Preclinical Development of NaV1.7 InhibitorsLocation:253 CSpeaker: – Merck & Co., Inc.
Preclinical Development – Chemical
Jeanine Ballard, M.S. – Merck & Co., Inc. ### 857292###Speaker###Principal Scientist###Merck & Co., Inc.###Speaker: – Merck & Co., Inc.
### 9:00 AM – 10:30 AM ET
Symposium: Targeted Drug Discovery and Molecular PharmacologyDiscovery and Basic Research
9:00 AM – 10:30 AM ET
Symposium: Targeted Drug Discovery and Molecular PharmacologyLocation:255Discovery and Basic Research
Adam M. Gilbert, PhD – Pfizer ### 1695211###Moderator###Executive Director###Pfizer###Moderator: – Pfizer
### 9:00 AM – 9:30 AM ET
Expanding Functional Protein Sequence Spaces Using Generative Adversarial NetworksLocation:255Speaker: – CHALMERS UNIVERSITY OF TECHNOLOGY
Discovery and Basic Research
Aleksej Zelezniak, Ph.D. – CHALMERS UNIVERSITY OF TECHNOLOGY ### 1650358###Speaker###Assistant Professor###CHALMERS UNIVERSITY OF TECHNOLOGY###Speaker: – CHALMERS UNIVERSITY OF TECHNOLOGY
### 9:30 AM – 10:00 AM ET
Novel Targeted Gene Therapy in Hearing Loss DiseasesLocation:255Speaker: – University of Florida College of Pharmacy
Discovery and Basic Research
Xiaoshu Pan, PhD – University of Florida College of Pharmacy ### 1328564###Speaker###Postdoctoral Associate###University of Florida College of Pharmacy###Speaker: – University of Florida College of Pharmacy
### 10:00 AM – 10:30 AM ET
Leveraging PROTACs to Overcome Resistance in Targeted Cancer Therapies and ImmunotherapiesLocation:255Speaker: – Baylor College of Medicine
Discovery and Basic Research
Jin Wang, PhD – Baylor College of Medicine ### 1695210###Speaker###Michael E. DeBakey Professor in Pharmacology###Baylor College of Medicine###Speaker: – Baylor College of Medicine
### 9:00 AM – 11:00 AM ET
Symposium: A Look Into the Future of Bioanalytics (BM)Moderator: – PPD, A ThermoFisher Company
Bioanalytics – Biomolecular
9:00 AM – 11:00 AM ET
Symposium: A Look Into the Future of Bioanalytics (BM)Location:253 BModerator: – PPD, A ThermoFisher Company
Bioanalytics – Biomolecular
Catherine Vrentas, PhD – PPD, A ThermoFisher Company ### 1650329###Moderator###Senior Research Scientist###PPD, A ThermoFisher Company###Moderator: – PPD, A ThermoFisher Company
### 9:00 AM – 9:30 AM ET
PK Assay Platform Considerations for Supporting CAR-T and Next Gen CART ModalitiesLocation:253 BSpeaker: – Bristol Myers Squibb
Bioanalytics – Biomolecular
Vibha Jawa, Ph.D., FAAPS – Bristol Myers Squibb ### 567586###Speaker###Executive Director###Bristol Myers Squibb###Speaker: – Bristol Myers Squibb
### 9:30 AM – 10:00 AM ET
Challenges and Solutions for Quantitating Transgene Protein Expression in Gene TherapyLocation:253 BSpeaker: – Sangamo Therapeutics
Bioanalytics – Biomolecular
Yonghua Pan, PhD – Sangamo Therapeutics ### 844125###Speaker###Senior Scientist###Sangamo Therapeutics###Speaker: – Sangamo Therapeutics
### 10:00 AM – 10:30 AM ET
Cellular Kinetics by Flow Cytometry for Existing and Next Generation CAR-TsLocation:253 BSpeaker: – Novartis Institutes for BioMedical Research, Inc.
Bioanalytics – Biomolecular
Robert Dodge, PhD – Novartis Institutes for BioMedical Research, Inc. ### 758596###Speaker###Global Lead, Biologics Bioanalysis###Novartis Institutes for BioMedical Research, Inc.###Speaker: – Novartis Institutes for BioMedical Research, Inc.
### 10:30 AM – 11:00 AM ET
Sensitivity for qPCR Assays: Challenges and OpportunitiesLocation:253 BBioanalytics – Biomolecular
Kelly S. Colletti, PhD, MBA – Charles River ### 639053###Speaker###Scientific Director###Charles River###Speaker: – Charles River
### 9:00 AM – 11:00 AM ET
Symposium: A Look Into the Future of Bioanalytics (CE)Bioanalytics – Chemical
9:00 AM – 11:00 AM ET
Symposium: A Look Into the Future of Bioanalytics (CE)Location:253 ABioanalytics – Chemical
Amanda Hays, Ph.D. – BioAgilytix ### 1529523###Moderator###Scientific Officer###BioAgilytix###Moderator: – BioAgilytix
### 9:00 AM – 9:30 AM ET
Good Practices in Bioanalysis of Biotherapeutics Using LC-MS Based ApproachesLocation:253 AGovernment Speaker: – US Food and Drug Administration
Bioanalytics – Chemical
Jinhui Zhang, PhD – US Food and Drug Administration ### 603101###Government Speaker###Chemist###US Food and Drug Administration###Government Speaker: – US Food and Drug Administration
### 9:30 AM – 10:00 AM ET
Best Practices in Biomarker Assay Validation by LC-MSLocation:253 ASpeaker: – Labcorp Drug Development
Bioanalytics – Chemical
Mark E. Arnold, PhD, FAAPS – Labcorp Drug Development ### 1311049###Speaker###Director of Science###Labcorp Drug Development###Speaker: – Labcorp Drug Development
### 10:00 AM – 10:30 AM ET
Workflow to Quantify Protein Biomarkers By Liquid Chromatograph-Tandem Mass SpectrometryLocation:253 ASpeaker: – Janssen Research and Development
Bioanalytics – Chemical
Karan Agrawal, PhD – Janssen Research and Development ### 1417721###Speaker###Scientist###Janssen Research and Development###Speaker: – Janssen Research and Development
### 10:30 AM – 11:00 AM ET
Rapid Prostate Cancer Noninvasive Biomarker Screening Using Segmented Flow Mass Spectrometry-Based Untargeted MetabolomicsLocation:253 ASpeaker: – University of Florida, Department of Pathology
Bioanalytics – Chemical
Timothy J. Garrett, PhD – University of Florida, Department of Pathology ### 803624###Speaker###Associate Professor###University of Florida, Department of Pathology###Speaker: – University of Florida, Department of Pathology
### 9:00 AM – 11:00 AM ET
Symposium: Cells as Carriers of Therapy: From Factories to HitchhikingModerator: – University of Illinois Chicago
Discovery and Basic Research
9:00 AM – 11:00 AM ET
Symposium: Cells as Carriers of Therapy: From Factories to HitchhikingLocation:254 BModerator: – University of Illinois Chicago
Discovery and Basic Research
Zongmin Zhao, PhD – University of Illinois Chicago ### 1680386###Moderator###Assistant Professor###University of Illinois Chicago###Moderator: – University of Illinois Chicago
### 9:00 AM – 9:30 AM ET
Cargocytes: The Next Generation Therapeutic Delivery SystemLocation:254 BDiscovery and Basic Research
Richard Klemke, PhD – UC San Diego ### 1680387###Speaker###Professor###UC San Diego###Speaker: – UC San Diego
### 9:30 AM – 10:00 AM ET
Small Circular mRNA VaccinesLocation:254 BSpeaker: – Virginia Commonwealth University
Discovery and Basic Research
Guizhi Zhu, PhD – Virginia Commonwealth University ### 1377872###Speaker###Assistant Professor###Virginia Commonwealth University###Speaker: – Virginia Commonwealth University
### 10:00 AM – 10:30 AM ET
Development of Lipid Nanoparticles for On-Target Genome EditingLocation:254 BSpeaker: – Tufts University
Discovery and Basic Research
Qiaobing Xu, PhD – Tufts University ### 1741085###Speaker###Professor###Tufts University###Speaker: – Tufts University
### 10:30 AM – 11:00 AM ET
Engineering Bacteria as Drug Deliver Vehicles for CancerLocation:254 BSpeaker: – Harvard University
Discovery and Basic Research
Tetsu Harimoto, PhD – Harvard University ### 1699110###Speaker###Postdoctoral fellow###Harvard University###Speaker: – Harvard University
### 9:00 AM – 11:00 AM ET
Symposium: Cross-Modality and Modality Agnostic Approaches to Development and Manufacturing 1Moderator: – Waters Corporation
Manufacturing & Analytical Characterization
9:00 AM – 11:00 AM ET
Symposium: Cross-Modality and Modality Agnostic Approaches to Development and Manufacturing 1Location:205 CModerator: – Waters Corporation
Manufacturing & Analytical Characterization
Isabelle Vu Trieu, MA, Chemistry; MS, Chemical Engineering – Waters Corporation ### 803450###Moderator###Market Development Manager###Waters Corporation###Moderator: – Waters Corporation
### 9:00 AM – 9:30 AM ET
ICHQ2(R2)/Q14 – The Future of Analytical Procedure Development and ValidationLocation:205 CManufacturing & Analytical Characterization
Nina S. Cauchon, PhD – Amgen ### 567462###Speaker###Director###Amgen###Speaker: – Amgen
### 9:30 AM – 10:00 AM ET
Analytical Procedures Life Cycle: A Holistic View of Analytical Method PerformanceLocation:205 CSpeaker: – US Pharmacopeia
Manufacturing & Analytical Characterization
Horacio Pappa, PhD – US Pharmacopeia ### 1650335###Speaker###Sr. Director, Science General Chapters###US Pharmacopeia###Speaker: – US Pharmacopeia
### 10:00 AM – 10:30 AM ET
Method Performance Analysis and MonitoringLocation:205 CSpeaker: – Merck Sharpe and Dohme LLC
Manufacturing & Analytical Characterization
David J. Lavrich, PhD – Merck Sharpe and Dohme LLC ### 1666084###Speaker###Senior Principal Scientist###Merck Sharpe and Dohme LLC###Speaker: – Merck Sharpe and Dohme LLC
### 10:30 AM – 11:00 AM ET
Material Sparing Analytical Tools for Material Property Characterization of PowdersLocation:205 CSpeaker: – University of Minnesota
Manufacturing & Analytical Characterization
Changquan Calvin Sun, PhD – University of Minnesota ### 846725###Speaker###Professor###University of Minnesota###Speaker: – University of Minnesota
### 9:00 AM – 11:00 AM ET
Symposium: Evolution in Patient-Centric Drug Formulation and Delivery (BM)Formulation and Delivery – Biomolecular
9:00 AM – 11:00 AM ET
Symposium: Evolution in Patient-Centric Drug Formulation and DeliveryLocation:204 ABFormulation and Delivery – Biomolecular
Yun Liu, PhD – Spark Therapeutics ### 1464109###Moderator###Research Scientist###Spark Therapeutics###Moderator: – Spark Therapeutics
### 9:00 AM – 9:30 AM ET
Microneedle Delivery of Formulated RNALocation:204 ABFormulation and Delivery – Biomolecular
Ana Jaklenec, PhD – MIT ### 846456###Speaker###Research Scientist ###MIT###Speaker: – MIT
### 9:30 AM – 10:00 AM ET
Sustained Delivery of Inhaled BiologicsLocation:204 ABSpeaker: – University of Louvain
Formulation and Delivery – Biomolecular
Rita Vanbever, PhD – University of Louvain ### 1650332###Speaker###Professor / Research director FNRS###University of Louvain###Speaker: – University of Louvain
### 10:00 AM – 10:30 AM ET
Pullulan and Trehalose Room Temperature Stabilization of VSV Vectored TherapeuticsLocation:204 ABFormulation and Delivery – Biomolecular
Jeremy Iwashkiw, Dr – Elarex ### 1748070###Speaker###Staff Scientist###Elarex###Speaker: – Elarex
### 10:30 AM – 11:00 AM ET
Exosome Delivery Approach for Precision MedicineLocation:204 ABSpeaker: – University of Florida
Formulation and Delivery – Biomolecular
Mei He, PhD – University of Florida ### 1010792###Speaker###Assistant Professor###University of Florida###Speaker: – University of Florida
### 9:00 AM – 11:00 AM ET
Symposium: Evolution in Patient-Centric Drug Formulation and Delivery (CE)Moderator: – University of Southern Denmark
Formulation and Delivery – Chemical
9:00 AM – 11:00 AM ET
Symposium: Evolution in Patient-Centric Drug Formulation and Delivery (CE)Location:205 ABModerator: – University of Southern Denmark
Formulation and Delivery – Chemical
Rene Holm, PhD – University of Southern Denmark ### 846278###Moderator###Professor###University of Southern Denmark###Moderator: – University of Southern Denmark
### 9:00 AM – 9:30 AM ET
Scalable Production and Efficacy of Inhaled Antibiotic-Loaded Lipid Nanoparticles for Treatment of Pulmonary InfectionsLocation:205 ABSpeaker: – St. John's University
Formulation and Delivery – Chemical
Vivek Gupta, PhD – St. John's University ### 604838###Speaker###Associate Professor, Pharmaceutical Sciences###St. John's University###Speaker: – St. John's University
### 9:30 AM – 10:00 AM ET
Assignment of Within-subject Variability During PBPK Based Virtual Bioequivalence StudiesLocation:205 ABSpeaker: – Certara / University of Manchester
Formulation and Delivery – Chemical
Amin Rostami-Hodjegan, PharmD, PhD – Certara / University of Manchester ### 465985###Speaker###Director of CAPKR and Chief Scientific Officer###Certara / University of Manchester ###Speaker: – Certara / University of Manchester
### 10:00 AM – 10:30 AM ET
Novel Approaches for Evaluating Bioavailability of Topical Dermatological Drug ProductsLocation:205 ABGovernment Speaker: – US Food and Drug Administration
Formulation and Delivery – Chemical
Tannaz Ramezanli, PhD – US Food and Drug Administration ### 584218###Government Speaker###Pharmacologist###US Food and Drug Administration###Government Speaker: – US Food and Drug Administration
### 10:30 AM – 11:00 AM ET
Approaches to Topical Product Development- an Industry PerspectiveLocation:205 ABSpeaker: – Solaris Pharma Corporation
Formulation and Delivery – Chemical
Lakshmi Raghavan, PhD – Solaris Pharma Corporation ### 1718883###Speaker###Founder & President###Solaris Pharma Corporation###Speaker: – Solaris Pharma Corporation
### 9:00 AM – 11:00 AM ET
Symposium: Overcoming Pitfalls in Moving Compounds From Preclinical Development to the Clinic: Examples From Bench to Bedside (BM)Preclinical Development – Biomolecular
9:00 AM – 11:00 AM ET
Symposium: Overcoming Pitfalls in Moving Compounds From Preclinical Development to the Clinic: Examples From Bench to Bedside (BM)Location:254 APreclinical Development – Biomolecular
Weiwei Tan, PhD – Pfizer Inc ### 1676855###Moderator###Senior Director###Pfizer Inc###Moderator: – Pfizer Inc
### 9:00 AM – 9:30 AM ET
Tackle the Conundrums of Anti-Tumor Antibody Drug Development with PK/PD ModelingLocation:254 ASpeaker: – Boehringer Ingelheim Corporation
Preclinical Development – Biomolecular
Jun Wang, PhD – Boehringer Ingelheim Corporation ### 605023###Speaker###Principal scientist###Boehringer Ingelheim Corporation###Speaker: – Boehringer Ingelheim Corporation
### 9:30 AM – 10:00 AM ET
Overcoming Pitfalls During the Development of mRNA Therapies From Bench to BedsideLocation:254 APreclinical Development – Biomolecular
Oleg Milberg, PhD – Moderna, Inc. ### 466135###Speaker###Associate Director, QSP Modeling###Moderna, Inc.###Speaker: – Moderna, Inc.
### 10:00 AM – 10:30 AM ET
ADME Approaches for the Pfizer Oral COVID-19 Protease Inhibitor ProgramLocation:254 APreclinical Development – Biomolecular
Amit Kalgutkar, PhD – Pfizer ### 856254###Speaker###Senior Research Fellow###Pfizer###Speaker: – Pfizer
### 10:30 AM – 11:00 AM ET
Challenges and Opportunities with Preclinical to Clinical Translation of CAR-T Cell TherapyLocation:254 ASpeaker: – Takeda Pharmaceuticals, USA
Preclinical Development – Biomolecular
Aman P. Singh, M.S., PhD – Takeda Pharmaceuticals, USA ### 1328476###Speaker###Associate Director, Clinical and Quantitative Pharmacology Lead, Cell Therapy Clinical Pharmacology###Takeda Pharmaceuticals, USA###Speaker: – Takeda Pharmaceuticals, USA
### 9:00 AM – 11:00 AM ET
Symposium: Translational Biomarkers: From Bench to Bedside (BM)Clinical Pharmacology – Biomolecular
9:00 AM – 11:00 AM ET
Symposium: Translational Biomarkers: From Bench to BedsideLocation:152Clinical Pharmacology – Biomolecular
Yow-Ming Wang, PhD – US Food and Drug Administration ### 1690187###Government Speaker###Associate Director for Biosimilars and Therapeutic Biologics###US Food and Drug Administration###Government Speaker: – US Food and Drug Administration
### 9:00 AM – 9:30 AM ET
Predictive and Therapeutic Biomarkers in CAR T-Cell TherapyLocation:152Speaker: – Takeda Pharmaceuticals, USA
Clinical Pharmacology – Biomolecular
Aman P. Singh, M.S., PhD – Takeda Pharmaceuticals, USA ### 1328476###Speaker###Associate Director, Clinical and Quantitative Pharmacology Lead, Cell Therapy Clinical Pharmacology###Takeda Pharmaceuticals, USA###Speaker: – Takeda Pharmaceuticals, USA
### 9:30 AM – 10:00 AM ET
Pharmacodynamic Systems Analysis for Identifying Biomarkers of Allogeneic CAR-T-Cell TherapyLocation:152Speaker: – University at Buffalo, SUNY/Enhanced Pharmacodynamics, LLC
Clinical Pharmacology – Biomolecular
Donald E. Mager, PharmD, PhD – University at Buffalo, SUNY/Enhanced Pharmacodynamics, LLC ### 576352###Speaker###Professor and Vice Chair of Pharmaceutical Sciences/President and CEO###University at Buffalo, SUNY/Enhanced Pharmacodynamics, LLC###Speaker: – University at Buffalo, SUNY/Enhanced Pharmacodynamics, LLC
### 10:00 AM – 10:30 AM ET
Biomarkers for Oncolytic Viruses and Intratumoral ImmunotherapyLocation:152Speaker: – Massachusetts General Hospital/Harvard Medical School/Ankyra Therapeutics
Clinical Pharmacology – Biomolecular
Howard Kaufman, MD – Massachusetts General Hospital/Harvard Medical School/Ankyra Therapeutics ### 1650359###Speaker###Clinical Associate/Lecturer/CEO###Massachusetts General Hospital/Harvard Medical School/Ankyra Therapeutics###Speaker: – Massachusetts General Hospital/Harvard Medical School/Ankyra Therapeutics
### 10:30 AM – 11:00 AM ET
It Takes Two to Tango: FDA-Approved Immune Checkpoint Inhibitors and Companion DiagnosticsLocation:152Government Speaker: – Office of Biotechnology Products (OBP), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA)
Clinical Pharmacology – Biomolecular
Baolin Zhang, PhD – Office of Biotechnology Products (OBP), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA) ### 1650365###Government Speaker###SBRBPAS Expert###Office of Biotechnology Products (OBP), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA)###Government Speaker: – Office of Biotechnology Products (OBP), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA)
### 9:00 AM – 11:00 AM ET
Symposium: Translational Biomarkers: From Bench to Bedside (CE)Clinical Pharmacology – Chemical
9:00 AM – 11:00 AM ET
Symposium: Translational Biomarkers: From Bench to Bedside (CE)Location:151 ABClinical Pharmacology – Chemical
Gurunadh Chichili, PhD – Astellas ### 1686444###Moderator###Senior Director###Astellas###Moderator: – Astellas
### 9:00 AM – 9:30 AM ET
Scientific and Operational Strategies for Clinical Biomarker DevelopmentLocation:151 ABSpeaker: – Takeda Pharmaceuticals, Inc.
Clinical Pharmacology – Chemical
Saileta Prabhu, PhD – Takeda Pharmaceuticals, Inc. ### 653569###Speaker###Vice President / Global Head###Takeda Pharmaceuticals, Inc.###Speaker: – Takeda Pharmaceuticals, Inc.
### 9:30 AM – 10:00 AM ET
Companion Diagnostics: Past, Present & Future – A Global Central Lab PerspectiveLocation:151 ABClinical Pharmacology – Chemical
Alan Wookey – Q2 Solutions ### 1688938###Speaker###VP Companion Diagnostics & Oncology###Q2 Solutions###Speaker: – Q2 Solutions
### 10:00 AM – 10:30 AM ET
Drug Transporters Biomarkers and Their Role in Guiding Drug DevelopmentLocation:151 ABClinical Pharmacology – Chemical
Manthena V. varma, PhD – Pfizer ### 567481###Speaker###Research Fellow###Pfizer###Speaker: – Pfizer
### 10:30 AM – 11:00 AM ET
Imaging Biomarker for Clinical TrailsLocation:151 ABSpeaker: – Novartis Institutes for Biomedical Research
Clinical Pharmacology – Chemical
Alexander Goehler, MD, PhD (he/him/his) – Novartis Institutes for Biomedical Research ### 1688939###Speaker###Global Head, Clinical and Precision Medicine Imaging###Novartis Institutes for Biomedical Research###Speaker: – Novartis Institutes for Biomedical Research
### he/him/his9:30 AM – 10:00 AM ET
Coffee Break in the Solution Center
9:30 AM – 10:00 AM ET
Coffee Break in the Solution CenterLocation:Exhibit Hall A&B
9:30 AM – 10:30 AM ET
Novel Plasma Fractionation Process to Produce Intravenous Immunoglobulin (IVIG)Tech Spotlight Speaker: – Prolytix
Manufacturing & Analytical Characterization
9:30 AM – 10:30 AM ET
Novel Plasma Fractionation Process to Produce Intravenous Immunoglobulin (IVIG)Location:360 Stage #2, Exhibit Hall A&BTech Spotlight Speaker: – Prolytix
Manufacturing & Analytical Characterization
Matthew Whelihan, PhD (he/him/his) – Prolytix ### 1764088###Tech Spotlight Speaker###Associate Principal Scientist###Prolytix###Tech Spotlight Speaker: – Prolytix
### he/him/his9:30 AM – 10:30 AM ET
Speaker Spotlight: Lessons Learned from Prodrug Design- Lactone Stabilized Camptothecin From Comprehensive Preclinical Pharmacokinetics Translating to Clinical TrialSpotlight Speaker: – University of Houston
Moderator: – Pfizer Worldwide Research and Development
Formulation and Delivery
9:30 AM – 10:30 AM ET
Speaker Spotlight: Lessons Learned from Prodrug Design- Lactone Stabilized Camptothecin From Comprehensive Preclinical Pharmacokinetics Translating to Clinical TrialLocation:Spotlight Stage 3, Exhibit Hall A&BSpotlight Speaker: – University of Houston
Moderator: – Pfizer Worldwide Research and Development
Formulation and Delivery
Diana S-L Chow, PhD – University of Houston ### 605969###Spotlight Speaker###Professor and Director###University of Houston###Spotlight Speaker: – University of Houston
### @@@ Jaymin C. Shah, PhD – Pfizer Worldwide Research and Development ### 1554431###Moderator###Research Fellow and Head of Topical and Advanced Drug Delivery###Pfizer Worldwide Research and Development###Moderator: – Pfizer Worldwide Research and Development
### 9:30 AM – 10:30 AM ET
Speaker Spotlight: Monitoring CAR-T Persistence by Droplet Digital PCRModerator: – Janssen R&D/ Johnson & Johnson
Spotlight Speaker: – Tessa Therapeutics
Bioanalytics
9:30 AM – 10:30 AM ET
Speaker Spotlight: Monitoring CAR-T Persistence by Droplet Digital PCRLocation:Spotlight Stage 2, Exhibit Hall A&BModerator: – Janssen R&D/ Johnson & Johnson
Spotlight Speaker: – Tessa Therapeutics
Bioanalytics
Kate B. Herr, M.S. – Janssen R&D/ Johnson & Johnson ### 1730310###Moderator###Scientist###Janssen R&D/ Johnson & Johnson###Moderator: – Janssen R&D/ Johnson & Johnson
### @@@ Shian-Jiun Shih, PhD – Tessa Therapeutics ### 1762950###Spotlight Speaker###Consultant###Tessa Therapeutics###Spotlight Speaker: – Tessa Therapeutics
### 10:00 AM – 11:00 AM ET
Hot Topic: Manufacturing and Analytical CharacterizationHot Topic Moderator: – GSK
Manufacturing & Analytical Characterization
10:00 AM – 11:00 AM ET
Hot Topic: Manufacturing and Analytical CharacterizationLocation:153 BCHot Topic Moderator: – GSK
Manufacturing & Analytical Characterization
Sayantan Chattoraj, Ph.D. – GSK ### 828674###Hot Topic Moderator###Director & GSK Fellow, Drug Product Development###GSK###Hot Topic Moderator: – GSK
### 10:00 AM – 11:00 AM ET
Long Acting Ocular DeliveryLocation:153 BCHot Topic Speaker: – Genentech
Manufacturing & Analytical Characterization
Karthik Nagapudi, PhD – Genentech ### 605020###Hot Topic Speaker###Director and Senior Principal Scientist###Genentech###Hot Topic Speaker: – Genentech
### 10:30 AM – 11:30 AM ET
How reducing protein viscosity can improve formulation and process economicsPartner Presentation Speaker: – MilliporeSigma
Formulation and Delivery
10:30 AM – 11:30 AM ET
How reducing protein viscosity can improve formulation and process economicsLocation:360 Stage #1, Exhibit Hall A&BPartner Presentation Speaker: – MilliporeSigma
Formulation and Delivery
Presented By Millipore Sigma
Tobias Rosenkranz, PhD – MilliporeSigma ### 1092556###Partner Presentation Speaker###Senior Manager, Head of Biomolecule Formulation – Technology & Innovation###MilliporeSigma###Partner Presentation Speaker: – MilliporeSigma
### 10:30 AM – 11:30 AM ET
Is Entrepreneurship in your Pharmaceutical Career Crystal Ball?Career Center Speaker: – Astraea Therapeutics, LLC
Career Center Moderator: – AstraZeneca
Career Center Speaker: – Harvard University
Career Center Speaker: – SynerG BioPharma Group, LLC
Career Development
10:30 AM – 11:30 AM ET
Is Entrepreneurship in your Pharmaceutical Career Crystal Ball?Location:360 Stage #3, Exhibit Hall A&BCareer Center Speaker: – Astraea Therapeutics, LLC
Career Center Moderator: – AstraZeneca
Career Center Speaker: – Harvard University
Career Center Speaker: – SynerG BioPharma Group, LLC
Career Development
Nurulain T. Zaveri, PhD, FAAPS – Astraea Therapeutics, LLC ### 567624###Career Center Speaker###Founder, President and Chief Scientific Officer###Astraea Therapeutics, LLC###Career Center Speaker: – Astraea Therapeutics, LLC
### @@@ Annette Bak, PhD, MBA, FAAPS (she/her/hers) – AstraZeneca ### 466184###Career Center Moderator###Executive Director###AstraZeneca###Career Center Moderator: – AstraZeneca
### she/her/hers @@@ Gregory Verdine, PhD (he/him/his) – Harvard University ### 1650374###Career Center Speaker###Founder & CEO###Harvard University###Career Center Speaker: – Harvard University
### he/him/his @@@ PRABU NAMBIAR, PhD MBA – SynerG BioPharma Group, LLC ### 1650375###Career Center Speaker###Founder and Principal###SynerG BioPharma Group, LLC###Career Center Speaker: – SynerG BioPharma Group, LLC
### 10:30 AM – 11:30 AM ET
Special Poster Collection
10:30 AM – 11:30 AM ET
Special Poster CollectionLocation:Poster Forum #2, Exhibit Hall A&BPoster Collection Host: – Bristol-Myers Squibb Company
Otilia M. Koo, PhD – Bristol-Myers Squibb Company ### 575911###Poster Collection Host###Executive Director###Bristol-Myers Squibb Company###Poster Collection Host: – Bristol-Myers Squibb Company
### 11:00 AM – 12:00 PM ET
Brace for (Regulatory) Impact: Proactive TiO2 Removal from Film CoatingsPartner Presentation Speaker: – JRS PHARMA LP
Formulation and Delivery
11:00 AM – 12:00 PM ET
Brace for (Regulatory) Impact: Proactive TiO2 Removal from Film CoatingsLocation:360 Stage #2, Exhibit Hall A&BPartner Presentation Speaker: – JRS PHARMA LP
Formulation and Delivery
Allison Labriola (she/her/hers) – JRS PHARMA LP ### 1743107###Partner Presentation Speaker###Senior Technical Sales Representative###JRS PHARMA LP###Partner Presentation Speaker: – JRS PHARMA LP
### she/her/hers11:00 AM – 12:00 PM ET
Transforming Drug Loads in Injectable Hydrogels, the Power of Small ParticlesPartner Presentation Speaker: – University of Manchester, UK
Formulation and Delivery
11:00 AM – 12:00 PM ET
Transforming Drug Loads in Injectable Hydrogels, the Power of Small ParticlesLocation:360 Stage #4, Exhibit Hall A&BPartner Presentation Speaker: – University of Manchester, UK
Formulation and Delivery
Christopher Worrall, PhD – University of Manchester, UK ### 1491373###Partner Presentation Speaker###Atropisomeric Diaryl Ethers###University of Manchester, UK###Partner Presentation Speaker: – University of Manchester, UK
### 11:00 AM – 1:30 PM ET
Dedicated Solution Center Hours
11:00 AM – 1:30 PM ET
Dedicated Solution Center HoursLocation:Exhibit Hall A&B
11:30 AM – 12:30 PM ET
Speaker Spotlight: Addressing Issues of Metabolism-Mediated Toxicity During Drug DevelopmentSpotlight Speaker: – Aranmore Pharma Consulting
Moderator: – Merck & Co., Inc.
Preclinical Development
11:30 AM – 12:30 PM ET
Speaker Spotlight: Addressing Issues of Metabolism-Mediated Toxicity During Drug DevelopmentLocation:Spotlight Stage 1, Exhibit Hall A&BSpotlight Speaker: – Aranmore Pharma Consulting
Moderator: – Merck & Co., Inc.
Preclinical Development
William Humphreys, PhD – Aranmore Pharma Consulting ### 1678287###Spotlight Speaker###Principal###Aranmore Pharma Consulting###Spotlight Speaker: – Aranmore Pharma Consulting
### @@@ Yasuhiro Tsume, PhD – Merck & Co., Inc. ### 583852###Moderator###Scientist###Merck & Co., Inc.###Moderator: – Merck & Co., Inc.
### 11:30 AM – 12:30 PM ET
Speaker Spotlight: Integrating Clinical Biomarkers in QSP Models: Applications in Drug DevelopmentSpotlight Speaker: – Denali Therapeutics
Moderator: – Nimbus Therapeutics
Clinical Pharmacology
11:30 AM – 12:30 PM ET
Speaker Spotlight: Integrating Clinical Biomarkers in QSP Models: Applications in Drug DevelopmentLocation:Spotlight Stage 2, Exhibit Hall A&BSpotlight Speaker: – Denali Therapeutics
Moderator: – Nimbus Therapeutics
Clinical Pharmacology
Kapil Gadkar, PhD – Denali Therapeutics ### 846568###Spotlight Speaker###Staff Scientist, Senior Director ###Denali Therapeutics ###Spotlight Speaker: – Denali Therapeutics
### @@@ Nimita Dave, PhD – Nimbus Therapeutics ### 1650370###Moderator###Director, Clinical Pharmacology###Nimbus Therapeutics###Moderator: – Nimbus Therapeutics
### 11:30 AM – 12:30 PM ET
Speaker Spotlight: Long Acting ImplantsSpotlight Speaker: – Merck & Co., Inc.
Moderator: – Organon
Manufacturing & Analytical Characterization
11:30 AM – 12:30 PM ET
Speaker Spotlight: Long Acting ImplantsLocation:Spotlight Stage 3, Exhibit Hall A&BSpotlight Speaker: – Merck & Co., Inc.
Moderator: – Organon
Manufacturing & Analytical Characterization
Stephanie Barrett, PhD – Merck & Co., Inc. ### 466169###Spotlight Speaker###Director, Sterile & Specialty Products###Merck & Co., Inc.###Spotlight Speaker: – Merck & Co., Inc.
### @@@ Maria Cruanes, PhD Chemistry (she/her/hers) – Organon ### 1680406###Moderator###Director Analytical Chemistry ###Organon###Moderator: – Organon
### she/her/hers11:30 AM – 12:30 PM ET
Special Poster Collection
11:30 AM – 12:30 PM ET
Special Poster CollectionLocation:Poster Forum #2, Exhibit Hall A&BPoster Collection Host: – Trinity College Dublin
Carsten Ehrhardt, Ph.D. – Trinity College Dublin ### 1536972###Poster Collection Host###Professor in Pharmaceutics and Biopharmaceutics###Trinity College Dublin###Poster Collection Host: – Trinity College Dublin
### 12:00 PM – 1:00 PM ET
Career in Pharma: Uncountable Roads, Several Bends and Steering RightCareer Center Speaker: – Takeda
Career Center Speaker: – M2 Consulting
Career Center Moderator: – Merck & Co., Inc.
Career Center Moderator: – St. John's University
Career Development
12:00 PM – 1:00 PM ET
Career in Pharma: Uncountable Roads, Several Bends and Steering RightLocation:360 Stage #3, Exhibit Hall A&BCareer Center Speaker: – Takeda
Career Center Speaker: – M2 Consulting
Career Center Moderator: – Merck & Co., Inc.
Career Center Moderator: – St. John's University
Career Development
Russ Weiner – Takeda ### 1650369###Career Center Speaker######Takeda###Career Center Speaker: – Takeda
### @@@ Marta Miles – M2 Consulting ### 1293430###Career Center Speaker###Principal###M2 Consulting###Career Center Speaker: – M2 Consulting
### @@@ Ashley Lay-Fortenbery, PhD – Merck & Co., Inc. ### 604157###Career Center Moderator###Associate Principal Scientist###Merck & Co., Inc.###Career Center Moderator: – Merck & Co., Inc.
### @@@ Vivek Gupta, PhD – St. John's University ### 604838###Career Center Moderator###Associate Professor, Pharmaceutical Sciences###St. John's University###Career Center Moderator: – St. John's University
### 12:00 PM – 1:30 PM ET
Phoenix Lunch and LearnPartner Presentation Speaker: – Certara
Partner Presentation Speaker: – Certara
12:00 PM – 1:30 PM ET
Phoenix Lunch and LearnLocation:360 Stage #1, Exhibit Hall A&BPartner Presentation Speaker: – Certara
Partner Presentation Speaker: – Certara
Michael Clifton – Certara ### 1795014###Partner Presentation Speaker###Product Owner###Certara###Partner Presentation Speaker: – Certara
### @@@ Christopher Mehl, M.S – Certara ### 606463###Partner Presentation Speaker###Phoenix Product Manager###Certara###Partner Presentation Speaker: – Certara
### 1:30 PM – 2:30 PM ET
Keynote: A Shared Goal to Support Drug Development Utilizing Clinical Biomarkers: Tales of a Public-Private Partnership (PPP) EnthusiastGovernment Speaker: – Foundation for the NIH
Moderator: – Pfizer
Clinical Pharmacology
1:30 PM – 2:30 PM ET
Keynote: A Shared Goal to Support Drug Development Utilizing Clinical Biomarkers: Tales of a Public-Private Partnership (PPP) EnthusiastLocation:151 ABGovernment Speaker: – Foundation for the NIH
Moderator: – Pfizer
Clinical Pharmacology
Joseph P. Menetski, PhD (he/him/his) – Foundation for the NIH ### 1595390###Government Speaker###Vice President###Foundation for the NIH###Government Speaker: – Foundation for the NIH
### he/him/his @@@ Mohamed Hassanein, PhD – Pfizer ### 1328461###Moderator###Associate Director###Pfizer###Moderator: – Pfizer
### 1:30 PM – 2:30 PM ET
Keynote: Advanced Spectroscopic and ML Approaches in Analytical CharacterizationKeynote Speaker:
Moderator: – Waters Corporation
Manufacturing & Analytical Characterization – Biomolecular
1:30 PM – 2:30 PM ET
Keynote: Advanced Spectroscopic and ML Approaches in Analytical CharacterizationLocation:205 CKeynote Speaker:
Moderator: – Waters Corporation
Manufacturing & Analytical Characterization – Biomolecular
Karl Booksh ### 1595394###Keynote Speaker#########Keynote Speaker:
### @@@ Isabelle Vu Trieu, MA, Chemistry; MS, Chemical Engineering – Waters Corporation ### 803450###Moderator###Market Development Manager###Waters Corporation###Moderator: – Waters Corporation
### 1:30 PM – 2:30 PM ET
Keynote: Bioanalytics Future State: Precise, Personal and Predictive
Bioanalytics – Chemical
1:30 PM – 2:30 PM ET
Keynote: Bioanalytics Future State: Precise, Personal and Predictive Location:253 ABioanalytics – Chemical
Kevin Bateman, PhD – Merck & Co., Inc. ### 580297###Keynote Speaker###Scientific Associate Vice President###Merck & Co., Inc.###Keynote Speaker: – Merck & Co., Inc.
### @@@ Amanda Hays, Ph.D. – BioAgilytix ### 1529523###Moderator###Scientific Officer###BioAgilytix###Moderator: – BioAgilytix
### 1:30 PM – 2:30 PM ET
Keynote: Cell Mediated Delivery of Therapeutics Keynote Speaker: – Harvard University
Moderator: – University of Illinois Chicago
Discovery and Basic Research
1:30 PM – 2:30 PM ET
Keynote: Cell Mediated Delivery of Therapeutics Location:254 BKeynote Speaker: – Harvard University
Moderator: – University of Illinois Chicago
Discovery and Basic Research
Samir Mitragotri, Professor – Harvard University ### 606428###Keynote Speaker######Harvard University###Keynote Speaker: – Harvard University
### @@@ Richard A. Gemeinhart, PhD (he/him/his) – University of Illinois Chicago ### 1378471###Moderator###Professor and Associate Vice Chancellor for Research###University of Illinois Chicago###Moderator: – University of Illinois Chicago
### he/him/his1:30 PM – 2:30 PM ET
Keynote: Continuous Manufacture of Active Pharmaceutical Ingredients: Current Status, Future ProspectsKeynote Speaker: – Massachusetts Institute of Technology
Moderator: – Merck & Co., Inc.
Manufacturing & Analytical Characterization
1:30 PM – 2:30 PM ET
Keynote: Continuous Manufacture of Active Pharmaceutical Ingredients: Current Status, Future ProspectsLocation:206 ABKeynote Speaker: – Massachusetts Institute of Technology
Moderator: – Merck & Co., Inc.
Manufacturing & Analytical Characterization
Allan S. Myerson, PhD – Massachusetts Institute of Technology ### 1595393###Keynote Speaker###Professor###Massachusetts Institute of Technology###Keynote Speaker: – Massachusetts Institute of Technology
### @@@ Robert F. Meyer, PhD – Merck & Co., Inc. ### 1666085###Moderator###Senior Principal Scientist###Merck & Co., Inc.###Moderator: – Merck & Co., Inc.
### 1:30 PM – 2:30 PM ET
Keynote: Drugging the Undruggable: Induced Proximity Medicines as the Next Wave of Drug DiscoveryKeynote Speaker: – Amgen
Moderator: – Pfizer
Discovery and Basic Research
1:30 PM – 2:30 PM ET
Keynote: Drugging the Undruggable: Induced Proximity Medicines as the Next Wave of Drug DiscoveryLocation:255Keynote Speaker: – Amgen
Moderator: – Pfizer
Discovery and Basic Research
Ryan Potts, PhD – Amgen ### 1090646###Keynote Speaker###Executive Director and Head of Induced Proximity Platform###Amgen###Keynote Speaker: – Amgen
### @@@ Adam M. Gilbert, PhD – Pfizer ### 1695211###Moderator###Executive Director###Pfizer###Moderator: – Pfizer
### 1:30 PM – 2:30 PM ET
Keynote: Evolving FDA Quality Assessment JourneyGovernment Speaker: – FDA
Moderator: – AbbVie
Preclinical Development – Chemical
1:30 PM – 2:30 PM ET
Keynote: Evolving FDA Quality Assessment JourneyLocation:253 CGovernment Speaker: – FDA
Moderator: – AbbVie
Preclinical Development – Chemical
Lawrence Yu – FDA ### 465959###Government Speaker###Office Director, Office of new Drug Products, OPQ, CDER###FDA###Government Speaker: – FDA
### @@@ Maya Lipert, PhD – AbbVie ### 1611945###Moderator###Principal Scientist I###AbbVie###Moderator: – AbbVie
### 1:30 PM – 2:30 PM ET
Keynote: Intra-Target Microdosing (ITM) - A Novel Drug Development Approach - Enabling Safe, Human-Specific, and Rapid Preclinical Candidate Selection and Translation of Novel Drug CompoundsKeynote Speaker: – Phase-0/Microdosing Network
Moderator: – Schrodinger, Inc. USA
Preclinical Development – Biomolecular
1:30 PM – 2:30 PM ET
Keynote: Intra-Target Microdosing (ITM) - A Novel Drug Development Approach - Enabling Safe, Human-Specific, and Rapid Preclinical Candidate Selection and Translation of Novel Drug CompoundsLocation:254 AKeynote Speaker: – Phase-0/Microdosing Network
Moderator: – Schrodinger, Inc. USA
Preclinical Development – Biomolecular
Tal Burt, MD – Phase-0/Microdosing Network ### 1595387###Keynote Speaker###President###Phase-0/Microdosing Network###Keynote Speaker: – Phase-0/Microdosing Network
### @@@ Naveen Thakral, PhD – Schrodinger, Inc. USA ### 1664123###Moderator###Director, Pharmaceutical Sciences###Schrodinger, Inc. USA###Moderator: – Schrodinger, Inc. USA
### 1:30 PM – 2:30 PM ET
Keynote: Opportunities and Challenges with Long Acting Injectable FormulationsKeynote Speaker: – GSK
Moderator: – Pfizer Worldwide Research and Development
Formulation and Delivery – Chemical
1:30 PM – 2:30 PM ET
Keynote: Opportunities and Challenges with Long Acting Injectable FormulationsLocation:205 ABKeynote Speaker: – GSK
Moderator: – Pfizer Worldwide Research and Development
Formulation and Delivery – Chemical
Manish Gupta, PhD – GSK ### 1044965###Keynote Speaker###Senior Director###GSK###Keynote Speaker: – GSK
### @@@ Jaymin C. Shah, PhD – Pfizer Worldwide Research and Development ### 1554431###Moderator###Research Fellow and Head of Topical and Advanced Drug Delivery###Pfizer Worldwide Research and Development###Moderator: – Pfizer Worldwide Research and Development
### 1:30 PM – 2:30 PM ET
Keynote: qPCR Application in Cell and Gene TherapiesModerator: – Janssen R&D / J&J
Keynote Speaker: – Janssen R&D/ Johnson & Johnson
Bioanalytics – Biomolecular
1:30 PM – 2:30 PM ET
Keynote: qPCR Application in Cell and Gene TherapiesLocation:253 BModerator: – Janssen R&D / J&J
Keynote Speaker: – Janssen R&D/ Johnson & Johnson
Bioanalytics – Biomolecular
William Hallet, PhD (he/him/his) – Janssen R&D / J&J ### 1723662###Moderator###Associate Scientific Director###Janssen R&D / J&J###Moderator: – Janssen R&D / J&J
### he/him/his @@@ Kate B. Herr, M.S. – Janssen R&D/ Johnson & Johnson ### 1730310###Keynote Speaker###Scientist###Janssen R&D/ Johnson & Johnson###Keynote Speaker: – Janssen R&D/ Johnson & Johnson
### 1:30 PM – 8:00 PM ET
Exhibitor Move-Out
1:30 PM – 8:00 PM ET
Exhibitor Move-Out
Location:Exhibit Hall A&B
3:00 PM – 3:45 PM ET
Rapid Fire: A Look Into the Future of Bioanalytics (CE)Rapid Fire Moderator: – Merck
Bioanalytics – Chemical
3:00 PM – 3:45 PM ET
Rapid Fire: A Look Into the Future of Bioanalytics (CE)Location:253 ARapid Fire Moderator: – Merck
Bioanalytics – Chemical
Tuo Meng, PhD – Merck ### 1690276###Rapid Fire Moderator###Senior scientist###Merck###Rapid Fire Moderator: – Merck
### 3:00 PM – 3:15 PM ET
The Mass Spec Topics That are New/Different From the Previous Guidelines (Facts/Comparison—No Opinions)Location:253 ARapid Fire Speaker: – Eli Lilly and Company
Bioanalytics – Chemical
Enaksha Wickremsinhe, PhD – Eli Lilly and Company ### 627103###Rapid Fire Speaker###Senior Director###Eli Lilly and Company###Rapid Fire Speaker: – Eli Lilly and Company
### 3:15 PM – 3:30 PM ET
Patient Centric Sampling Implementation in Paxloid Clinical DevelopmentLocation:253 ARapid Fire Speaker: – Clinical Pharmacology, Global Product Development, Pfizer Inc
Bioanalytics – Chemical
Olga Kavetska, PhD – Clinical Pharmacology, Global Product Development, Pfizer Inc ### 1371088###Rapid Fire Speaker###Executive Director, Global Clinical Bioanalytics Head###Clinical Pharmacology, Global Product Development, Pfizer Inc###Rapid Fire Speaker: – Clinical Pharmacology, Global Product Development, Pfizer Inc
### 3:30 PM – 3:45 PM ET
Bioanalytical Opportunities and Considerations for Patient Centric SamplingLocation:253 ARapid Fire Speaker: – BioData Solutions LLC
Bioanalytics – Chemical
Katelyn Crizer, PhD – BioData Solutions LLC ### 1767729###Rapid Fire Speaker###Senior Consultant###BioData Solutions LLC###Rapid Fire Speaker: – BioData Solutions LLC
### 3:00 PM – 3:45 PM ET
Rapid Fire: Advances in Engineering Technologies For Drug Substance and Enabling Drug Product (BM)
3:45 PM – 4:00 PM ET
Patient-Centric Implants and Scaffolds: An Imminent Paradigm Shift with Additive-ManufacturingLocation:205 CRapid Fire Speaker: – Auburn University
Formulation and Delivery – Biomolecular
ISHWOR POUDEL, M.S. – Auburn University ### 847460###Rapid Fire Speaker###Graduate Student###Auburn University###Rapid Fire Speaker: – Auburn University
### 3:00 PM – 3:45 PM ET
Rapid Fire: Translational Biomarkers: From Bench to Bedside (CE)Rapid Fire Moderator: – Agios Pharmaceuticals
Clinical Pharmacology – Chemical
3:00 PM – 3:45 PM ET
Rapid Fire: Translational Biomarkers: From Bench to Bedside (CE)Location:151 ABRapid Fire Moderator: – Agios Pharmaceuticals
Clinical Pharmacology – Chemical
Punit Marathe, PhD – Agios Pharmaceuticals ### 1010799###Rapid Fire Moderator###Vice President DMPK-TOX###Agios Pharmaceuticals###Rapid Fire Moderator: – Agios Pharmaceuticals
### 3:00 PM – 3:15 PM ET
Tape Stripping: A Non-Invasive Method for the Study of Stratum Corneum BiomarkersLocation:151 ABRapid Fire Speaker: – Pfizer
Clinical Pharmacology – Chemical
Carolina Owen, PhD – Pfizer ### 1762951###Rapid Fire Speaker###Senior Principal Scientist###Pfizer###Rapid Fire Speaker: – Pfizer
### 3:15 PM – 3:30 PM ET
Diagnostic Approaches for Patient Enrollment in Rare Disease Clinical TrialsLocation:151 ABRapid Fire Speaker: – Passage Bio
Clinical Pharmacology – Chemical
Yan G. Ni, PhD – Passage Bio ### 803355###Rapid Fire Speaker###Executive Director###Passage Bio###Rapid Fire Speaker: – Passage Bio
### 3:30 PM – 3:45 PM ET
Evaluation of Phosphorylated Neurofilament Heavy Chain (pNF-H) as a Biomarker to Bridge Riluzole Treatment and Motor Outcomes in Patients with Acute Spinal Cord Injury (SCI)Location:151 ABRapid Fire Speaker: – College of Pharmacy, University of Houston
Clinical Pharmacology – Chemical
Junghwa Park, Pharm.D. – College of Pharmacy, University of Houston ### 1690581###Rapid Fire Speaker###Ph.D. student in Pharmaceutics###College of Pharmacy, University of Houston###Rapid Fire Speaker: – College of Pharmacy, University of Houston
### 3:00 PM – 4:00 PM ET
Hot Topic: Classification Systems in Formulation Development StrategiesHot Topic Moderator: – Quotient Sciences, UK
Hot Topic Moderator: – University of Maryland School of Pharmacy
Formulation and Delivery – Chemical
3:00 PM – 4:00 PM ET
Hot Topic: Classification Systems in Formulation Development StrategiesLocation:153 BCHot Topic Moderator: – Quotient Sciences, UK
Hot Topic Moderator: – University of Maryland School of Pharmacy
Formulation and Delivery – Chemical
Shriram M. Pathak, PhD – Quotient Sciences, UK ### 847359###Hot Topic Moderator###Senior Research Fellow, Drug Development Consulting###Quotient Sciences, UK###Hot Topic Moderator: – Quotient Sciences, UK
### @@@ James E. Polli, Ph.D., FAAPS – University of Maryland School of Pharmacy ### 605881###Hot Topic Moderator###Professor###University of Maryland School of Pharmacy###Hot Topic Moderator: – University of Maryland School of Pharmacy
### 3:00 PM – 3:20 PM ET
Biopharmaceutics Classification System (BCS) History and Future PerspectivesLocation:153 BCHot Topic Speaker: – Pfizer Inc.
Formulation and Delivery – Chemical
Jack Cook, PhD – Pfizer Inc. ### 845566###Hot Topic Speaker###Clinical Pharmacology###Pfizer Inc.###Hot Topic Speaker: – Pfizer Inc.
### 3:20 PM – 3:40 PM ET
Developability Classification System (DCS)-A Paradigm Shift in Formulation Development StrategiesLocation:153 BCHot Topic Speaker: – GlaxoSmithKline (GSK)
Formulation and Delivery – Chemical
James M. Butler, Dr. – GlaxoSmithKline (GSK) ### 605566###Hot Topic Speaker###Senior Fellow###GlaxoSmithKline (GSK)###Hot Topic Speaker: – GlaxoSmithKline (GSK)
### 3:40 PM – 4:00 PM ET
Panel DiscussionLocation:153 BCHot Topic Moderator: – Quotient Sciences, UK
Hot Topic Moderator: – University of Maryland School of Pharmacy
Hot Topic Speaker: – Pfizer Inc.
Formulation and Delivery – Chemical
Shriram M. Pathak, PhD – Quotient Sciences, UK ### 847359###Hot Topic Moderator###Senior Research Fellow, Drug Development Consulting###Quotient Sciences, UK###Hot Topic Moderator: – Quotient Sciences, UK
### @@@ James E. Polli, Ph.D., FAAPS – University of Maryland School of Pharmacy ### 605881###Hot Topic Moderator###Professor###University of Maryland School of Pharmacy###Hot Topic Moderator: – University of Maryland School of Pharmacy
### @@@ Jack Cook, PhD – Pfizer Inc. ### 845566###Hot Topic Speaker###Clinical Pharmacology###Pfizer Inc.###Hot Topic Speaker: – Pfizer Inc.
### 3:00 PM – 4:00 PM ET
Hot Topic: Fit-For-PurposeHot Topic Moderator: – Merck & Co. Inc.
Bioanalytics – Chemical
3:00 PM – 4:00 PM ET
Hot Topic: Fit-For-PurposeLocation:153 AHot Topic Moderator: – Merck & Co. Inc.
Bioanalytics – Chemical
Faye Vazvaei, M.S. – Merck & Co. Inc. ### 1529547###Hot Topic Moderator###Executive Director###Merck & Co. Inc.###Hot Topic Moderator: – Merck & Co. Inc.
### 3:00 PM – 3:10 PM ET
Fit-For-Purpose Metabolite Bioanalysis—A IQ Metabolite Bioanalysis Working Group Biotransformation PerspectiveLocation:153 AHot Topic Speaker: – Merck
Bioanalytics – Chemical
Yuexia Liang – Merck ### 1749183###Hot Topic Speaker###Principal Scientist ###Merck###Hot Topic Speaker: – Merck
### 3:10 PM – 3:20 PM ET
Fit-For-Purpose IQ Metabolite BioanalysisLocation:153 AHot Topic Speaker: – Merck & Co., Inc.
Bioanalytics – Chemical
Ryan Vargo, Ph.D – Merck & Co., Inc. ### 1651141###Hot Topic Speaker###Sr. Director###Merck & Co., Inc.###Hot Topic Speaker: – Merck & Co., Inc.
### 3:20 PM – 3:30 PM ET
Fit-For-Purpose Metabolite Bioanalysis—A IQ Metabolite Bioanalysis Working Group PerspectiveLocation:153 AHot Topic Speaker: – Novartis
Bioanalytics – Chemical
Wenkui Li, Ph.D – Novartis ### 602507###Hot Topic Speaker###Director###Novartis###Hot Topic Speaker: – Novartis
### 3:30 PM – 4:00 PM ET
Panel DiscussionLocation:153 AHot Topic Moderator: – Merck & Co. Inc.
Government Speaker: – FDA
Government Speaker: – Food and Drug Administration
Bioanalytics – Chemical
Faye Vazvaei, M.S. – Merck & Co. Inc. ### 1529547###Hot Topic Moderator###Executive Director###Merck & Co. Inc.###Hot Topic Moderator: – Merck & Co. Inc.
### @@@ Brian Booth, PhD – FDA ### 576429###Government Speaker###Director, DCP I###FDA###Government Speaker: – FDA
### @@@ Xinning Yang, PhD – Food and Drug Administration ### 796147###Government Speaker###Policy Lead###Food and Drug Administration###Government Speaker: – Food and Drug Administration
### 3:00 PM – 4:00 PM ET
Rapid Fire: A Look Into the Future of Bioanalytics (BM)Bioanalytics – Biomolecular
3:00 PM – 4:00 PM ET
Rapid Fire: A Look Into the Future of Bioanalytics (BM)Location:253 BBioanalytics – Biomolecular
Ran Ye ### 1776779###Rapid Fire Moderator#########Rapid Fire Moderator:
### 3:00 PM – 3:15 PM ET
Regulated qPCR Validation and qPCR/ddPCR Cross-ValidationLocation:253 BRapid Fire Speaker: – Frontage Laboratories
Bioanalytics – Biomolecular
Ryan C. Haley, PhD – Frontage Laboratories ### 1690566###Rapid Fire Speaker###Senior Scientist I###Frontage Laboratories###Rapid Fire Speaker: – Frontage Laboratories
### 3:15 PM – 3:30 PM ET
Impact of Anti-Drug Antibody (ADA) Binding Properties on Assay PerformanceLocation:253 BRapid Fire Speaker: – Genentech
Bioanalytics – Biomolecular
Jennifer A. Getz, PhD – Genentech ### 1755681###Rapid Fire Speaker###Senior Scientist###Genentech###Rapid Fire Speaker: – Genentech
### 3:30 PM – 3:45 PM ET
Challenges in the Method Development and Sample Analysis for the Determination of Nucleoside Phosphates in Peripheral Blood Mononuclear Cells (PBMCs) and Tissue Samples in Support of Molnupiravir ProgramLocation:253 BRapid Fire Speaker: – Merck & Co., Inc.
Bioanalytics – Biomolecular
Cynthia M. Chavez-Eng, PhD – Merck & Co., Inc. ### 1042540###Rapid Fire Speaker###Senior Principal Scientist###Merck & Co., Inc.###Rapid Fire Speaker: – Merck & Co., Inc.
### 3:45 PM – 4:00 PM ET
Comparison of ICHM10 to previous BMV guidelines/LBALocation:253 BRapid Fire Speaker: – Biotech
Bioanalytics – Biomolecular
Mark Ma, MD (he/him/his) – Biotech ### 1792079###Rapid Fire Speaker###VP, Head of Translational Clinical Sciences###Biotech###Rapid Fire Speaker: – Biotech
### he/him/his3:00 PM – 4:00 PM ET
Rapid Fire: Cells as Carriers of Therapy: From Factories to HitchhikingDiscovery and Basic Research
3:00 PM – 4:00 PM ET
Rapid Fire: Cells as Carriers of Therapy: From Factories to HitchhikingLocation:254 BDiscovery and Basic Research
3:00 PM – 3:15 PM ET
Engineering Extracellular Vesicles derived from M2 macrophage for Atherosclerosis treatmentLocation:254 BRapid Fire Speaker: – n/a
Discovery and Basic Research
Guanghao Wu – n/a ### 1755666###Rapid Fire Speaker###teacher###n/a###Rapid Fire Speaker: – n/a
### 3:15 PM – 3:30 PM ET
Nano-Transfection for On Demand Cellular Packaging of Extracellular VesiclesLocation:254 BRapid Fire Speaker: – University of Florida
Discovery and Basic Research
Nina Erwin – University of Florida ### 1755669###Rapid Fire Speaker###Graduate Student###University of Florida###Rapid Fire Speaker: – University of Florida
### 3:30 PM – 3:45 PM ET
The Cationic Antimicrobial Peptide, D-LAK-120A, as a Potential Anti-cancer Therapeutic for Non-Small Cell Lung Cancer (NSCLC)Location:254 BRapid Fire Speaker: – St. John's University
Discovery and Basic Research
Suyash M. Patil – St. John's University ### 1755691###Rapid Fire Speaker###Doctoral Candidate###St. John's University###Rapid Fire Speaker: – St. John's University
### 3:45 PM – 4:00 PM ET
DNA-Based cGAS Agonists as a Novel Approach to cGAS-STING Activation for Cancer ImmunotherapyLocation:254 BRapid Fire Speaker: – Virginia Commonwealth University
Discovery and Basic Research
Shurong Zhou, MS (she/her/hers) – Virginia Commonwealth University ### 1377964###Rapid Fire Speaker###PhD Student###Virginia Commonwealth University###Rapid Fire Speaker: – Virginia Commonwealth University
### she/her/hers3:00 PM – 4:00 PM ET
Rapid Fire: Cross-Modality and Modality Agnostic Approaches to Development and Manufacturing (BM)Rapid Fire Moderator: – Merck
Manufacturing & Analytical Characterization – Biomolecular
3:00 PM – 4:00 PM ET
Rapid Fire: Cross-Modality and Modality Agnostic Approaches to Development and Manufacturing (BM)Location:205 CRapid Fire Moderator: – Merck
Manufacturing & Analytical Characterization – Biomolecular
Kaizhu Guo, PhD – Merck ### 1755923###Rapid Fire Moderator###Senior Scientist###Merck###Rapid Fire Moderator: – Merck
### 3:00 PM – 3:15 PM ET
Pharmaceutical Open Innovation Test Bed for GMP Manufacturing of NanopharmaceuticalsLocation:205 CRapid Fire Speaker: – MyBiotech GmbH
Manufacturing & Analytical Characterization – Biomolecular
Nazende Guenday-Tuereli, PhD – MyBiotech GmbH ### 1044791###Rapid Fire Speaker###Chief Technology and Innovation Officer###MyBiotech GmbH###Rapid Fire Speaker: – MyBiotech GmbH
### 3:15 PM – 3:30 PM ET
Latest Advances in USP’s Compendial Efforts on Novel Excipients DevelopmentLocation:205 CRapid Fire Speaker: – United States Pharmacopeial Convention (USP)
Manufacturing & Analytical Characterization – Biomolecular
Tong (Jenny) Liu, PhD – United States Pharmacopeial Convention (USP) ### 1755687###Rapid Fire Speaker###Principal Scientist###United States Pharmacopeial Convention (USP)###Rapid Fire Speaker: – United States Pharmacopeial Convention (USP)
### 3:30 PM – 3:45 PM ET
When Resolution Matters: Column Temperature Control and Peptide PurificationLocation:205 CRapid Fire Speaker: – Shimadzu Scientific Instruments, Inc.
Manufacturing & Analytical Characterization – Biomolecular
Brian Domanski – Shimadzu Scientific Instruments, Inc. ### 857137###Rapid Fire Speaker###Strategic Collaborations Scientist - Pharmaceuticals###Shimadzu Scientific Instruments, Inc.###Rapid Fire Speaker: – Shimadzu Scientific Instruments, Inc.
### 3:00 PM – 4:00 PM ET
Rapid Fire: Cross-Modality and Modality Agnostic Approaches to Development and Manufacturing (CE)Rapid Fire Moderator: – Merck Co & Inc
Manufacturing & Analytical Characterization – Chemical
3:00 PM – 4:00 PM ET
Rapid Fire: Cross-Modality and Modality Agnostic Approaches to Development and Manufacturing (CE)Location:206 ABRapid Fire Moderator: – Merck Co & Inc
Manufacturing & Analytical Characterization – Chemical
Xiaolong Zhu, PhD – Merck Co & Inc ### 1755684###Rapid Fire Moderator###Senior Scientist###Merck Co & Inc###Rapid Fire Moderator: – Merck Co & Inc
### 3:00 PM – 3:15 PM ET
Factors Affecting the Ethylene-Vinyl Acetate Copolymer Crystallinity in Islatravir ImplantsLocation:206 ABRapid Fire Speaker: – Merck Co & Inc
Manufacturing & Analytical Characterization – Chemical
Xiaolong Zhu, PhD – Merck Co & Inc ### 1755684###Rapid Fire Speaker###Senior Scientist###Merck Co & Inc###Rapid Fire Speaker: – Merck Co & Inc
### 3:15 PM – 3:30 PM ET
Pharmaceutical Experiments for MicrogravityLocation:206 ABRapid Fire Speaker: – Improved Pharma
Manufacturing & Analytical Characterization – Chemical
Stephan D. Parent, Consultant – Improved Pharma ### 1755683###Rapid Fire Speaker###Consultant###Improved Pharma###Rapid Fire Speaker: – Improved Pharma
### 3:30 PM – 3:45 PM ET
Use of Predictive Dissolution to Guide Oral Formulation DevelopmentLocation:206 ABRapid Fire Speaker: – Merck & Co., Inc.
Manufacturing & Analytical Characterization – Chemical
Zhao Liu, PhD – Merck & Co., Inc. ### 1689758###Rapid Fire Speaker###Assoc. Principal Scientist###Merck & Co., Inc.###Rapid Fire Speaker: – Merck & Co., Inc.
### 3:45 PM – 4:00 PM ET
ID Testing Through Transparent and Opaque Containers Using Handheld SORSLocation:206 ABRapid Fire Speaker: – Agilent Technologies, Inc.
Manufacturing & Analytical Characterization – Chemical
Yanqia (Cha) Wang, PhD – Agilent Technologies, Inc. ### 1767300###Rapid Fire Speaker###Application Scientist###Agilent Technologies, Inc.###Rapid Fire Speaker: – Agilent Technologies, Inc.
### 3:00 PM – 4:00 PM ET
Rapid Fire: Evolution in Patient-Centric Drug Formulation and Delivery (BM)Rapid Fire Moderator: – Merck & Co., Inc.
Formulation and Delivery – Biomolecular
3:00 PM – 4:00 PM ET
Rapid Fire: Evolution in Patient-Centric Drug Formulation and Delivery (BM)Location:204 ABRapid Fire Moderator: – Merck & Co., Inc.
Formulation and Delivery – Biomolecular
Xin Oliver Tong, PhD – Merck & Co., Inc. ### 1765979###Rapid Fire Moderator###Senior Scientist###Merck & Co., Inc.###Rapid Fire Moderator: – Merck & Co., Inc.
### 3:00 PM – 3:15 PM ET
Extending the Duration of Action of Antibodies in the EyeLocation:204 ABRapid Fire Speaker: – University College London
Formulation and Delivery – Biomolecular
Nkiruka A. Ibeanu – University College London ### 1755675###Rapid Fire Speaker###PhD Research Student###University College London###Rapid Fire Speaker: – University College London
### 3:15 PM – 3:30 PM ET
Simple Extended Release Injectable FormulationLocation:204 ABRapid Fire Speaker: – Eastman Chemical
Formulation and Delivery – Biomolecular
Walter Thompson, PhD – Eastman Chemical ### 1755677###Rapid Fire Speaker###ADTS Lead###Eastman Chemical###Rapid Fire Speaker: – Eastman Chemical
### 3:30 PM – 3:45 PM ET
RESOMERO Polymers for Long-Acting Injectable FormulationsLocation:204 ABRapid Fire Speaker: – Evonik Inc.
Formulation and Delivery – Biomolecular
Manish Rane, PhD – Evonik Inc. ### 1690792###Rapid Fire Speaker###Associate Director###Evonik Inc.###Rapid Fire Speaker: – Evonik Inc.
### 3:45 PM – 4:00 PM ET
Reinventing Cyclodextrins as Novel Excipients for Inhaled FormulationsLocation:204 ABRapid Fire Speaker: – St. John's University
Formulation and Delivery – Biomolecular
Vivek Gupta, PhD – St. John's University ### 604838###Rapid Fire Speaker###Associate Professor, Pharmaceutical Sciences###St. John's University###Rapid Fire Speaker: – St. John's University
### 3:00 PM – 4:00 PM ET
Rapid Fire: Evolution in Patient-Centric Drug Formulation and Delivery (CE)Rapid Fire Moderator: – Merck & Co., Inc.
Formulation and Delivery – Chemical
3:00 PM – 4:00 PM ET
Rapid Fire: Evolution in Patient-Centric Drug Formulation and Delivery (CE)Location:205 ABRapid Fire Moderator: – Merck & Co., Inc.
Formulation and Delivery – Chemical
Ashish Punia, PhD – Merck & Co., Inc. ### 1378020###Rapid Fire Moderator###Associate Principal Scientist###Merck & Co., Inc.###Rapid Fire Moderator: – Merck & Co., Inc.
### 3:00 PM – 3:15 PM ET
Improving the Bioavailability of Weak Bases with Enhanced Conventional FormulationsLocation:205 ABRapid Fire Speaker: – Merck & Co., Inc.
Formulation and Delivery – Chemical
Jiaying Liu, PhD – Merck & Co., Inc. ### 1689756###Rapid Fire Speaker###Senior Scientist###Merck & Co., Inc.###Rapid Fire Speaker: – Merck & Co., Inc.
### 3:15 PM – 3:30 PM ET
It’s Never Too Early to Put the Patient FirstLocation:204 ABRapid Fire Speaker: – Seda Pharmaceutical Development Services
Formulation and Delivery – Biomolecular
Claire M. Patterson, MPharm (Hons) PhD – Seda Pharmaceutical Development Services ### 1378052###Rapid Fire Speaker###Senior Principal Scientist###Seda Pharmaceutical Development Services###Rapid Fire Speaker: – Seda Pharmaceutical Development Services
### 3:30 PM – 3:45 PM ET
NanoLipoSome (NLS)-Technology for Oral Delivery of Peptides, Proteins, PROTAC´sLocation:205 ABRapid Fire Speaker: – Losan Pharma GmbH
Formulation and Delivery – Chemical
Matthias Rischer, PhD – Losan Pharma GmbH ### 1446848###Rapid Fire Speaker###Director Drug Delivery & Innovation Projects###Losan Pharma GmbH###Rapid Fire Speaker: – Losan Pharma GmbH
### 3:45 PM – 4:00 PM ET
Patient Centric Sustained Subcutaneous Thermo-Responsive Gels for Small MoleculesLocation:205 ABRapid Fire Speaker: – AstraZeneca Pharmaceuticals
Formulation and Delivery – Chemical
Wenzhan Yang, PhD – AstraZeneca Pharmaceuticals ### 1755694###Rapid Fire Speaker###Associate Principal Scientist###AstraZeneca Pharmaceuticals###Rapid Fire Speaker: – AstraZeneca Pharmaceuticals
### 3:00 PM – 4:00 PM ET
Rapid Fire: Overcoming Pitfalls in Moving Compounds From Preclinical Development to the Clinic: Examples From Bench to Bedside (BM)Rapid Fire Moderator: – Merck & Co., Inc.
Preclinical Development – Biomolecular
3:00 PM – 4:00 PM ET
Rapid Fire: Overcoming Pitfalls in Moving Compounds From Preclinical Development to the Clinic: Examples From Bench to Bedside (BM)Location:254 ARapid Fire Moderator: – Merck & Co., Inc.
Preclinical Development – Biomolecular
Suman A. Luthra, PhD – Merck & Co., Inc. ### 1689830###Rapid Fire Moderator###Director###Merck & Co., Inc.###Rapid Fire Moderator: – Merck & Co., Inc.
### 3:00 PM – 3:15 PM ET
Translation of Half-Life Extended Antibody Pharmacokinetics: Utility of hFcRn Tg Mouse ModelsLocation:254 ARapid Fire Speaker: – Novartis Institutes for Biomedical Research
Preclinical Development – Biomolecular
Ryan Polli, PhD – Novartis Institutes for Biomedical Research ### 1777897###Rapid Fire Speaker###Principal Scientist II - Pharmacokinetic Sciences###Novartis Institutes for Biomedical Research###Rapid Fire Speaker: – Novartis Institutes for Biomedical Research
### 3:15 PM – 3:30 PM ET
Evaluation of Topical Microbicides for Their Ability to Induce Proinflammatory Cytokines TNF-a, IL-1b, IL-6 and IL-8 in Peripheral Blood Mononuclear Cells and MacrophagesLocation:254 ARapid Fire Speaker: – University of Charleston School of Pharmacy
Preclinical Development – Biomolecular
Aladin Siddig, Ph.D. – University of Charleston School of Pharmacy ### 623860###Rapid Fire Speaker###Associate Professor###University of Charleston School of Pharmacy###Rapid Fire Speaker: – University of Charleston School of Pharmacy
### 3:30 PM – 3:45 PM ET
Natural Killer Cell-Derived EVs for Immune Therapy in Lung CancerLocation:254 ARapid Fire Speaker: – Florida A&M University
Preclinical Development – Biomolecular
Aakash Nathani, MS (he/him/his) – Florida A&M University ### 1755703###Rapid Fire Speaker###PhD Student###Florida A&M University###Rapid Fire Speaker: – Florida A&M University
### he/him/his3:45 PM – 4:00 PM ET
DMPK Strategy for Viral and Non-Viral Gene Therapies Location:254 ARapid Fire Speaker: – Takeda
Preclinical Development – Biomolecular
Nagendra V. Chemuturi, GDMPK – Takeda ### 1010805###Rapid Fire Speaker###Scientific Director Research###Takeda###Rapid Fire Speaker: – Takeda
### 3:00 PM – 4:00 PM ET
Rapid Fire: Overcoming Pitfalls in Moving Compounds From Preclinical Development to the Clinic: Examples From Bench to Bedside (CE)Rapid Fire Moderator: – AbbVie
Preclinical Development – Chemical
3:00 PM – 4:00 PM ET
Rapid Fire: Overcoming Pitfalls in Moving Compounds From Preclinical Development to the Clinic: Examples From Bench to Bedside (CE)Location:253 CRapid Fire Moderator: – AbbVie
Preclinical Development – Chemical
Daniel Bow, PhD – AbbVie ### 575910###Rapid Fire Moderator###Senior Principal Research Scientist###AbbVie###Rapid Fire Moderator: – AbbVie
### 3:00 PM – 3:15 PM ET
The Amazing Race of Upadacitinib from Molecule, Crystal to MedicineLocation:253 CRapid Fire Speaker: – AbbVie
Preclinical Development – Chemical
Alessandra Mattei, PhD – AbbVie ### 1755678###Rapid Fire Speaker###Principal Research Scientist###AbbVie###Rapid Fire Speaker: – AbbVie
### 3:15 PM – 3:30 PM ET
Amphiphilic API: Liability or Design Tool?Location:253 CRapid Fire Speaker: – Pfizer
Preclinical Development – Chemical
Ellen M. Knapp, PhD (she/her/hers) – Pfizer ### 1755689###Rapid Fire Speaker###Senior Scientist###Pfizer###Rapid Fire Speaker: – Pfizer
### she/her/hers3:30 PM – 3:45 PM ET
Physiological Based Biopharmaceutics Modeling (PBBM) for pH-dependent DDI Risk Identification and Formulation Selection for a Weak Base CompoundLocation:253 CRapid Fire Speaker: – Merck&Co., Inc.
Preclinical Development – Chemical
Di Wu, PhD – Merck&Co., Inc. ### 1778819###Rapid Fire Speaker###Sr Scientist###Merck&Co., Inc.###Rapid Fire Speaker: – Merck&Co., Inc.
### 3:45 PM – 4:00 PM ET
Rapid Preclinical Assessment for Extended Release Drug Delivery ViabilityLocation:253 CRapid Fire Speaker: – FreeThink Technologies, Inc.
Preclinical Development – Chemical
Jennifer Chu, PhD – FreeThink Technologies, Inc. ### 1755676###Rapid Fire Speaker###Technology Development Lead###FreeThink Technologies, Inc.###Rapid Fire Speaker: – FreeThink Technologies, Inc.
### 3:00 PM – 4:00 PM ET
Rapid Fire: Targeted Drug Discovery and Molecular PharmacologyRapid Fire Moderator: – Labcorp Drug Development
Discovery and Basic Research
3:00 PM – 4:00 PM ET
Rapid Fire: Targeted Drug Discovery and Molecular PharmacologyLocation:255Rapid Fire Moderator: – Labcorp Drug Development
Discovery and Basic Research
Mark E. Arnold, PhD, FAAPS – Labcorp Drug Development ### 1311049###Rapid Fire Moderator###Director of Science###Labcorp Drug Development###Rapid Fire Moderator: – Labcorp Drug Development
### 3:00 PM – 3:15 PM ET
Exosome-Based Allele-Specific Genome Editing for Hearing Loss DiseasesLocation:255Rapid Fire Speaker: – University of Florida College of Pharmacy
Discovery and Basic Research
Xiaoshu Pan, PhD – University of Florida College of Pharmacy ### 1328564###Rapid Fire Speaker###Postdoctoral Associate###University of Florida College of Pharmacy###Rapid Fire Speaker: – University of Florida College of Pharmacy
### 3:15 PM – 3:30 PM ET
Curcumin Analogs-Induced Epigenetic Changes in Tumor CellsLocation:255Rapid Fire Speaker: – University of Charleston
Discovery and Basic Research
Tamer E. Fandy, PhD, BCGP, FCP – University of Charleston ### 1378497###Rapid Fire Speaker###Professor & Chair, Department of Pharmaceutical & Adminstrative Sciences###University of Charleston###Rapid Fire Speaker: – University of Charleston
### 3:30 PM – 3:45 PM ET
Endogenous Blood-Brain Barrier Transporters are Critical Determinants of Neuroprotective Drug Efficacy in Ischemic StrokeLocation:255Rapid Fire Speaker: – University of Arizona College of Medicine
Discovery and Basic Research
Patrick T. Ronaldson, PhD – University of Arizona College of Medicine ### 653543###Rapid Fire Speaker###Professor###University of Arizona College of Medicine###Rapid Fire Speaker: – University of Arizona College of Medicine
### 3:45 PM – 4:00 PM ET
An End-to-End Method for AI-Driven Peptide Vaccine Formulation and Translation through Deep Learned Exosome Precision Drug DeliveryLocation:255Rapid Fire Speaker: – University of Florida
Discovery and Basic Research
Zachary Greenberg, MS – University of Florida ### 1328730###Rapid Fire Speaker###Doctoral Student###University of Florida###Rapid Fire Speaker: – University of Florida
### 3:00 PM – 4:00 PM ET
Rapid Fire: Translational Biomarkers: From Bench to BedsideRapid Fire Moderator: – Johnson and Johnson
Clinical Pharmacology
3:00 PM – 4:00 PM ET
Rapid Fire: Translational Biomarkers: From Bench to BedsideLocation:152Rapid Fire Moderator: – Johnson and Johnson
Clinical Pharmacology
Hardik Mody, PhD – Johnson and Johnson ### 1010836###Rapid Fire Moderator###Principal Scientist###Johnson and Johnson###Rapid Fire Moderator: – Johnson and Johnson
### 3:00 PM – 3:15 PM ET
Translational PKPD Biomarker Analysis: KRASG12C Inhibitor GDC-6036 in Lung CancerLocation:152Rapid Fire Speaker: – Genentech
Clinical Pharmacology
Sandhya Mandlekar, PhD – Genentech ### 1042534###Rapid Fire Speaker###Distinguished Scientist###Genentech###Rapid Fire Speaker: – Genentech
### 3:15 PM – 3:30 PM ET
Translating Neutrophil Serine Protease Biomarkers from Preclinical to Clinical StudiesLocation:152Rapid Fire Speaker: – Insmed
Clinical Pharmacology
Jessica Basso – Insmed ### 1777054###Rapid Fire Speaker###Associate Scientist###Insmed###Rapid Fire Speaker: – Insmed
### 3:30 PM – 3:45 PM ET
A Quantitative Systems Toxicity Workflow to Model Adverse Outcome Pathways’ BiomarkersLocation:152Rapid Fire Speaker: – Certara UK
Clinical Pharmacology
Sebastian Polak, PhD – Certara UK ### 602670###Rapid Fire Speaker###Senior Scientific Advisor###Certara UK###Rapid Fire Speaker: – Certara UK
### 3:45 PM – 4:00 PM ET
Miscomprehensions on Quantitative Liquid Biopsy as Biomarkers of Hepatic ADMET ProteinsLocation:152Rapid Fire Speaker: – Certara / University of Manchester
Clinical Pharmacology
Amin Rostami-Hodjegan, PharmD, PhD – Certara / University of Manchester ### 465985###Rapid Fire Speaker###Director of CAPKR and Chief Scientific Officer###Certara / University of Manchester ###Rapid Fire Speaker: – Certara / University of Manchester
### 4:15 PM – 5:30 PM ET
Closing Plenary with Dr. Udit BatraPlenary Speaker: – Waters Corporation
4:15 PM – 5:30 PM ET
Closing Plenary with Dr. Udit BatraLocation:Grand Ballroom, Boston Convention and Exhibition CenterPlenary Speaker: – Waters Corporation
Udit Batra, Ph.D. – Waters Corporation ### 1655136###Plenary Speaker###President and Chief Executive Officer###Waters Corporation###Plenary Speaker: – Waters Corporation
### 5:30 PM – 6:30 PM ET
Closing Reception
5:30 PM – 6:30 PM ET
Closing ReceptionLocation:Grand Ballroom Foyer, Boston Convention and Exhibition Center
- Thursday, October 20, 2022
8:00 AM – 12:00 PM ET
Exhibitor Move-Out
8:00 AM – 12:00 PM ET
Exhibitor Move-Out
Location:Exhibit Hall A&B